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CHOLEDOCODUOENOSTOMYOR
HEPATICOJEJUNOSTOMY IN CHOLEDOCOLITHIASIS:A
RANDOMIZEDCONTROLLED TRIAL.
G ZEITOUN and A. FINGERHUT, F. LACAINE, D. BRISSET, P.L. FAGNIEZ,
J.M. HAY
When biliary enteric anastomosis is indicated for choledocholithiasis,
the surgeon has the choice between choledocoduodenostomy (CD), which
carries a risk of cholangitis by reflux of duodenal contents, and
hepaticojejunostomy (HJ), which is more time consuming and precludes
further endoscopic exploration. As of yet, one technique has not been
shown to be superior to the other in controlled trials. Between January
1978 and November 1990, 130 patients (31 males and 99 females), 61 +
15 (m _+ sd) years old were enrolled in this randomized study. CD was
performed in 64 patients, while HJ was performed in 66 (side-to-side in 25
cases and end-to-side in 41). The major end point was the occurrence of
cholangitis within the 3 years following the operation as defined as
biological cholestasis associated or not with fever or pain. Other criteria
were postoperative mortality, morbidity, and reoperations on the main bile
duct. Postoperative mortality was 3.8% (5 patients), without any statistical
difference between the 2 groups (4 in the CD group vs in the HJ group ).
Postoperative morbidity was not different: biliary fistula in the CD
group (1.6%) vs 5 in the HJ group (7.5%). Late results in 120 patients
(mean follow-up: 55 + 11 months) showed that: a) 107 patients (89.2%)
had no symptoms related to biliary-enteric anastomosis; b) cholangitis
episodes occurred in 13 patients (10.8%) (6 in the CD group and 7 in the
HJ group, NS); c) cholangitis occurred during the 1st year in 8 patients
(61%) and during the 2nd year in 5 patients (39%); d) no marginal ulcer
was found in the HJ group. This randomized controlled trial confirms the
good results ofCD and HJ in choledocholithiasis, with similar mortality
and morbidity rates in both groups, and 90% asymptomatic patients in the
long term follow-up. Nonetheless, these results favor the use ofCD in
choledocolithiasis, because CD is less time-consuming than HJ, and does
not preclude further endoscopic exploration.
F002
STRESSRESPONSEANDLUNGFUNCTIONAFTER
CLASSICALANDLAPAROSCOPICCHOLECYSTECTOMY
J.RINGERS B.M.P. RADEMAKER, J.A. ODOOM, L.TH. DE WIT
Dept. Anaest. and Surg., Academic Medical Center, Amsterdam, The Netherlands
In this study the effects of classical cholecystectomy (CC) and LPC on
lung function and stress response were compared. Secondly the effect of
general anesthesia with or without thoracic epidural anesthesia (TA) were
compared. Thirty patients were randomly allocated into three groups; 1-
CC, 2-LPC, 3-LPC+TA. Peak expiratory flow (PEF) forced expiratory
flow FVC and forced expiratory flow in one second (FeV 1) were
measured pre-, 2, 4, 8, and 24 hours postoperatively. Arterial blood
samples were taken pre and postoperatively to assess plasma levels of
cortisol and glucose. Data are expressed as mean + SD. Results were
analyzed with repeated measures ANOVA and Wilcoxin-signed rank test.
P values <0.05 were considered significant.
Results: The groups were similar with respect to height, weight,
duration of the operation and age of the patients. Two hours post-
operatively FVC decreased significantly in all groups compared to
preoperative values. Group- 1: 3.8+0.94L to 1.07_+0.27L (P<0.01).
Group-2: 3.63+1.46L to 2.13+0.4L (P<0.05). Group-3: 3.76+0.92L to
2.84_+0.90L(P<0.05). In group- the reduction was larger than in Group-2
and 3 (P<0.05). Differences between Group-2 and 3 were not significant.
These changes remained unaltered for 24 hours. Similar changes were
observed with FeV1 and peakflow measurements. FVC to FeV1 remained
unchanged. After surgery levels of glucose and cortisol increased in all
groups, but levels remained unchanged in group 3 after 120 rain. Glucose
levels after induction of anesthesia and the epidural catheter were higher in
group 3 (P<0.05).
Conclusion: During LPC the endocrine metabolic response is not
abolished. Thoracic epidural anesthesia alters this response but does not
significantly influence pulmonary function. The reduction in pulmonary
function was less with LPC as compared with CC.LPC should be the
treatment of choice in pulmonary compromized patients since the
reduction in pulmonary function is less in LPC, compared to CC.
F003
FINALREPORTOFRANDOMIZED TRIALCOMPARING
DISTALSPLENO-RENALSHUNTANDSCLEROTHERAPY IN
THEPREVENTIONOFVARICEALREBLEEDING.
G.P. SPINA, R. SANTAMBROGIO, E. OPOCHER. B. RASHIDI, F. COSENTINO,
E. MORANDI, R. MOTTA
University of Milan, San Paolo, Institute of Biomedical Sciences, Milan, Italy
In 1984 we initiated a prospective controlled trial comparing
endoscopic sclerotherapy (ES) with the distal spleno-renal shunt (DSRS)
in the elective treatment of variceal hemorrhage in cirrhotic patients. The
study comprised 80 patients (Child A-B) assigned to one of the 2 groups
according to random number table: 40 to DSRS and 40 to ES. During the
postoperative period, no DSRS patient died, while ES patient died of
uncontrolled hemorrhage Rebleeding: 2 DSRS patients (1 from varices,
from duodenal ulcer) and 8 ES patients (4 from varices, 4 from esophageal
ulceration). Long-term follow-up was complete in 100% pf patients.
However, in the ES group, patient was successfully submitted to liver
transplantation and another to shunt surgery. 5 years survival rate, was
83% forDSRS and 36% for ES groups (p=N.S.). The global percentage of
rebleeding was 5% in DSRS patients (2 from duodenal ulcer) 38% for ES
patients (3 from varices, 3 from hypertensive gastropathy and from an
unknown source p=0.0028). 3 DSRS and 2 ES patients suffered mild
chronic encephalopathy (p=N.S.). This trial seems to indicate that DSRS,
in patients with good liver function, is more effective that ES in
preventing gastroesophageal rebleeding, without serious sequela and with
a tendency to improve survival.
F004
DNA-ANALYSIS,ONCOGENEEXPRESSIONAND CATHEPSIN
DFORPROGNOSTICEVALUATION INSURGICAL
PANCREATICCANCERPATIENTS
J.W. HEISE. H. BOJAR, F. BORCHARD, H. BECKER, S. THOMSEN, H.-D R)HER
Department of General and Trauma Surgery, Institute of Oncological Biochemistry and
Pathology, Heinrich-Heine-University, Dtisseldorf, Germany
Disappointing survival rates, even after extensive resectional treatment
of pancreatic cancer patients call for more differentiated and sufficient
prognostic tools thanTNM classification or histopathological grading are
at present. Aim of this study was to evaluate a set ofnew
immunohistochemical and molecularbiological parameters in patients
operated for pancreatic malignancies in order to develop an individual
oncologic risk profile.
In 42 patients Iaparotomized for ductal (n--33) or other periampullary
(n=9) carcinomas the following parameters were determined in fresh
tumor tissue: Status of ploidy, percentage of proliferating cells by
monoclonal antibody Ki-67, EGF-receptor and cerbB-2 oncogene
expression, and content of the protease cathepsin-D. Results were
correlated with the kind of tumor, TNM-status, grading, and survival.
The actual median survival was only 98+33 days in the hypodiploid
group, compared to 215 + 84 and 229 _+ 51 of the diploid and triploid
tumors, respectively. Percentage of Ki-67 positive cells was 19.2 + 3.4%
in ductal adenocarcinoma as compared to 8.2 + 1.8% in periampullary
cancer. Five of 10 patients with distant metastases showed a strong EGF-
receptor expression but only 2/30 in case of local disease. Cathepsin-D
content was 99.6 _+ 15.7 in Tx Nx M1 but only 58.2 + 6.6 in Tx Nx M0
cases.
The parameters evaluated proved to be discriminitive for survival and
biological behavior of the tumor. Thus, they might be useful to define
subgroups of patients benefitting of adjuvant or additive palliative
treatment modalities.F005
RATIONALEFORPYLORUS-PRESERVINGPANCREATO-
DUODENECTOMY vs WHIPPLEOPERATION INTHE
TREATMENTOFMALIGNANTPERIAMPULLARYTUMORS
H. BECKER J. W. HEISE, F. BORCHARD, H.-D. ROHER
Department of General and Trauma Surgery,
Institute of Pathology-Heinrich-Heine University, Dtisseldoff, Germany
Whipple’ operation in many institutions still is the golden standard for
resective surgery in periampullary tumors. Recently the pylorus-
preserving pancreatoduodenectomy (PPPD) became increasingly popular.
Goal of the present study was to provide rationales for choosing PPPD
rather than the Whipple procedure in resection of malignancies of the
periampullary region.
From 4/’86 to 11/’91 a total of 55 patients with malignant
periampullary lesions underwent pancreatic head resection, either
Whipple (n=37) or PPPD (n=l 8). The ratio of ductal adenocarcinoma to
other periampullary tumors was 31/6 and 9/8, respectively.
Mortality was 2/37 (5.4%) after Whipple procedure and 0/18 following
PPPD. Morbidity in the latter group consisted mainly in delayed gastric
emptying in 7/18 (39%) cases, but needed reintervention in any instance.
Histopathological examination of all Whipple specimens did show node
involvement above the pyloric level along the lesser and greater curvature
in only 1/37 (2.7%).
We conclude PPPD to be the surgical technique of choice in the vast
majority of resectable malignancies of the pancreatic head region. Up to
now zero mortality.and lack of histopathological evidence, that removal of
the distal stomach improves local tumor clearance probably will restrict
the classic Whipple procedure to few cases, where the tumor is otherwise
technically not resectable.
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DIGESTIVEANDNUTRITIONALCONSEQUENCES
FOLLOWINGPANCREATIC RESECTION: THEROLEOF
PYLORICPRESERVATION
R. BELLANTONE G.B. DOGLIETTO, D. FRONTERA, A. FERRANTE, G. VIOLA,
F. CRUCITTI
Department of Surgery, Catholic University School of Medicine, Rome, Italy.
The digestive function and nutritional status of 13 patients (8
cephalic pancreatectomies- CP, 5 total pancreatectomies- TP)
submitted to pylorus-sparing pancreatic resection for periampullary
cancer have been studied; the results have been compared with those
obtained in a "traditional" (associated gastrectomy) resection group (8
CP, 5 TP).
Each patient, free of neoplastic recurrence, underwent, year after
surgery, a nutritional evaluation (weight change, serum total proteins and
albumin, lymphocyte count, cholesterolemia, etc.) and specific tests for
digestive functioning (glucose absorption test, fatty meal test
pancreolauryl test, oxalate test, fecal chimotrypsine, plasma minerals
magnesium, phosphate, iron, copper, zinc).
We observed a 69% rate of digestive and absorptive failure in pylorus-
spare patients, but only in subclinical terms. 61.5% of gastroresected
patient were seen to have malabsorption, and 3 patients were really
malnourished. Digestive impairment was more common after TP(100%),
and 2 patients out of 5 were heavily malnourished.
Therefore, we think gastro-pyloric preservation may be effective, at
least in TP, in reducing post-pancreatectomy digestive consequences.
Moreover, the procedure does not modify, also in our experience
(3 patients), the oncological radicality.
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GASTRICEMPTYING (GE)ANDMYOELECTRICACTIVITY
INTHEEARLYPOSTOPERATIVEPERIODAFTERPYLORUS
PRF_ERVINGPANCREATODUODENECTOMY (PPPD)
W.A.J.J.M. HAAGH L.M.A. AKKERMANS, H. OBERTOP
Dept. of Surgery, University Hospital Utrecht, The Netherlands
Introduction. Delayed gastric emptying DGE) has been reported as a
frequent complication ofPPPD. Gastric dysrhythmias have been
postulated as a mechanism for this phenomenon. Also pancreatic cancer
patients may have DGE prior to surgery. Pre- and early postoperative GE,
in combination with gastric myoelectric activitiy have never been
adequately studied and are therefore the subject of this presentation.
Patients and methods. GE of a liquid meal (300ml, 375 kcal) was
studied in 8 pancreatic and periampullary cancer (PP) patients (4 M, 4 F;
mean age 53 + 21 yrs) using Applied Potential Tomography (APT.
Myoelectric activity was measured by surface electrogastrography (EGG)
during hr fasting and 1.5 hrs postprandially, and analyzed by
computerized power spectrum analysis. 5 of these patients were also
studed within the first 2 weeks following PPPD. The same measurements
were done in 20 controls (12 M, 8 F; mean age 63 + 8 yrs).
Results. Gastric emptying was delayed in both pre- and postoperative
PP patients compared to controls, the tl/2 being resp. 154.3+137,
139.4+122 and 83.1+32 rain (p N.S.). Gastric dysrhythmias were not
observed in the preoperative and postoperative period. The
postprandial/fasting power ratio of the postoperative PP patients was
significantly decreased compared to normal (1.30-2-_0.92 resp. 6.28_+4.82;
p=.005), indicating a decrease in gastric motor activity in these patients.
Postprandial peak power and power ratio in the postoperative period
decreased compared to the preoperative period (p=.06). A significant
correlation between pre- and postprandial mean gastric frequency and tl/2
could be demonstrated.
Conclusion. Although many uncontrolable factors may govern GE,
myoelectrical abnormalities of the stomach may play a role in the early
postoperative gastric dysfunction following PPPD. Slowing ofGE prior to
surgery cannot be explained by disturbances in gastric myoelectric
activity, but may involve tumor-related effects. Gastric dysrhytmias, when
present, probably play a role in the development ofDGE.
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OCTREOTIDE INTHEPREVENTIONOFPANCREATIC
FISTULAAFTERRESECTIVEPANCREATIC SURGERY: A
PROSPECTIVECONTROLLEDRANDOMIZEDSTUDY
M. MONTORSI, M. ZAGO, M. PIVI*, R. PEREGO*, G. PEZZUOLI and the PFOS
Study Group
Istituto di Chirurgia Generale University of Milano, Milano, Italy.
Direzione Medica Italfarmaco Milano, Italy.
Prevention of pancreatic fistula remains an important challenge in
pancreatic surgery. In order to evaluate the efficacy of Octreotide in the
prevention of pancreatic fistula following pancreatic resection, a
multicentric controlled randomized double blind study (PFOS) was started
in July 1990; patients (pts.) were enrolled in 35 national surgical
departments with recognized experience in pancreatic surgery. The design
of the study provides peri- and postoperative administration of Octreotide
vs. placebo in two groups of 110pts. undergone elective pancreatic
resection. Mortality and specific and general morbidity are recorded. At
present, 222 pts. were included. 53 (23.9%) of these were not resected and
considered drop-out. A preliminary analysis was thus possible on 169
resected pts. (93 males and 76 females, with a mean age of 58.2 years).
Among these, 83 (49.1%) had exocrine pancreatic cancer (66 of the head,
14 of the body, 3 of the tail), 10 (5.9%) endocrine pancreatic tumors, 30
(17.7%) periampullary tumors, 23 (13.6%) other abdominal neoplasms
requiring pancreatic resection, 23 (13.6%) chronic pancreatitis. The
following operations were performed: 119 (70.4%)
pancreaticoduodenectomy (68 Whipple, 51 Longmire), 35 (20.7%) left
pancreatectomy, 11 (6.4%) subtotal pancreatectomy, 4 (2.3%)
enucleations of endocrine tumors. Overall mortality rate was 9.2%,
whereas pancreatic fistula appeared in 17 pts. (10%). Other complications
specifically related to pancreatic surgery occurred in 35 pts. (20.7%).
Definitive results and analysis are expected within February 1992.
Notwithstanding improvement in patients’ treatment, morbidity and
mortality after pancreatic resections still remain a major problem for
surgeons. This study will clarify the role of Octreotide in reducing
incidence of this complication.F009
PYLORUS PRESERVINGPANCREATODUODENECTOMY:
TEN YEARS EXPERIENCEWITH 129 CASES
F. MOSCA, P.C. GIULIANOTTI, F. D’ELIA, A. PIETRABISSA, F. SARTON1,
F. VATI’ERONI, T. BALESTRACCI, A. COSTA, A. GUADAGNI, U. BOGGI,
A. CAMPATELLI, M. FERRARI, M. OLEGGINI
Istituto di Chirurgia Generale Sperimentale, Universitga di Pisa, Italy
In 1978 Traverso and Longmire revived the idea ofpreserving the pylorus during
pancreatoduodenectomy. Since that time a lot ofcases have been reported. Our
experience with 129 procedures is here reported. Pylorus preserving pancreato
duodenectomy (PPPD) does not adversely affect morbidity or survival as compared
to Whipple resection even dealing with pancreatic cancer moreover improving the
patient post operative quality of life.
129 PPPD (8lm--48f), including 9 total pancreatectomies were performed between
Jan. 1982 and Jun. 1991.18 pts had chronic pancreatitis, 68 pancreatic cancer, 26
papillary cancer, 11 common bile duct cancer, 5 duodenal cancer and
retroperitoneal lymphoma. The mean age was 63.69+/-11.08 in the neoplastic group
and 46.72+/- 10.6 in the chronic pancreatitis group. Operative morbidity rate was
8,85% (4% in the last 3 yrs.), half of the deaths occurring not for abdominal causes.
The mortality rate was 3.79% and 6 pts. required reoperation. Postoperative
nasogastric suction was maintained for an average of 12.3 days (5-27), in the 22% of
pts. a delayed gastric emptying (more than two weeks) was observed (no additional
surgery required). Food reintroduction was satisfactory accomplished by the majority
of pts. The weight gain average, six months after surgery (excluding pts. with early
neoplastic recurrence), was 3.7 kg (some pts. gained 7-10 kg). Specific late
complications were observed in 5 pts. 2 perforations from peptic ulcer requiring
surgery (1 during chemotherapy for lymphoma and the other aspirin induced 5
months after surgery), pt. bled from duodenum (42 months after surgery), 2 pts.
bled from antral gastritis, all ofthem were successfully treated with medical therapy.
22 pts. operated on for pancreatic cancer are still alive: is free ofrecurrence after
9 yrs.; is alive more than 7 yrs. after resection; 2 more than 4 yrs., 2 more than 3
yrs. and 4 more than yrs. (1 with liver metastases). The remaining 12 survivors are
between 6 and 12 months from surgery. 43 pts. died by cancer recurrence: the
median survival in this group was 10.23 months. Among the 37 pts. resected for
periampullary cancer 23 are still alive; the five years actuarial survival has been
67.64%.All pts. operated on for pancreatitis are alive except one, who died for
laryngeal cancer; late complications in this group were: stricture of the
hepaticojejunostomy, successfully treated with percutaneous dilatation and small
bowel subocclusion due to adhesions spontaneously relieved. Pain reliefwas
satisfactory obtained in every pt. Survival analysis, retrospectively comparing 2
homogeneous groups of pts. who underwent resection for pancreatic cancer, failed to
demonstrate any significant difference between those in whom a Whipple procedure
was performed as compared to the ones resected according to Longmire’s technique.
F010
PERI-OPERATIVERENALTUBULARDYSFUNCTION IN
PATIENTSWITHOBSTRUCTIVEJAUNDICE: THEVALUEOF
URINARYENZYMOLOGICAL STUDIES
D N ANDERSON. ROTHNIE, BROOM, R KEENAN, PH WHITING
Departments of Surgery and Clinical Biochemistry,
University ofAberdeen, Aberdeen Royal Infirmary, Aberdeen, Scotland
Urinary enzyme excretion studies can highlight the inadequacy of
conventional parameters of renal function, in determining the incidence of
peri-operative renal tubular dysfunction in patients with obstructive jaundice.
Using established automated assay techniques the urinary activities of the
proximal renal tubular brush border enzymes, gamma-glutamyl
transpeptidase (CST) and alanine aminopeptidase (AAP), along with that of
the intracellular lysosomel hydrolase N-acetyl-B-D-glucosaminidase (NAG)
were measured in the urine of 14 jaundiced patients (group 1: immediately
prior to, and 24 hours after biliary surgery. Additional urinary enzyme
excretion patterns were studied in 45 non-jaundice patients undergoing minor
surgery (group 2), and surgery (group 3).
In group 2, the pre- and post-operative urinary activities ofNAG, GGT and
AAP did not differ significantly, at 24 _+ 16 vs 30 + 28 U/mmol creatinine; 3.8
_+ 1.3 vs 4.1 + 3.8 U/mmol creatinine and 1. _+ 0.7 vs 1.3 + 1.2 U/mmol
creatin respectively. However those with obstructive jaundice (group 1)
demonstrated, not only a significantly (p<0.01) elevated pre-operative urinary
excretion ofNAG (236 + 153 U/mmol creatinine), GGT (6.6 _+ 2.5 U/mmol
creatinine) and AAP 5.8 + 1.1 U/mmol), but also further significant
elevation ofNAG (328 + 182) p<0.01, GGT (11.5 + 5.0) p<0.05 and AAP
(10.1 _+ 6.1) p<0.01, activity following surgical intervention. Them was no
correlation between the duration of the obstructive jaundice nor the degree of
hyperbilirubinaemia and the levels of enzymuria detected. Urinary NAG
levels were also significantly elevated following aortic reconstructive surgery,
45 _+ 38 vs 128 + 88 U/mmol creatinine p<0.05, though this was less marked
than in the jaundiced group. The surgical and anaesthetic insult in these two
groups was comparable. The serum creatinine concentration remained static
in both thejaundiced (92 _+ 32 vs 89 + 20 umol/1) and the aortic
reconstructive (32 _+ 49 vs 90 _+ 47 umol/1) groups, in the peri-operative
period. Urinary enzymology, applied to patients with obstructive jaundice,
reveals a significant proximal renal tubular dysfunction compounded by
surgical intervention. Serum creatinine concentration, the conventional
measurement of renal function, lacks this sensitivity, especially in the early
post-operative period, and its diagnostic value is limited.
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BACTERIAL TRANSLOCATION INEXPERIMENTAL BILIARY
OBSTRUCTION
J.w. DING, R. ANDERSSON V. SOLTESZ*, S. BENGMARK
Departments of Surgery and Microbiology*, Lund, Sweden
Obstructivejaundice is frequently associated with septic complications
and enteric bacteria have been isolated from both the infectious focus and
bile injaundiced patients. The mechanisms by which enteric bacteria
translocate from the gut are not clarified, though an impaired
reticuloendothelial function in obstructivejaundice has been reported.
Sprague-Dawley rats were subjected to sham operation (n=10) or
common bile duct ligation and transection (CBDL; n=35). After 2 weeks,
jaundiced animals received either oral administration ofphysiological saline
(n=15), muramyl tripeptide-phosphatidylethanolamine (MTP-PE)
liposomes (n=10) or placebo (empty) liposomes, while sham operated rats
received physiological saline, 48 h prior to evaluation of enteric bacterial
translocation. Both portal and systemic blood, bile and cekal content were
collected and cultured aerobically and anaerobically, as well were tissue
samples from the liver, spleen and mesenteric lymph nodes (MLN).
PositiveMLN cultures in jaundice + saline (7/15; 47%) andjaundice +
placebo animals (4/10; 40%) significantly differed (p<0.05) from sham
operated animals (1/10; 10%). No positiveMLN cultures were seen in
jaundiced animals treated with MTP-PE (p<0.05 as compared to other
jaundiced animals). One positive liver culture was noted both among sham
operated, jaundice + saline andjaundice + placebo animals. Cekal counts
(CFU/gm) of E.coli, Lactobacillus acidophilus and aerobic and
microaerobic bacteria did not statistically differ, though the number of E.
coli tended to be higher injaundiced animals. Histological examination of
the terminal ileum demonstrated subepithelial oedema in alljaundiced
animals.
In conclusion, bacterial translocation was demonstrated in rats with 2
weeks of biliary obstruction, which together with the previously reported
impaired RES function might explain the increased incidence of septic
complications. Oral administration of liposomal MTP-PE prevented
bacterial translocation.
F012
THEIMPORTANCEOFANTIENDOTOXINANTIBODIES IN
PATIENTSWITHOBSTRUCTIVEJAUNDICE
D McCRORY. M HALLIDAY, G R BARCLAY*,M D McCAIGUE, P ERWIN,
S STEPHENS# B ROWLANDS
Department of Sugery, The Queen’ University of Belfast
*Blood Donor Centre, Edinburgh. # Celltech Ltd. Slough.
Introduction Patients with biliary obstruction have a high mortality and
morbidity following surgical intervention. Endotoxin and tumour necrosis
factor (TNF) have been implicated in the pathogenesis of these
complications but have only been found sporadically in obstructive
jaundice. Antibodies are produced in response to endotoxin and persist
long after release of an endotoxin pulse. Antiendotoxin antobodies may be
a better measurement of chronic endotoxin exposure.
Methodology Preoperative plasma samples were obtained from 19
jaundiced and 11 control patients. TNF was quantified using an ELISA.
Endotoxin was measured by a quantitative limulus lysate assay. IgG and
IgM anti-core glycolipid (CGL) antibodies were measured using an
ELISA.
Results Meal’_+standard error: Jaundice n=19 Control n=l
TNF Endotxin IgM antiCGL IgG antiCGL
pg/ml pg/ml median units median units
Jaundice 1.4_+1.1 16.2_+8.1 87.9_+14.2 274.6_+55.7*
control 0_+0 6.7_+1.7 74.2_+12.7 113.6_+15.2
* Significant difference vs controls p<0.05 Mann Whitney
Conclusions The inability to detect significantly increased
concentrations of endotoxin and TNF implies that single daily
measurements are of little clinical benefit. In contrast the significant rise
in IgG antiCGL antibodies indicates chronic exposure to endotoxin.
These results emphasise the need for specific antiendotoxin therapies in
jaundiced patients.F013
MONOCYTEANDPLASMALEVELSOFTRANSFORMING
GROWTHFACTORBETA (TGF) INOBSTRUCTIVE
JAUNDICEPATIENTS
MCA PUNTIS ANDWG JIANG
Department of Surgery, University ofWales, College of Medicine, Cardiff, UK
Transforming growth factor beta(TGF) down-regulates some aspects
of immunity (T cell, NK cells & humoral immunity). We have
investigated TGF[ levels in plasma and monocytes fromjaundiced
patients.
Plasma and monocyte were separated fromjaundiced (n=44, mean
bilirubin 179.2 mM/L) and control (n=30, mean bilirubin 9.9 raM/L)
patients blood. Monocyte were then stimulated by LPS. The TGFO levels
were measured by the standard CCL64 cell bioassay. Total bile acids in
the plasma was measured using an Enzabile kit. Results are shown as
mean+SEM and statistics are by StudentT test. (RU=international
Reference Unit).
Plasma TGFO(RU/ml) Monocyte TGF(RU/ml)
Benign Malignant Benign Malignant
Control 27.1+6.3 27.9+8.1 33.9+3.9 32.7+7.3
Jaundice 90.6+25.5* 193.9+33.1"# 31.5+4.6 32.3+2.8
*p<0.05 vs control. # vs benign
Plasma TGF[ levels are increased in jaundiced patients and are highest
in malignancy. The highest levels (>200 RU/ml) were seen in patients
with poorest prognosis. There is no statistical correlation between bilirubin
and TGFI](r=-0.17) or between bile salts and TGF(r=--0.02).
Conclusion: Patients with obstructive jaundice have significantly
increased plasma TFGI] level which is probably not related to monocyte
production. This increase shows a relationship to the patients prognosis.
F014
SMALLBOWELMORPHOLOGY INCONVENTIONALAND
GERMFREERATS INOBSTRUCTIVEJAUNDICE
M.S. QURAISHY, D. CHESCOE, R.H. HINTON, M.E. BAILEY
Royal Surrey County Hospital, Guildford and University of Surrey, Guildford, United
Kingdom
Increased morbidity in patients undergoing surgery for obstructive
jaundice is attribuited to systemic endotoxaemia which may be due to
increased absorption secondary to changes in the intestinal epithelium.
Small bowel mucosal morphology has been studied in conventional and
germ free rats with obstructive jaundice. Methods used included light
microscopy, enzyme histochemistry and electron microscopy. The
chromogenic limulus amoebycyte lysate assay was used to assess blood
endotoxin levels. Significant changes were found in models where
obstructivejaundice had been induced. In bile duct ligated animals
morphological changes were observed with PAS and alcian blue stains
which revealed an increased intensity of staining of the goblet cells.
Enzyme histochemisty showed that the brush border activity of alkaline
phosphatase was decreased with some regions showing virtually no
activity. The activity of the cell membrane marker enzyme 5 nucleotidase
was also decreased. Electron microscopy revealed damage to the
microvilli, thickening of the rootlets, hypertrophy of the Golgi apparatus,
scattered mitochondrial damage and changes in the nuclei and cell
membrane of the epithelial cells. Mitochondrial changes were not
paralleled by activities of succinic dehydrogenase and cytochrome oxidase
which were normal. No morphological differences were found between
conventional and germ free animals. The data presented indicates that
changes in jejunal morphology are not secondary to endotoxins but are
most likely due to the absence of bile.
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POSTOPERATIVEBILELEAKAGE: THEENDOSCOPIC
MANAGEMENT
PHP DAVIDS. EAJ RAUWS, K HUIBREGTSE, TM VAN GULIK,MNVAN DER
HEYDE, GNJ TYTGAT
HPB-UNIT, Academical Medical Center, Meibergdreef 9, 1105 AZ Amsterdam,
The Netherlands
Postoperative bile leakage is a serious complication, in which surgical
treatment has its limitations. This study evaluates the endoscopic
management.
Patients: Between 1982 and 1990, 55 patients (28 female, 27 male;
mean age 55) were referred with postoperative bile leakage. Initial surgery
included cholecystectomy in most cases. T-tubes were employed in 17
patients. The patients presented with a biliary-cutaneous fistula (n=27),
peritonitis (n=10), recurrent intraabdominal abscess formation (n=5),
progressive jaundice (n=7) cholangitis (n=5) or pancreatitis (n=1). The
mean interval between initial surgery and presentation was 37 days, (range
5-292). Therapy consisted of standard sphincterotomy, if needed
subsequent stone extraction, with or without endoprosthesis placement.
The aim of all treatment modalities was to facilitate bile flow into the
duodenum.
Results: The biliary tract and the site of the leakage were visualized
during ERCP in 98%. The site of leakage was the cystic duct stump
(n=37), the CHD (n=6), the CBD (n=6), a hepatic radical (n=4) and a
surgical anastomosis (n= 1). Distal obstruction due to retained gallstones
was present in 15 patients and due to concomitant strictures in 18. Overall,
48 of 55 patients were treated endoscopically: sphincterotomy (n= 11),
sphincterotomy and stone extraction (n--10), stone extraction and stent
placement (n=5), stent placement (n=19) and stent placement followed by
nasobiliary drainage. An excellent outcome (clinical and radiological
improvement and closure of the bile fistula) was achieved in 43 patients
(90%). Despite adequate therapy, 5 patients (10%) had ongoing sepsis
resulting in a fatal outcome.
Conclusion: Postoperative bile leakage can be diagnosed effectively by
ERCP, and treated safely by subsequent endoscopic management.
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HIDA-SCINTIGRAPHYAFIRLAPAROSCOPIC
CHOLECYSTECTOMY
D.J. GOUMA P.M.N.Y.H. GO, M.J.P.G. VAN KROONENBURG, H.L.M. PASMANS.
Dept. Surgery and Dept. Nuclear Medicine, University Hospital Maastficht,
The Netherlands.
Obstruction of the bile ducts or bile leakage are serious complications
after laparoscopic cholecystectomy. HIDA-scintigraphy is a sensitive
method to evaluate the bile flow.
The aim of the study is to assess the value of HIDA-scintigraphy to
detect biliary complications after laparoscopic cholecystectomy.
In 51 patients a scintigraphy of the bile ducts was performed with
Tc99m-dimethylphenyl-carbamoxyl-methyl-IDA (n=8) or Tc99m-
trimethylbromo-IDA (n=43) in a dose of 3.5 mCi intravenously, 24 hours
after the operation. Anterior abdominal images were made at intervals
during hour or longer when necessary. The scintigraphic findings were
compared to the clinical course.
No biliary obstructions were noticed. In 5 patients bile leakage was
seen on the scintigraphic images. Three patients had no clinical symptoms
of bile leakage. In patient bile leakage from the cystic stump was found
at laparotomy. In another patient a bile collection was found at re-
laparoscopy. Better images were made using Tc99m-trimethylbromo-IDA
than Tc99m-dimethylphenyl-carbamoxyl-methyl-IDA. All patients
recovered uneventfully.
In conclusion: HIDA-scintigraphy with Tc99m-trimethyl-bromo-IDA
is a highly sensitive method for early diagnosis of bile leakage after
laparoscopic cholecystectomy, although routine postoperative
scintigraphy is not warranted.F017 F018
TREATMENT OF BENIGN BILIARY STRICTURES:
SURGERYORENDOSCOPY?
AKFTANKA. PHP DAVIDS,TMVAN GULIK, RAUWS EAJ, LTDE WIT,
PLM VERBEEK, DJVAN LEEUWEN, K HUIBREGTSE, GNJ TYTGAT,
MNVANDERHEYDE
HPB-Unit, Academic Medical Center, Amsterdam, The Netherlands
Benign biliary strictures (BBS) remain a therapeutic challenge. This
study compares the treatment results of surgery and endoscopy in one
institution.
Patients: Between 1981 and 1990, 35 patients were treated surgically
(ST) and 66 by endoscopic biliary stenting (ET). In almost all patients the
initial trauma occurred during biliary tract surgery. Patient characteristics,
previous repairs and level of obstruction were comparable in both groups.
ST consisted of constructing a biliary-digestive anstomosis in healthy
tissue. ET consisted ofplacement of endoprostheses, with elective
exchange trimonthly for a one year period.
Initial Results: In 35 ST patients a proximal hepaticojejeunostomy (HJ)
was performed. Postoperative complications included: septicaemia (n=5),
bile leakage (n=2) and major bleeding necessitating relaparotomy (n=2).
ET related early complications comprised: minor papillary bleeding (n= 1),
cholangitis (n=2) and pancreatitis (n=2). During treatment all
complications were stent related: cholangitis (n--14), recurrent cholestasis
(n=2) and stent migration (n=2). In 46 patients the endoprostheses were
eventually removed.
Late Results: After a mean period of follow-up of 50 months (range 10-
85), 5 of 35 ST patiens (14%) restrictured. Recurrent stricturing occurred
in 8 of46 ET patients (17%) after a mean period of follow-up of42 months
(range 4-99). Subsequently, 6 patients underwent a HJ and 2 were
restented.
Conclusion: Surgical or endoscopic treatment ofBBS yields comparable
results. Indications for ST are complete transsections, previous repairs and
failures ofET. Candidates forET are those unfit for surgery or presenting
with concomitant biliary fistula. In all other patients we advocate ET as the
initial treatment.
WHYANDWHEN BILEDUCT INJURY OCCURS
TARGARONA EM, GARCIA OLIVARES E,MARCO C
Dept of Surgery, Hosp. Clinic and Hosp. de Mutua de Terrassa, Univ. of Barcelona,
Barcelona, Spain
Bile duct injury (BDI) is the most dangerous complication after
cholecystectomy. The incidence ofBDI usually low (0.2-1%), but it is associated
with high morbidity and mortality. Factors that has been considered to be related
with BDI are the surgeon skill, variations of the bile duct anatomy, inflammatory
local conditions, and intraoperative cholangiography.
Aim: To investigate the clinical features and the predisposing factor for BDI
in a consecutive series of 3,051 cholecystectomies.
Patients and Methods: The clinical records of 3,051 patients who underwent
choleycystectomy between June 1977 and January 1990 in a surgical unit of a
600 bed teaching hospital were reviewed. BDI was classified as Group I: BDI
diagnosed intraoperatively, Group II: BDI diagnosed in the inmediate
postoperative time, and Group III: BDI with late presentation. Age, sex,
intraoperative diagnosis, surgeon skill (staff or resident), technical difficulty,
intraoperative cholangiography, anatomy of the bile duct and the results after
surgical repair were evaluated.
Results: During the period of study we observed 26 BDI. 19 BDI occurred
after biliary surgery (19/3051, [0.6%]), and 2 after gastric surgery (2/470,
[0.4%]). 18 BDI were diagnosed intraoperatively (Group I), 4 in the inmediate
postoperative time (Group II), and 4 cases presented months or years (3m-18y)
after cholecystectomy (Group III). In 62% of cases, the intraoperative
cholangiography demonstrated the BDI. BDI were significantly more frequent in
cases operated by staff surgeons than by residents (p<0.001), and in cases with a
more difficult surgical field (p>0.005). 2 patients died after surgical repair of a
BDI (2/26, 7.7%). The morbidity rate was 54%. 28% patients developed late
complications (cholangitis, setenosis or choledocholithiasis).
Conclusions: 1. BDI occurred more frequently in cases technically difficult
and operated by skilled surgeons. 2. Intraoperative cholangiography has been
useful for preoperative detection of BDI. 3. The incidence ofBDI is low, but it is
associated with high morbidity and mortality. These results must be considered
when comparing open cholecystectomy with new alternative treatments of
cholelithiasis as laparoscopic cholecystectomy.
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OPERATIVE RISKOFREHEPATECTOMIESFORLIVER
TUMORS
G. BORGONOVO, C. VONS, V. KARAA, D. GRANGE, D. FRANCO, C. SMADJA
H6pital Antoine B6cl6re, 92141 Clamart C6dex, H6pital Louise Michel, 91014 Evry
C6dex, France
Rehepatectomies for recurrent primary or secondary liver carcinomas
have become more frequent. The purpose of this work was to assess the
operative risk of rehepatectomies. Between 1984 and 1991,295 liver
resections have been performed. Twenty-severn resections (9.2%) were
rehepatectomies: second’resection in 23 patients and third resection in 4
patients. Mean age (16 males and 7 females) was 53 years (range: 18 to 73
years). Ten patients had recurrent metastases from colorectal primary, 7
patients (6 with cirrhosis) had recurrent hepatocellular carcinoma and 6
patients had another kind of tumor. The first liver resection in these
patients had been major resection in 9 cases, segmentectomy (1 or 2
segments) in 10 cases and atypical resection in 4. Rehepatectomy was
major in 7 patients, segmental in 7, and atypical in 13. Operative mortality
was 4.4% (1 patient). Mean operative blood transfusion was 4.5 + 5.2
units ofpacked red cells, twice the mean blood transfusion in first-hand
hepatectomies in our series. Four patients (14.8%) had operative
complications: thrombosis of portal vein requiring a portocaval shunt,
injury to hepatic duct resulting in T-tube drainage, and coagulation
disorders with diffuse bleeding in 2 patients. The latter complication
occurred in 2 of the four patients with a third liver resection. Bleeding
stopped after packing in one patient with a normal liver. Bleeding resulted
in death from exsanguination in the second patient who had liver cirrhosis.
Severe operative complications were more frequent in patients with a third
hepatectomy (50%) than in patients with a second hepatectomy (8.7%).
These results suggest that the operative risk of rehepatectomy is far
more important than that of a first liver resection. Indication of a third
hepatectomy should be cautious, particularly in patients with cirrhosis.
F020
EFFECTOFPORTALANDPERIPHERALSERUMON
CULTUREDHEPATOCYTF_SANDCOLONCARCINOMA
CELLSAFTERPARTIALHEPATECTOMY INRATS
K.P. DEJONG H.E. LONT, A.M. BIJMA, R. VAN STRIK*, R.L. MARQUET,
O.T. TERPSTRA
Dept of Surgery and *Biostatistics, University Hospital, Dr Molewaterplein 40, 3015 GD
Rotterdam, The Netherlands
For patients with liver metastases of a colorectal carcinoma (CC) a
partial hepatectomy (PH) is the only hope for cure. The majority of
patients die however because of recurrences. After PH an overwhelminbg
multiplicaiton of cells occurs in the remnant liver in order to restore liver
mass and function (regeneration). There is circumstantial evidence that
tumor cells are stimulated also during the peak of liver regeneration. The
aim of the study is to detect whether portal or peripheral serum contains
factors responsible for this phenomenon. In Wag-Rij rats a 70% PH, sham
(SH) or no operation (CO) is performed. After various time intervals (24
hours and 14 days) portal and peripheral (fight atrial) serum is withdrawn
for addition to cell cultures of hepatocytes (H) and CC cells. Portal serum
is added to mixed cultures ofCC and H. DNA replication is measured by
3H-thymidine incorporation, using a scintillation counter producing
desintegrations per minute (dpm). Cell cultures ofCC cells show a 10 fold
increase in dpm if cultured with PH serum taken from rats 24 hours after
operation compared to SH orCO serum (p--0.005). PH, SH orCO portal
serum taken 14 days after the procedure reveals no significant differences.
Peripheral serum shows a higher number ofdpm comparing portal serum
taken 14 days after PH, SH or CO. Using mixed cultures ofH and CC
cells (ratio 1:1 and 1:10) a significant increase in dpm is found compared
to cells cultured separately (p<0.01). This potentiating effect is not found
if a ratio of 10:1 (CC:H) is used.
Conclusions: Portal serum taken 24 hours afterPH contains factors
stimulating the growth ofCC cells. A potentiating effect can be found ifH
and CC cells are cultured in conjunction. A minimal amount ofH seems
to be essential for the interactive stimulation.F021
SURGICALAPPROACHTOSEGMENT IFORMALIGNANT
TUMORS
D. ELIAS, PH. LASSER, E. DESRUENNES, H. MANKARIOS
Gustave-Roussy Institute Cancer Center, 94805 Villejuif, France
Seven complete and thirteen partial resections of segment (caudate
lobe) were performed for malignant tumors. In all cases except one,
removal of segment was associated with other types of hepatic resection
either for technical or carcinological reasons. Six were iterative hepatic
resections for recurrent liver metastases. In two cases the future remaining
left lobe was pre-operatively hypertrophied by right portal venous
embolization. Hepatectomies were performed with intermittent portal triad
clamping (mean total duration: 63 minutes, range 20-120) and after
preparation for total vascular exclusion. Associated partial resection of the
inferior vena cava was necessary in three cases. Mean duration of
operation was 285 minutes (range 60-540) and mean blood loss was 1749
milliters (range 200-5200). There was no postoperative mortality and
morbidity was low (30%). Surprisingly we retrospectively discovered that
free margins were small, less than 5 millimeters in 83% of the cases. In
spite of limited free margins and six iterative hepatectomies, eight patients
are free of disease with a mean follow-up of 19.2 months. Techonical
problems were different for each case and case by case adaptation was
necessary. Left, right, and central approaches were used accordingly. If
resection of segment associated with a right or left hepatectomy can be
currently considered as a standard major hepatic resection, isolated
complete resection of segment remains a real technical challenge.
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HEPATIC ISCHEMICTOLERANCE: COMPARATIVE
ANALYSISOFWARMANDCOLDISCHEMIA
P. LAMESCH C.RABE, B. RINGE, G. GUBERNATIS, J. HAUSS,
R. Pichlmayr Klinik ftir Abdominal und Transplantationschirurgie
Medizinische Hochschule Hannover, 3000 Hannover 61 FRG
Hepatic ischemic damage was studied in experimental and clinical
settings comparing warm ischemia (pringle manoeuvre) and after
hypothermic in situ protection.
MATERIALAND METHODS: A. Experimental study: in 10 pigs
(20-25 kg BW) vascular exclusion of the liver and installation of a porto-
caval-jugular bypass. E-group (n=5): 2 h warm ischemia; E-group 2
(n-5) hypothermic in situ protection (HTK solution 5C) and subsequent
2 h ischemia. B. Clinical study: 16 patients (C-group 1) underwent
conventional hepatic resections (Pringle maneuvre): ischemic time: 25
min [0-47]. 8 patients (C-group 2) liver resection was performed after
vascular exclusion and hypothermic in situ protection (HTK sol.).
Ischemic time: 137 min [29-180]. Conventional labarotory parameters
were compared in the postoperative course on day 1, 3 and 7. [results
given as median; *p<0.05 (U-test)]
RESULTS:
postop, day
E-Group
E-group 2
C-group
C-group 2
GOT U/L
3 7
449* 36 24
127 12 25
163 37 22
399 56 18
GLDHU/L
3 7
101 28 14
181 151" 21"
Bili umol/1
3 7
13 5 3
8 5 3
58 46 28
65 31 15"
PTr%
3 7
56 67 78
63* 63 87
CONCLUSIONS: The experimental study showed the significant
protective effect ofhypothermic in situ protection of the liver compared to
warm ischemia. From the clinical results it can be concluded that inspite a
5 fold prolonged ischemic time, ischemic damage (transaminases) was
moderately more pronounced, functional parameters (bilirubin, PTT) were
less depressed.
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WATER-SOLUBLEETHYLHYDROXYETHYL CELLULOSE
PREVENTSBACTERIALTRANSLOCATIONINDUCEDBY
MAJORLIVERRESECTION INTHERAT
X.D. WANG, R. ANDERSSON V. SOLTESZ*, S. BENGMARK
Departments of Surgery and Medical Microbiology*, Lund, Sweden
Enteric bacteria might act as pathogens, translocating across the
intestinal barrier to extraintestinal sites after major liver resection.
Methods to decrease the incidence of translocation are thus sought for.
Water-soluble ethylhydroxyethyl cellulose (EHEC) was administered
orally or intravenously prior to 70% or 90% hepatectomy in the rat. The
influence of enteric bacterial translocation to mesenteric lymph nodes
(MLN) and blood, enteric bacterial population and bacterial adherence on
the intestinal surface was determined. Phagocytic capacity by visceral and
circulating macrophages were determined by the uptake of 25I-labeled,
heat-killed E. coli.
Oral or intravenous administration ofEHEC reduced the incidence of
bacterial translocation to MLN and blood following major liver resection.
Oral EHEC appeared more effective than i.v. administration in protecting
against bacterial translocation to MLN in animals with 90% hepatectomy.
EHEC (oral and i.v.) significantly diminished intestinal macrophage
uptake capacity of 25I-labeled, heat-killed E. coli as compared to animals
without EHEC administration. Overgrowth or colonization of enteric
bacteria following major liver resection could be prevented by both oral
and i.v. EHEC. Adherence of 14C-labeled, alive E. coli on the intestinal
mucosa decreased following EHEC treatment in animals subjected to
major liver resection.
In conclusion, EHEC seems to be a potent agent preventing
translocation of enteric bacteria from the gut following major liver
resection, probably by balancing enteric microflora, inhibiting bacterial
attachment onto the intestinal surface and blocking phagocytosis by
intestinal macrophages.
F024
PANCREATICINSULINOMAS: OURPERSONAL
EXPERIENCE
G.R. FRONDA. S. ENRICO, M.P. CAPOZZI, M.TOPPINO, U. CATTANEO
Department of Surgery. University of Torino (Italy)
(Head: Prof. F. Morino)
Pancreatic insulinomas represent the main cause of primitive
hyperinsulinism. Since 1959 we have operated 36 patients for suspected
insulin-secreting neo-plasms of the pancreas; 29 cases turned out to be
insulinomas (2 multiple, 3 malignant) 5 diffuse insular hyerplasia; 2
hypoglycemic syndromes with no specific anatomo-phatological features.
The preoperatory localization was obtained in 18 patients (50%);
intraoperatory diagnosis was established in 79.9% of the cases, 96.5% in
the 29 cases of true insulinoma. In 28 cases of true insulinomas, 18
corporo-caudal resections and 10 enucleations were carried out; the 3
malignant insulinomas were treated with extensive distal pancreatectomy;
in 2 cases, hepatic metastasis were already present (palliative enucleation
in one and resection in the other). For the neoplasms not localized, the
intervention consisted on a programmed, monitored distal resection: we
observed case of occult insulinoma and 5 insular hyperplasia, while in 2
patients no insulinoma was found. The operative mortality was zero:
postoperative complications, specific and aspecific, occurred in 10 pts.
Long-term results (mean follow-up 9 yrs), in the 26 cases ofbenign
insulinomas, included 22 complete resolutions and 4 improved clinical
conditions. In the 3 cases of malignant lesions we observed residual
hypoglycemia only in 2 patients that presented hepatic metastasis. The 7
cases of diffused hyperplasia had a decisive and definitive improvement,
temporarily present in those two patients with a negative hystological
exam. In these neoplasma, the relative diagnostic facility contrasts with
the difficulty encountered in localizing the neoplasms. In the cases that
concerned simple adenomas, the therapeutic possibilities depend on tumor
site, reserving the resections for multiple localizations or uneasy
enucleations. Resections is a must in the malignant forms. Unlocalized
lesions, on the other hand, require a resection with simultaneous
monitoring of the glycemic blood levels combined to a hystologic control.F025
VITAMINAABSORPTION,ANEWTESTFOR
QUANTITATIVEEVALUATIONOFEXOCRINEFUNCTION IN
CHRONIC PANCREATITIS (CP)
I.P. HAJJ, M.C.A. PUNTIS, D. JAMES*
Departments of Surgery and *Biochemistry, University ofWales College of Medicine,
Heath Park, CARDIFF CF4 4XN, South Wales, U.K.
There is a need for non invasive repeatable techniques to measure
exocrine function in chronic pancreatitis.
VitaminA esters are hydrolysed in the gut by a pancreatic lipase before
absorption into mucosal cells. This phemomenon forms the basis of a new
and simple test of pancreatic exocrine function.
A physiological but safe oral dose of 10,000 IU VitaminA is given
after a 12 hour fast. Pre-dose and them hourly blood samples are taken for
retinyl, esters (RE), retinol binding protein (RBP), retinol and pre-albumin
(PA). In 30 CP patients (diagnosed clinically and by ERCP), the mean RE
level at 3 hours was 63 nmol/1 compared with 296 nmol/1 in a control
population.
We think that this significant difference in absorption is due to
inadequate enzyme secretion from the pancreas to hydrolyze the
administered Vitamin A ester. We know that most of the patients had
normal RBP levels (38 mg/lit) and normal liver function tests as well,
consistent with normal protein synthesis.
The degree of VitaminA absorption failure correlates with the severity
of other features of CP. There are in addition, differences in the pattern of
absorption between CP patients with alcoholic and non-alcoholic
aetiology.
F026
OPERATIONFORCHRONICPANCREATITIS
M. ROKKJAER. J. JEPSEN, A. KRUSE, J. RAVNSBAEK
Surgical Department L, Aarhus University Hospital, Denmark
71 patients with chronic pancreatitis were operated 1982-1989 because
of severe chronic pain: 54 men, aged 15-72 years, median 43, and 17
women, 30-76 years, median 37.The pain had lasted for 1/2-10 years,
median 2 years, no difference between the three types of operations.
42 patients were operated with a Partington-Rochelle drainage
procedure, 18 a.m. Whipple, and 11 patients with resection ofbody and
tail. Type of operation was decided by ERCP: drainage was performed in
diffuse disease with dilatation of the whole pancreatic duct to at least 6
ram; in severe changes without dilated duct resection was performed.
Supplementary biliary surgery was done in 6 drainage operations and 2
resections.
No perioperative mortality. Median hospitalization time 14 days for all
three types of operations. Two patients had to be re-operated because of
complications 17 patients died before follow-up, in four cases death was
related to pancreatitis.
77 patients (80%) answered a questionnaire after an observation time of
11/2-81/2 years, median 41/2 years: Visick 1: 47%, Visick 2:11%, Visick
3: 21% Visick 4: 21%. 5 patients had diabetes preoperatively and another
20 at the time of follow-up. 35 patients had diarrhoea preoperatively, 8 of
these had normal stools after drainage. 40% were unemployed and a
further 30% after operation, worst in the Whipple group. In carefully
selected patients with painful chronic pancreatitis operation will yield
satisfactory results in 70-80%.
F027
PANCREATICMUCINOUS CYSTADENOMAAND
CYSTADENOCARCNOMA.AMULTICENTERSTUDYOF 51
CASES
G. ZEITOUN J.M. HAY
French Association for Surgical research.
8, des Peupliers, 92270 Bois-Colombes, France
Pancreatic mucinous cystadenoma (MCA) is a potentially malignant
tumor which can change into pancreatic cystadeno-carcinoma (CAC).
This retrospective multicenter study conducted by the French Association
for Surgical Research from 1.1978 to 12.1987 was designed to compare
the prognosis of these two pathologies.
MCA: all patients were females (mean age 44 yrs, ranging from 23 to
72). The tumor was localized in the head: 3, in the body: 5, and in the tail:
21 cases. Mean diameter of the tumor was 8 cm. Surgical procedures were
as follows: biopsy, cystojejunostomy, 27 total resection of the tumor:
Whipple procedure, 24 distal pancreatectomies, 2 tumorectomies. No
postoperative death occurred. All patients are alive, free of any recurrence
at last follow-up.
CAC: There were 11 males and 11 females (mean age 63 yrs ranging
from 49 to 82). The tumor was localized in the whole pancreas: 3, in the
head: 12, in the body: 6, and in the tail: case. Surgical procedures were
as follows: 8 curative resecions, 4 palliative resections, 10 internal biliary
and digestive bypasses. Two patients died postoperatively. Twelve
patients died during follow-up with a mean survival of 10 months Eight
patients are alive, but 4 with recurrence.
These results suggest thatMCA of the pancreas should be
systematically resected. This is justified by: 1/the potential risk ofMCA to
change into CAC; 2/the good results of surgical treatment of the MCA;
3/the poor prognosis ofCAC even if radical surgery is performed.
F028
INTRAOPERATIVERAPIDRADIOIMMUNOASSAYFOR
INSULIN (IRRD INLOCALIZINGINSULINOMA
K.H. ZHANG Z.Y. GU
Dept. of Surgery, Chinese PLA General Hospital, Beijing, China
Abstract: In patients with organic hyper-insulinism, intraoperative rapid
radioimmunoassay for insulin (IRRI) in veins draining the pancreas might
help localize the tumor. Blood samples for IRRI are taken at various sites
in the splenic and portal veins developed by us in a simple way. Of 13
patients, the highest insulin concentrations correlated with the site of the
tumor in 12. The high insulin level is detected at the hepatic hilus in
remaining one with diffuse insulopathy. Also, Small insulinomas less than
cm in diameter could be found. In one patient with a tumor of 0.4 cm in
diameter and another one with two microinsulinoms are rationally
resected by distal pancreatectomy, which could not be detected by any
imaging procedure and palpation at operation. Therefore, it could be avoid
blind distal resection of the pancreas, and possibly invasive preoperative
diagnostic procedures.F029
ADJUVANTINTRAOPERATIVERADIATIONTHERAPY
VERSUS RESECTIONALONE INTHETREATMENTOF
PANCREATIC CANCER
A. ZERBI, D. PAROLINI, M. CARLUCCI, V FOSSATI*, V. DI CARLO
Pat. Chirurgica, Radioth.*-IRCCS S. Raffaele-Univ. Milan-Italy
We report our experience on the association of surgical resection with
intraoperative radiation therapy (IORT) in the treatment of pancreatic
cancer.
Between 1985 and 1991, 61 resections for pancreatic cancer, out of 192
observed cases, were performed at our institution. In 25 patients IORT
was added to resection (group 1), whereas other 36 patients underwent
resection alone (group 2) because of unavailability of linear accelerator or
patient’ refusal. Radiation doses from 15 to 20 Gy, with electron beam
energies between 6 and 12 Mev, were delivered. Extension of the disease
was analyzed: the mean diameter of the tumor was 3.1 cm in group 1, 3.5
cm in group 2; the percentage of nodal involvement resulted 62% in group
1, 43% in group 2. Operative mortality and overall post-operative
complications were respectively 4% and 32% in group 1, 2.7% and 25%
in group 2; no directly IORT-related complications were observed. One-
year, two-year and three-year
survival rate according to life-table method were respectively 62%,
27% and 22% in group 1; 40%, 18% and 11% in group 2. Median
disease-free survival resulted 9 months in group 1,7 months in group 2.
Among patients with evidence of recurrent disease, a local recurrence was
detected in 3 out 10 patients in group (30%), and in 10 out 15 patients in
group 2 (66%).
Our results suggest that a better local control and an improved survival
could be obtained in patients with pancreatic cancer by adjuvant IORT.
F030
INFLUENCEOF CLINICO-PATHOLOGICALVARIABLESON
SURVIVALAFTERPANCREATICODUODENECTOMY.
P JAGANNATH. L.J. DESOUZA, G. SINGH, V.M. MOHANDAS,
V. SHANTISWAROOP
Tara Memorial Hospital, Parel, Bombay, India-400 012
Pancreaticoduodenectomy is a standard surgical procedure for
adenocarcinomas involving the ampulla and head of pancreas. The
significance of clinicopathological factors is controversial. Fifty seven
patients underwent pancreaticoduodenectomy in a specialised cancer
centre during 1985-90. A retrospective analysis of clinicopathological
variables was undertaken. Majority (n=47) were ampullary carcinomas
and head pancreas lesions formed only 17% which reflects the low
resectability rate. 75% had moderately differentiated adenocarcinoma. The
size of the tumour was measured on fresh resected specimens. The
pathological variables were subjected to univariate analysis (SPSS).
Actuarial survival was calculated using Kaplan-Mier life table analysis.
31.7% had positive peripancreatic nodes. There was no significant
difference in survival of node +ve and node -ve patients. However size of
the primary tumour had significance influence on overall survival. Median
survival (MS) of tumours less than cm in size was 4 years. 1-2cms
lesions had 2 yr 7m (MS) and tumours more than 2 cms had dismal
survival of 7 months. Node positivity did not correlate with depth of
duodenal infiltration in an ampullary lesion.
Mortality has decreased to 4.7% with a pancreatic leak rate of 2.4%.
We conclude that though pancreaticoduodenectomy is a safe procedure in
a specialised centre, the indication should perhaps be limited to tumours
less than 2 cms.
F031
VALIDITYOFCOMBINEDRESECTIONOFTHEPANCREAS
ANDPORTALVEINFORCARCINOMAOFTHEPANCREAS
s. TAKAHASHI Y. OGATA, D. MAEDA, S. MURAI, K. YAMATAKA, T. TSUZUKI
Department of Surgery, Keio University School of Medicine, Tokyo, Japan
It seems to be prevalent opinion that patients with pancreatic cancer
have a poor prognosis as a result of low resectability rate and extremely
low long term survival rate. We have improved the result by performing
combined resection of the pancreas and portal vein.
Between March 1976 and September 1991,236 patients with
pancreatic cancer were admitted to our clinic and 138 underwent
resection. Seventy-seven 56% of the 138 patients received such procedure.
As a result of this policy, resectability increased to 58%.
Pancreatoduodenectomy and total pancreatectomy were carried out in 45
and 32 patients, respectively. According to pTNM classification, 11
patients were in stage I, 12 in stage II, 40 in stage III, and 14 in stage IV.
Curative resection was performed in 39 (51%) of the 77 patients.
Thirteen patients (17%) died postoperatively and the remaining 64 were
discharged from the hospital. The mean survival periods were 24 months
in the curative resection group and seven months in the non-curative
resection group, a statistically significant difference. Four patients
undergoing curative resection lived more than five years and the longest
survivor is alive well eight years and three months.
Combined resection of the pancreas and portal vein is a worthwhile
procedure to improve the treatment for pancreatic cancer.
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EXCHANGEEFFECTOFPARTIALGASTRECTOMYON
PANCREATIC CARCINOGENESIS
PWATANAPA B FLAKS, H OZTAS, PH DEPREZ, CALAM,RCN WILLIAMSON
Department of Surgery and Medicine, Hammersmith Hosp., RPMS, Du
Cane Road, LondonW12 ONN, United Kingdom
The controversial issue of enhanced pancreatic cancer risk following
partial gastrectomy has been explored in male Wistar rats (n=40)
weighing 250-300g Animals were randomised to receive either 60% distal
gastrectomy with Roux-en-Y reconstruction or gastrotomy and resuture
(control). Immediately after operation each group was further divided into
subgroups, receiving i.p. injections of saline or azasefine (30mg/kg/wk
for 3 wks). At 15 mo blood was obtained at 0,5,15 and 30 minutes after a
fatty meal for cholecystokinin (CCK) assay; rats were then killed.
Pancreatic wet weight was measured, and histological sections were
examined for atypical acinar cell loci (AACF), the putative precursor
lesion of carcinoma. There were no significant differences in body weight
or pancreatic weight between controls and rats with gastrectomy. Only
azaserine-treated rats had acidophilic AACF. Partial gastrectomy
substantially increased the number of acidophilic AACF per pancreas
(median 26.05 vs 2.09,P<0.005), with a 9-fold increase their volume
(p<0.005). Basal and postprandial plasma CCK concentrations were
higher after gastrectomy than in controls (P<0.05). Partial gastrectomy has
an enhancing effect on azaserine-induced pancreatic carcinogenesis,
probably by means of increased CCK release.
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NEOADJUVANT CHEMORADIATIONFORLOCALLY
ADVANCEDPANCREATICANDAMPULLARYCARCINOMA
RS YEUNG. JL WEESE, AR PAUL, JP HOFFMAN, LJ SOLIN, PFENGSTROM and
MJ KOWALYSHYN
Fox Chase Cancer Center and Presbyterian Cancer Center, Philadelphia, Pa. USA
A prospective study involving preoperative chemoradiation (CRT) for
locally advanced pancreatic and periampullary carcinoma was evaluated.
Thirty patients (14 females, 16 males;ages 37-79) with biopsy proven
adenocarcinoma of greater than 4 cms involving the pancreas (25 head, 2
body/tail) and duodenum (3) received radiation (5040 cGy, 180 cGy/fx, 5
days/week) concurrent with 5-FU, gm/m2/day continuous infusion (days
2-5, 28-32) and mitomycin C 10mg/m bolus (day 2). One patient died of
biliary sepsis prior to completion ofCRT. On restaging, 4 had metastases,
2 had portal vein occlusion, had poor performance status and refused
operation. The remainder underwent laparotomy 3-6 weeks after CRT.
Fourteen pancreatectomies (10 total, 2 Whipple, 2 distal) were performed
with two in-hospital deaths. Resectability rate 44% (12/27) for pancreatic
and 67% (2/3) for duodenal carcinoma. All specimens revealed clear
margins and extensive necrosis with hyalinization. Lymph node
metastasis were found in 14%. The two duodenal carcinomas had no
residual tumor. The actuarial 5 year survival was 43% and 0% for the
resected and non-resected groups respectively (p=.04). Considering
pancreatic carcinoma alone, the actuarial three year survival was 35% for
the resected group and 0% for non-resected group (p=.07). Pattern of
failure included 1/14 locoregional, 2/14 hepatic and 1/14 pulmonary.
Neoadjuvant therapy can be given safely and allows for complete
resection in 67% of those who come to laparotomy.
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DIAGNOSISOFPANCREATICCANCERBYDETECTIONOF
CANCER-ASSOCIATEDANTIGENS INSERUMWITH
MONOCLONALANTIBODIES
M Yuan
China Great Wall Hospital, Beijing China.
A panel of monoclonal antibodies were derived from BALB/c mouse
immunized with mucin of pancreatic cancer cell line SW1990.four of
them designed as PS-1, PS-2, PS-7 and PS-10, all secreated IgM. When
tested in paraffin sections of malignant and normal human tissues by
SABC immunohistochemical methods, 90% of pancreatic cancer tissues
reacted with PS-1, PS-2, and PS-10, while 70% reacted with PS-7. Most
of gastric cancer, colorectal cancer and Vater’ ampulla cancer reacted
with these four antibodies, but less in other cancers. Normal pancreatic
tissue reacted with PS-1, PS-2 and PS-10 differently, but not with PS-7.
The related antigens of four antibodies are highly glycosylated molecules
(200KD) with mucin-like biochemical characteristics. They are all
gastrointestinal cancer-associated antigens.
The detection of cancer-associated antigens in sera is based on the
inhibition of binding of antibodies to target antigens. The positive rate was
determined by the ELISA when index of binding inhibition greater than
the mean +2SD of normal individuals. In pancreatic cancer patients,
58.8%, 62.5%, 75.8% and 87.5% were positive with PS-1, PS-2, PS-7
and PS-10. While in normal individuals, 4%, 4%, 3%, and 6% were
positive. When these four monoclonal antibodies were used in
combination (cock-tail), the positive rate was increased to 96.2% in
pancreatic cancer and only 7% in normal individuals and 15.2% in non-
malignant diseases. These study show the potential usefulness of
monoclonal antibody in the diagnosis ofhuman pancreatic cancer.
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FACTORSINVOLVEDWITHLOCAL SPREAD,REGIONAL
LYMPHNODEMETASTASISAND SURVIVAL INRESECTED
PANCREATICCANCER
S.T. BROWER MD. R. NEWMAN MD, D. PERTSEMLIDIS MD, I. KREEL MD,
A.H. AUFSES, JRMD
Department of Surgery, Mount Sinai School of Medicine, Gustave L. Levy Place, New
York, New York 10029.
We have examined the histopathological factors affecting the degree of
local spread, regional lymph node (RLN) metastases, and overall survival
(O.S.) in a group of50 cases of resected carcinoma of the exocrine
pancreas. Although the mean O.S. for the group was 14.3 months,
resected patients withoutRLN involvement had a mean survival of 24
months. In contrast the mean O.S. rate was 8 months for patients with
RLN involved. Size, tumor location, and histological grade were
compared to RLN involvement and O.S. The mean size ofprimary tumor
did not differ significantly between patients with or without RLNs (5.1 vs
4.6cms). However, 7 of 8 T1 tumors were <4cm and 35% of tumors <4cm
were T1 lesions. In contrast, only of 17 (6%) oftumors >4cm was T1.
Histological grade was correlated with nodal status and O.S. There was a
significant difference between histological grade and the presence of
metastatic lymph nodes (G1, 37% positive, G2-4 55% positive). Patients
with well differentiated tumors had a mean survival of 21 months
compared to a mean survival of 10 months for less differentiated tumors
(p<0.05). This difference was even more significant when stratified for
nodal status. The patients with well differentiated tumors and noRLN
involvement had a mean survival of 36.1 months compared to 8.6 months
for well differentiated tumors with RLN involvement. In summary, we
have shown that size, histological grade, and local spread predict for nodal
status. However, specific patient subsets (G1, node negative) exhibit an
excellent survival when curative pancreas resection is successful.
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EXFOLIATIVECYTOLOGYFORDIAGNOSISOFBILIARY
STRICTURES
T. KURZAWINSKI B. DAVIDSON, R. DICK, A. DEERY, J.S. DOOLEYAND
K.E.F. HOBBS
Hepatobiliary & Liver Transplantation Unit, Cytology Dept, Royal Free Hospital and
School ofMedicine, London, UK.
Imaging of biliary strictures may suggest malignancy but bile (BIC)
and brush (BRC) cytology can provide tissue diagnosis.
We studied 92 consecutive patients (median age 66 years, range 39-91)
with biliary strictures on ERCP (71) or PTC (21). Brushings (38) were
taken using a modified Geenan cytology brush (6 Fr, Wilson Cook)
passed alongside a guide wire which remained through the stricture. Bile
(92) was aspirated after internal/external catheter or endoprosthesis
insertion. Specimens were examined by one experienced cytologist (AD)
and reported as positive or negative for malignant cells. Malignant (66) or
benign disease (14) was confirmed by histology or laparotomy in 52
patients and by follow up in 28.12 patients with uncertain diagnosis were
excluded. The overall sensitivity ofBRC was significantly greater that
BIC (59% vs 30%; p<0.01) as was diagnostic accuracy (69% vs 43%;
p<0.01). Specificity was 100%. Sensitivity for each tumor was:
BIC
BRC
Pancreatic Cholangio Ampullary Other
carcinoma carcinoma carcinoma tumours
(28) (20) (7) (11)
30% 30% 29% 18%
55% 57% 100%
There was no procedure related complication and the average sampling
time was less than 5 rain.
We conclude thatBRC is more sensitive than BIC in detecting
malignancy and with the technique described is safe and rapid.
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PERCUTANEOUS USEOF SELFEXPANDABLEMETALLIC
STENTS INADVANCEDMALIGNANTHILARLESIONS
J.S. LAMERIS, J. STOKER, H.W. TILANUS, M. VAN BLANKENSTEIN,
O.T. TERPSTRA
Department of Radiology, Gastroenterology and Surgery, University Hospital Rotterdam,
Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands.
Purpose: The value of self expandable stents (wallstent; Medinvent,
Lausanne) in the palliative treatment of patients with malignant hilar
obstruction was studied.
Methods: Fifty-one patients were treated by a total of 72 stents. Six
patents had a type lesion, 9 a type II lesion and 36 a type III or IV lesion.
Stent diameter was cm; length 3.5-10.5 cm.
Results: In all but 7 patients (type III or IV) bilirubin levels turned to
normal values. The median survival of 32 patients who died was 4.3
months (0.7-18m). Nineteen patients are alive after a median period after
stent placement of 10 months (1-28M). Recurrence or worsening of the
jaundice was seen in 17 patients, after a median period of 8 months.
Tumor overgrowth at the proximal end of the stent(s) was the cause in 7,
at the distal end in 4, tumor ingrowth, haemobilia and angling of the stent
each in one patient. The cause was not established in two patients. Re-
intervention was performed in 15 patients (29%). Thirteen patients
benefited from the re-interventions (median follow up 3 months).
Conclusion: The use of the Wallstent in malignant hilar biliary
obstruction compares favourable to plastic stents, as re-obstruction is
mostly not stent related, but caused by tumor progression.
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IMMUNOHISTOCHEMICALEXPRFSIONFOREGF
RECEPTORAND c-erbB-20NCOGENEPRODUCT INBILE
DUCTCANCER
R. SASAKI. S. KANNO, T. SUTO, Y. TAMASAWA, H. TOYOSHIMA, H. OHMORI
and K. SAITO
In order to reveal the cell-biological character of bile duct cancer,
expression of epidermal growth factor receptor (EGFR) and c-erbB-2
oncogene product were studied immunohistochemically. Further, the
relationships between those expressions and histopathological parameters
or prognosis were investigated.
MATERIALS AND METHODS: Twenty-six cases of bile duct cancer
were used. The avidin-biotin peroxidase complex (ABC) method using
monoclonal antibodies for EGFR and c-erbB-2 product was performed.
RESULTS:
1) The expression for EGFR was observed in 7 of 26 cases (26.9%) and
c-erbB-2 product was in 13 (50.0%).
2) EGFR expression was higher in the cases of papillary
adenocarcinomas (41.7%) and well differentiated adenocarcinomas
(40.0%), compared with in moderately (0%) or poorly (0%) differentiated
adenocarcinomas. C-erbB-2 product was highly stained in the cases of
long tumor length (44.4% less than 3cm, 62.5% more than 3 cm), and in
advanced stage (stage 0%, 2 44.4%, 3 44.4%, 4 71.4%)
3) In EGFR positive cases (n=7) five year survival rate was 0%, on the
other hand, in EGFR negative cases it was 63.6%.
CONSLUSIONS: These results suggest that the immunohistochemical
expression for EGFR may be a prognostic factor in bile duct cancer.
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LONG-TERMSURVIVALOFPATIENTSWITHCARCINOMA
OFTHEMAINHEPATICDUCTJUNCTION
Y. SUGIURA S. NAKAMURA, S. IIDA, Y. HOSODA, S. IKEUCHI, T. TSUZUKI
Keio Bile Duct Cancer Study Group, 35 Shinanomachi, Shinjuku, Tokyo Japan
Long-term survival of patients with carcinoma of the main hepatic duct
junction is now the issue. We herein report on 10 patients who lived more
than five years after surgery. Surgery was carried out by surgeons in six
institutions, who were trained at Keio University Hospital, under the same
policy that extensive resection of the bile duct combined with liver
resection be the procedure of choice. In a total of 140 patients, 79
underwent resection, a resectability rate of 56.4%, 7 patients died
postoperatively, an operative mortality rate of 8.8%. Ten of the 79 patients
lived more than five years after surgery. Procedures of liver resection in
the 10 patients were right trisegmentectomy in four, right lobectomy in
threeand left lobectomy in three.. Combined resection of the portal vein
was carried out in three. The resected margins of the bile ducts were clear
in all patients. Histologic diagnosis was well differentiated
adenocarcinoma in five and moderately differentiated adenocarcinoma in
four. Lymphatic metastases were observed in two. It should be stressed
that extensive resection of the bile ducts combined with liver resection is
feasible and valid.
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LIVERINVOLVEMENT IN GALLBLADDERCARCINOMA:
ASTUDYOF ITSMODES
Y. SHIRAI. K. YOSHIDA, K. TSUKADA, T. MUTO
Department of Surgery, Niigata University School of Medicine, Niigata, Japan.
The aim of this study is to clarify the modes of liver involvement in
gallbladder carcinoma (GBC).
Patients and Methods: Eighty-five cases ofGBC underwent a radical
surgery. Twenty cases (24%) showed liver involvement around the
gallbladder bed. The resected liver was examined histologically by a
multiple section technique in the 20 cases.
Results: (1) The spread was classified into 3 types as follows: 1) direct
extension type (4 cases), 2) lymphatic spread type (13 cases), and
3) hematogenous spread type (3 cases). The direct extension type was
defined as an expansive tumor growth without any satellite lesion. The
lymphatic spread type was defined as the tumor with marked lymphatic
involvement in the portal apace around the tumor. Hematogenous spread
type was defined as the lesion with satellite deposits ofhematogenous
origin. (2) Microscopic non-contiguous satellite lesions, which were not
grossly identified, were found in all cases of hematogenous spread any
lymphatic spread. Hematogenous spread type showed microscopic
satellite lesions within mm from gross tumor. Lymphatic spread type
showed microscopic satellite lesions within mm from gross tumor.
Lymphatic spread type showed microscopic satellite lesions at a distance
ranging from 0.8 to 11.5 ram. The distance (=Y mm) from the gross
border of liver invasion to the farthest satellite lesion correlates to the
gross depth (=X mm) of the liver invasion. The formula of the correlation
was: Y=0.34X+1.2 (p<0.01).
Conclusions: (1) Lymphatic spread along the portal space was a
predominant mode of liver involvement. (2) Surgical margin of liver
resection should be decided in consideration of the possibility of non-
contiguous satellite lesions.
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RF_ULTSOFARANDOMIZEDSTUDYOFBOLUS VS.
CONTINUOUS I.V.APPLICATIONOFAPROTININFOR
REDUCTIONOFBLOODPRODUCTREQUIREMENTS IN
ORTHOTOPIC LIVERTRANSPLANTATION (OLT)
W.O. BECHSTEIN. G. HIMMELREICH, H. RIESS, M. MUSER, R. ROSSAINT,
P. NEUHAUS
Depts. of Surgery, Internal Medicine, and Anesthesiology,
University Clinic Rudolf Virchow, Berlin, Germany
A reduction of blood product requirements in OLT with systemic
application of aprotinin has been reported. However, randomized studies
are still lacking. Effects of different aprotinin regimes on hemostatic
changes and blood product requirements in OLT were investigated in an
open, prospective, randomized study. OLT was carried out according to
standard techniques. Adult patients were randomized to receive either
bolus treatment of aprotinin (3 x 0.5 mio. KIU (kallikrein inhibitor units)
(n=13)(group= 1) or continuous aprotinin infusion of 0.1-0.4 mio. KIU/h
(n= 10)(group 2). Signs of hyperfibrinolysis before and after graft
reperfusion were significantly lower in group 2 as measured by whole
blood clot lysis time in thrombelastography (TEG). Tissue plasminogen
activator (t-PA) activity increased significantly less in group 2 than in
group during the anhepatic phase. Intraoperative blood product
requirements were higher in group (median RBC u. 8 [4-1 than in
group 2 (median RBC u. 7 [4-13]) (n.s.) Transfusion requirements during
the first 3 postoperative days were significantly lower in group 2 than in
group (median RBC u. 1.5 vs. 3.5 [p<0.05]). Analysis of the early
perfusate of the liver graft detected signs of decreased t-PA release of the
graft in group 2, pointing to a protective effect of high aprotinin
concentrations to hepatic endothelial cells. The results demonstrate the
advantage of continuous aprotinin infusion over bolus application in OLT.
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PROTEINASE INHIBITOR (APROTININ)FORTHE
TREATMENTOF REPRFUSIONINJURYAFTERLIVER
TRANSPLANTATION
ANEXPERIMENTALSTUDY INPIGS
K.J. OLDHAFER J. HAUSS, H.U. SPIEGEL, R. PICHLMAYR
Hannover Medical School, Department of Surgery, F.R.G.
Recent work had shown that cold preservation produced a sinusoidal
lining cell injury in liver allografts and that the attachment mechanisms of
sinusoidal lining cells to the extracellular matrix might be involved in this
pathogenesis. The purpose of this study was to determine whether
aprotinin given during the reperfusion may reduce this injury in a pig liver
transplantation model.
METHODS: Pigs weighting 18-26 kg were used for orthotopic liver
transplantation (OLT). Aprotinin was administered IV in 7 recipients:
20.000 KIU/kg body weight as a bolus and 7.500 KIU/kg body weight per
hour as continuous infusion for 6 hours after reperfusion. The cold
ischemic time was 5.9_+0.5 h in the untreated (n=8) and 5.7_+0.75 h in the
aprotinin-treated group (n=7). Blood samples were drawn in the donor, in
the recipient after starting the operation, and 6 hours after reperfusion
and on postoperative days 1,3 and 5. Liver injury was assessed from
release of transaminases.
RESULTS: In the untreated group 5 out of 8 pigs and in the aprotinin-
treated group all pigs survived. In both groups GOT levels increased
postoperatively and reached maximal values on the first postoperative day.
However, in the aprotinin-treated group the increase ofGOT was
significantly lower (430-+172 U/I) than in untreated group (887_+375 U/I)
CONCLUSION: The results indicate that inhibition of proteases by
aprotinin after revascularization is able to reduce the reperfusion injury.
Since the hepatic extracellular matrix is mainly composed of
proteoglycans and glycoproteins which can be altered by proteinases,
protection of sinusoidal cell detachment may represent one important
pathway through which aprotinin exerts its protective action.
BILIARYTRACT COMPLICATIONS INLIVER
TRANSPLANATION
MORENO G.E; GARCIA G.I.; ALVARADO A.A.; LOINAZ S.C.; CGOMEZ S.R.;
JIMENEZ R.C.; GONZALEZ-PINTO A.I.; BERCEDO M.J.; IBANEZ A.J.; MORENO S.C.
Digestive Surgery Department.
Hospital 12 de Octubre. Madrid. Spain
INTRODUCTION: Biliary tract reconstruction is considered the
"Achille’ heel" of liver transplantation. Many forms of reconstruction
had been proposed to decrease morbidity (between 8 to 86% in literature
reports).
MATERIALAND METHODS: Between April 1986 to September
1991,233 orthotopic liver transplants (OLT) have been performed at "12
de Octubre" Hospital (three intraoperative deaths), 188 in adults and 12 in
children. Single layer suture of 5/0 poliglactic acid (Vycril) was the
technical preference, 8 to 12 F size of T-tube was the more common.
Biliary complications were diagnosed by biochemistry, radiology and
scintigraphy.
RESULTS:
Biliary Anastomosis CD-CD T CD-CD H-J TOTAL
Number ofOLT 125 52 50 *230
Total complications 13(10.4%) 6(11.5%) 6(12%) 25(18.8%)
CD-CD T: Choledocho-choledochostomy with T-tube
CD-CD: Choledocho-choledochostomy without T-tube or stent
H-J: Hepatico-jejunostomy
Three choledoco-choledocystojejunostomy without complications.
Complicatons include: biliary leakage (7); leakage after removal T-tube
(2); Fistula (3); Obstruction (1); Stenosis (4); Stenosis + stones (2);
Anastomotic dehiscence (2); Biloma and collection (4).
CD-CD is our first choice method of reconstruction T-tube has the
advantage of direct radiological access. Not using it simplifies the
technique, but may delay the diagnosis of complications.
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BILIARY COMPLICATIONSAFTERLIVER
TRANSPLANTATION
B. RINGE, K. KOHLHAW, A. SCHMIDT, M. GALANSKI, R. PICHLMAYR
Medizinische Hochschule Hannover, Hannover, F.R.G.
Biliary complications following liver transplantation have always
contributed significantly to postoperative morbidity. Despite better
management by interventional radiology and reduced mortality prevention
of these complications by a safe surgical techniques seems to be one of the
most important prerequisites.
Therefore, we analyzed retrospectively the incidence of biliary
complications in relation to the type of biliary reconstruction. Out of 635
operations performed within 18 years only 538 primary transplants were
evaluated, including 445 adults and 93 children. Major types of biliary
anastomosis were choledochocholedochostomy in a side-to-side =CdCdss
(n=300) or end-to-end CdCdee (n=60) fashion, and
choledochojejunostomy Cdj (n=165). 13 patients had no biliary
reconstruction.
The overall biliary complication rate necessitating surgical
reinterventions was 16.6% (87/525). The relationship between type of
anastomosis and kind of complications is shown in the following table:
Complications total no. (%) anastomosis T-tube others
CdCdss 26/300 (8.7) 15 (15.0) 9 (3.0) 2 (0.7)
CdCdee 18/60 (30.0) 8 (13.3) 9 (15.0) (1.7
Cdj 43/165 (26.1) 23 (13.9) 8 (4.8) 12 (7.3)
Apart from T-tube problems or especially bleeding from the Roux-en-Y
loop in patients with CdJ more than half of all complications were related
to the anastomosis: CdCdss had, by far, the lowest rate of only 5%, in
pediatric recipients there was no complication at all. These data from a
larger series confirm our previous experience that CdCdss is the safest
type of biliary reconstruction after liver transplantation, and should be
considered as the anastomosis of first choice.
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RF_ULTSOFLIVERTRANSPLANTATION INFULMINANT
HEPATIC FAILUREANDLATEONSETHEPATICFAILURE IN
CHILDREN
C.K. YEUNG. R. MONDRAGON, G.M. VERGANI, N. HEATON, A.P. MOWAT,
B. PORTMANN, R. WILLIAMS, K.C. TAN.
Department of Surgery, Paediatrics, and the Institute of Liver Studies.
King’s College Hospital, London, U.K.
The mortality rate of fulminant hepatic failure (FHF) and late onset
hepatic failure (LOHF) in childhood has remained between 70-95%
despite recent improvements in medical therapy. Liver transplantation has
become an important therapeutic option in adults with this entity, but has
been performed very infrequently in children.
Between March 1988 and October 1991, 13 children aged from
month to 14 years with FHF or LOHF received a total of 14 liver
transplants. This is the largest series reported in the literature. The
aetiology was viral hepatitis in 5, undetermined in 4, drug hepatotoxicity
(carbamazepine) in 2, autoimmune hepatitis and congenital
haemochromatosis in 1. Reduced-sized livers were used in 11 of the 14
transplants. The postoperative morbidity included infective complications
and abdominal bleeding. Two patients died from Graft Versus Host
Disease, one from brain aspergillosis and another from graft infarction
after portal vein thrombosis. Nine patients (70%) survive with a median
follow-up of 18 months.
Liver transplantation should be the therapeutic option in children with
FHF and LOHF where the chance of recovery with intensive medical
therapy is poor.
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ORTHOTOPICVSHETEROTOPICLIVER
TRANSPLANTATION INTHE PIG: EFFECTS OFLONG-TERM
GRAFTPRESERVATIONANDPROSTAGLANDIN E1ON
INTRAOPERATIVEHEMODYNAMIC CHANGES
JD. BLANKENSTEIJN P.M. SCHLEJEN, T.H.N. GROENLAND, O.T. TERPSTRA
Departments of Surgery and Anesthesiology, University Hospital Dijkzigt and the
Laboratory for Surgical Research, Erasmus University, Dr. Molewaterplein 40, 3015 GD
Rotterdam, The Netherlands
We compared the intraoperative hemodynamic changes during
orthotopic liver transplantation (OLT) with those during heterotopic liver
transplantation (HLT), after different duration of cold storage of the graft.
The effect of prostaglandin E1 (PGE)I on these parameters was also
studied. Sixty-nine female Yorkshire pigs underwent wither OLT (N=32)
or HLT (N=37) with a graft stored for 2 hr (N=31), 24 hr (N=I 6), 48 hr
(N=7), or 72 hr (N=15) in the University ofWisconsin solution. PGE1
was added to the preservation solution and both donor and recipient
animals in 16 transplantations of the various groups. Amongst others,
cardiac output (CO), mean arterial pressure (MAP), and systemic and
pulmonary vascular resistance (SVR, PVR) were measured at different
time points during the operative procedure. For the three main variables
i.e., the type of transplantation, the use ofPGE, and the preservation time,
multiple regression analysis was performed. During HLT, portal vein
clamping loweredMAP and CO, while during the anhepatic phase in
OLT, SVR increased and CO dropped. After reperfusion of the graft an
increase in PVR and a decrease in SVR was found in both OLT and
APLT. At different stages of the surgical procedure, longer graft storage
time diminished CO andMAP (P<0.001), especially in OLT. PGE1
appeared to reduce the cardiovascular reserves needed to compensate the
changes after recirculation of the graft. We demonstrated that extension of
the graft preservation period resulted in poor cardiac performance, more
so in OLT than HLT. The native liver in HLT might be able to metabolize
the myocardial depressant factors, released into the circulation upon
reperfusion. Prostaglandin E1 did not protect against the reperfusion
syndrome.
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SURGERYFORBILIARYATRESIA THEPLACEOFLIVER
TRANSPLANTATION
PJ FRIEND G NOBLE-JAMIESON, S REVELL, RY CALNE, NV JAMIESON, PS
JOHNSTON, ND BARNES.
The Departments of Surgery and Paediatrics, Addenbrooke’s Hospital, Hills Road,
Cambridge CB2 2QQ, UK
Although the benefits of porto-enterostomy in the primary treatment of
biliary atresia are widely accepted, many patients obtain limited benefit
and develop life threatening complications of chronic liver failure. The
Cambridge-King’ College Hospital liver transplant programme has
carried out paediatric transplants since January 1984. We have reviewed
the results of this procedure in patients with biliary atresia. The 73 such
patients transplanted up to September 1991 have been analysed in 2
periods 1984-88 (34 patients) and 1989-91 (39 patients).
The indications for transplantation were the development of life-
threatening complications, particularly gastro-intestinal bleeding, ascites,
recurrent sepsis, encephalopathy and cessation of growth.
In the earlier group 34 patients received 44 grafts (retransplant rate
29%). Graft survival at and 2 years was 46% and 39%. Patient survival
was 56% and 50%. In the later period 39 patients received 48 grafts
(retransplant rate 21%). Graft survival at both and 2 years was 66% and
patients survival 84%. No graft or patient was lost after 2 years in either
group.
The mean age of patients was 3.4 years (1984-8) and 4.6 years (1989-
91). However, 10 (29%) of the early group were aged less than 2 years
compared to 17 (44%) of the later group. More patients in the later series
were transplanted with "reduced size" grafts (33% vs 7%) these being
used in emergency cases, as a consequence of which very few patients
now die whilst awaiting transplantation.
The results of paediatric liver transplantation have improved rapidly in
recent years. We feel that this procedure should now be considered at an
early stage in those cases where conventional surgery has proved
unsuccessful.
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OTREATMENTOFBUDD-CHIARISYNDROME
(BCS) CONVENTIONALSURGERYORLIVER
TRANSPLANTATION?
B. RINGE, K. OLDHAFER, H. LANG, J. LAAS, H. LINK, R. PICHLMAYR
Medizinische Hochschule Hannover, Hannover, F.R.G.
BCS delineates a heterogenous group of various etiologic and
morphologic disorders leading to hepatic venous outflow obstruction.
Accordingly, the optimal treatment of this disease remains a controversial
issue.
In order to elucidate the role of different operations we analyzed our
own experience within the past ten years. This consecutive series includes
41 patients (30 females, 11 males) with ages ranging from 12-49 years.
The etiology ofBCS was known in approximately 50%; one patient had a
veno-occlusive disease following bone marrow transplantation. 10
patients underwent conventional surgery as primary therapy:
peritoneovenous shunt (2), caval thrombectomy and Maass stent (1),
portocaval side-side shunt (2), mesocaval shunt (2), cavomesoatrial shunt
(1), and dorsocranial liver resection and hepatoatrial anastomosis (2).
Total hepatectomy and liver transplantation (LTx) was performed in 31
cases as first option; 4 additional patients were transplanted after failed
previous surgery. So far, 15/41 patients have died. Only one of the
primary non-transplanted patients has survived; 3/4 patients out of this
group could be rescued by secondary LTx. 22/31 primary liver recipients
are alive with a maximum follow-up of nine years (5-year actuarial
survival 68%).
These results demonstrate clearly that LTx is one of the therapeutic
options to be considered for patients with BCS. Certainly, our own
experience is biased by the unfavourable outcome after conventional
surgery thus supporting the more aggressive attitude of LTx. Even more,
proper patient selection remains the crucial question which can only be
answered by better understanding and definition of the pathogenetic,
morphologic and clinical spectrum of this particular disease.
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AN INVITROMETHODFORCOMPARINGTHEEFFICACY
OFTWOPRESERVATIONSOLUTIONS INONE CANINE
LIVERUSINGTHE 5’-NUCLEOTIDASEASSAY
T.M. VAN GULIK, C.R. NIO, W.M. FREDERIKS, J. RINGERS, L. Th. DE WIT, P.C.M.
VERBEEK, P.J KLOPPER, M.N. VAN DER HEYDE.
Dept. of Surgery, Academic Medical Center, 9 Meibergdreef, 1105 AZ Amsterdam,
The Netherlands.
The value of 5’-nucleotidase (5’-NT) as a marker of liver graft viability
was studied in relation with liver preservation experiments. In 6 mongrel
dogs, the main fight and left branch of the portal vein were cannulated and
flushed separately in situ with cold UW-solution (UW) and EuroCollins
(EC), respectively. After hepatectomy, the fight and left liver lobes were
split and stored at4C in either solution. 5’-NT in liver tissue was
determined histochemically (lead salt method) in cryostat sections. After
48h storage in EC, the 5’-NT score had decreased to 31%+16% (n=6),
whereas in UW, 5’-NT score was 76%+10% (n=6). Significantly (p<0.05)
higher 5’-NT scores were found also after 24h and 72h preservation time
in UW. This result is in keeping with the higher preservation tolerance of
liver grafts preserved in UW. The 5’-NT assay was applied in relation
with graft function in orthotopic liver transplantation experiments in dogs.
All dogs with liver grafts preserved in UW-solution during 24h (n--4) and
48h (n=3) survived (>5 days). Pre-transplant 5’-NT scores ranged from
61% to 100%. The 72h preserved livers (n=5) did not show life supporting
function. Pre-transplant 5’-NT scores (33%+12%, n=5) were significantly
(p<0.05) decreased. In conclusion, the 5’-NT assay in conjunction with
the double flush method through the portal vein, provides a simple and
rapid in vitro method to test solutions for liver preservation.
F051
MODIFICATIONOFRETICULOENDOTHELIALFUNCTION
BYMURAMYL DIPEPTIDEENCAPSULATEDLIPOSOMES IN
JAUNDICEDRATS TREATEDWITHBILIARY
DECOMPRESSION
R. ADERSSON. J.W. DING, B. HULTBERG*, S. BENGMARK
Departments of Surgery and Clinical Chemistry*, Lund, Sweden
Septic complications and renal dysfynction are major causes of
morbidity and mortality following biliary surgery in the jaundiced patient.
In previous studies we demonstrated that reticuleondothelial system (RES)
function was severely depressed in rats with biliary obstruction and RES
function tended to normalize very slowly following biliary
decompression. Ways to increase the recovery ofRES function following
biliary obstruction are thus sought for. The present study investigates the
influence ofliposome encapsulated muramyl dipeptide (MDP)
administered in jaundiced and biliary decompressed animals.
Rats with 2 weeks biliary obstruction, with or without week of
concomitant biliary decompression relieving the jaundice, were treated
with either normal saline, free MDP, placebo liposomes or liposome
encapsulated MDP. RES function was evaluated by the blood clearance
(described as the corrected phagocytic index) and organ localization (liver,
spleen, lungs, kidneys) of i.v. injected 125I-labeled, heat-killed E. coil.
The corrected phagocytic index following week of biliary
decompression returned to normal levels in animals treated with MDP-
liposomes, while RES function was impaired in all otherjaundiced and
biliary decompressed groups. In the biliary decompressed, MDP-liposome
treated group, renal localization of radiolabeled E.coli was significantly
lower as compared to all otherjaundiced biliary decompressed groups.
We conclude that treatment with MDP-liposomes improves the
otherwise impaired RES function in rats with biliary obstruction and
especially in the early phase following biliary decompression ofjaundice.
F050
LIVERGRAFTASSESSMENT INORGANDONORSBYTHE
LIDOCAINE/MEGXTEST ISUNRELIABLE.
R. REDING A. FEYAERTS, P. WALLEMACQ, L. LAMBOTTE, J.B. OTTE.
Dept of Surgery, St-Luc Unixiersity Clinics, Brussels, Belgium
Lidocaine/monoethylglycinexylidide (MEGX) test was performed in
38 liver donors prior to organ harvesting. The serumMEGX 15 min after
an IV bolus of lmg/kg of lidocaine in the donor (MEGX t15) was
retrospectively correlated with outcome of the transplant and early liver
graft function. Three donors were excluded from the study because of pre-
test contamination with lidocaine. Among the remaining 35 liver
transplants (OLT), 4 patients were retransplanted within 10 days post-
OLT (primary nonfunction (PNF): n--4; early severe graft dysfunction:
n=2), and three recipients died, with median (range) donorMEGX t15
(ng/ml) at 100 (86-119) and 169 (146-182), respectively, when compared
to 87 (18-245) in the remaining 28 OLT patients alive with functioning
grafts. Considering the literature (1), aMEGX 15 value < or >80ng/ml
was considered arbitrarily as the cut-off point which may predict poor or
good liver graft quality, respectively. Donor and preservation data were
not statistically different in the 2 corresponding groups in terms ofmean
donor age (21.9 vs 21.0), days in intensive care unit (2.8 vs 2.6), ischemic
time in hours (13.6 vs 12.7) and T-cell crossmatch. One month graft
survival rate was significantly higher in the <80ng/ml group (12/12:
100%) when compared to the >80ng/ml group (7/23: 70%; p-.036),
Moreover, early (days 1-5) post-OLT cytolytic and functional parameters
were similar in both < or >80ng/m] MEGX tl5 groups: peak SGOT
(UI/1)(mean+SD: 2356+2622 vs 2173+3036, NS), peak SGPT
(UI/1)(1684+1476 vs 1952+1939, NS), mean SGPT (1051+791 vs
1354+1533, NS), minimum PT (%) (43+17 vs 43+13, NS), and peak total
bilirubin (mg/dl) (9.8+4.9 vs 10.6+5.0, NS). In conclusion, (1) theMEGX
test failed to predict graft outcome, as the 2 PNF cases had "excellent"
MEGX t15; (2) low donorMEGX t15 correlated neither with poor graft
outcome nor with early liver dysfunction. Low MEGX t15 value should
thus not preclude the use of a liver donor, particularly in the current
context of organ shortage.
(1) Adam R, et al. Transplant Proc 23: 2470, 1991
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CANWEDOAWAYWITHPTCD?
R.D. BAPAT, N.N. REGEAND S.A. DAHANUKAR
Department of Gastro-enterology Surgery and Department of Pharmacology, Seth G.S.
Medical College & K.E.M. Hospital, Parel, Bombay 400 012, India.
Percutaneous transhepatic cholangiography and drainage (PTCD) is
performed in surgical jaundice to decompress the biliary tree and improve
hepatic functions. However, the risk of sepsis is high in these patients due
to immunosuppression (1) and surgical outcome remains poor. This raises
a question can we do away with PTCD? To answer this query a study
was carded out in 2 phases. During the st phase mortality was compared
between 2 groups of patients: (A) those undergoing surgery without
PTCD (n=11) and (B) those undergoing surgery following PTCD (n=13).
The mortality was 57.14% in GpA as compared to 61.54% in Gp B.
Serial estimations of bilirubin levels carded out during the course of
drainage (3 wks) revealed a gradual and significant decrease, from 12.52 +
8.3 rag% to 6.9 + 3.4 rag%. Antipyfine half-life did not change
significantly (19.14 + 3.7 hrs) compared to basal values (21.96 + 3.8 hrs).
The phagocytic and intracellular capacities ofPMN remained suppressed
(Basal: 22.13 + 3.68% phago, and 19.1 + 4.49% ICK; post drainage: 20 +
8.48% phago, and 11.15 + 3.05% ICK). Thus PTCD did not improve
metabolic capacity of the liver and mortality was higher due to sepsis.
Considering this high incidence of sepsis and based on our earlier studies
which have demonstrated immunotherapeutic potential ofTinospora
cordifolia (TC) (2,3), 2 additional groups were studied: (C) patients
receiving TC during PTCD (n=16) and (D) patients receiving TC without
PTCD (n=14). A significant improvement inPMN functions occured by 3
weeks in both groups (31.25 + 4.65% phago and 24.8 + 5.6% ICK). The
mortality in Gp C &D was 25% and 14.2% respectively during
preoperative period. There was no mortality after surgery. It appears from
this study that host defences as reflected by PMN functions play an
important role in influencing prognosis. Further decompression of the
billiary tree by PTCD seems unwarranted.
(1) Rege et al, Ind J Med Res 1989:90,478
(2) Dahanukar et al, HPB Surg 1990:2 (Suppl), 38
(3) Bapat et al, HPB Surg 1990:2 (Suppl), 210.
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ENDOPROSTHESIS RELATED BILEDUCTPATHOLOGY
ANEXPERIMENTALSTUDY INTHEDOG
T. KARSTEN, P. DAVIDS, T.v. GULK, A. BOSMA, P.J. KLOPPER and
M.N.v.d. HEYDE
Depts. of Surgery, Gastroenterology and Pathology AMC, Amsterdam, The Netherlands
The histopathological changes of extrahepatic bile ducts after a period
of Endoprosthetic Biliary Drainage (ED) and its consequences for
subsequent Biliary Tract Surgery were assessed in 21 mongrel dogs. 5
dogs (group A) underwent ED during 4 weeks and were sacrificed 2
months after removal (RS) of the stent. In six dogs (group B) the 4 weeks
ofED was followed by hepaticojejunostomy (HJ) and observed for 2
months. In 5 dogs (group C) the common bile duct (CBD) was ligated (4
days) and treated subsequently with ED (4 wks) and HJ (2mths). In group
D (n=5) the effect ofCBD ligation (4 days) and direct HJ (2 mths) was
studied. Stenting was accomplished by duodenotomy and CBD biopsies
were obtained during HJ and upon sacrifice. Bile samples were cultured
(BC) during each step of the procedure.
N 4 days 4 wks
B(6)[ cbd 1-+-
pos. bile
culture
afterED 2 mths
CBD inflammation (-,+,++or+++)
sacrifice p.o. pos.bile
complications culture at
infect non-inf sacirifice
Conclusion: Endoprosthetic biliary drainage ofboth a normal and
obstructed CBD resulted in a distended fibrosing bile duct, showing
severe chronic inflammation with epithelial hyperplasia of the mucosa. At
2 months after removal of the stent the inflammation is still moderately
present. A higher incidence of postoperative (infectious) complications
was noted after biliary tract surgery with previous endoscopic stenting.
F055
CHANGEOFHEPATICMITOCHONODRIALREDOXSTATE
BY BILIARYDRAINAGE INOBSTRUCTIVEJAUNDICE
T. TSUBONO. Y. SHIRAI, K. TSUKADA, K. YOSHIDA, T. MUTO, T. SHIMIZU
Department of Surgery, Niigata University School ofMedicine, Niigata, Japan.
+Department of Surgery, Shinrakuen Hospital, Niigata, Japan.
Aim: The redox tolerance test (RTT) quantifies the changes of hepatic
mitochondrial redox state by measuring the arterial ketone body ratio
(KBR) in response to oral glucose load. The aim of this study is to clarify
the liver function as measured by the RTT in obstructive jaundice (OJ)
and to examine the changes in RTT during percutaneous transhepatic
biliary drainage (PTBD).
Patients and Methods: 22 patients with OJ underwent RTT before and
two weeks after PTBD. Patients with overt diabetes mellitus were
excluded. RTT was performed as described by Mori et al (Ann Surg 1990;
211:438-446). A redox tolerance index (RTI=100XAKBR/Aglucose),
which means the response of arterial KBR to glucose loading, was used as
an indicator for RTT. Results: The patients were classified into three
groups according to RTI (Group A: RTI (before) >0.5; Group B:
RTI(before)<0.5 and RTI (after)>0.5; Group C:RTI (before)<0.5 and RTI
[after] 0.5). RTI were maintained above 0.5 in all patients in Group A
(n=13) and no change was found after PTBD (before: 0.97_+0.35
(mean-+SD); after: 1.07_+0.38). RTI in Group B (n=5) were improved
variously after PTBD. There were no hospital deaths both in Group A and
B. In Group C (n=4), RTI of 2 patients were fallen afterPTBD and 3
patients died in the hospital by cholangitis. Conclusion: (1) RTT can be a
useful method for the evaluation of outcome in OJ. (2) From the
standpoint of hepatic mitochondrial redox state, PTBD has a limited role
in improving liver function.
F054
ANEWTHERAPEUTICAPPROCACHETOTREATMENTOF
HIGHRISKPATIENTS INBILIARYSURGERY
ZH. SJ. ZHUMADILOV D. R, MUSINOV, E. A, TAYGULOV
Semipalatinsk’s Medical Institute, Kazakhstan
A new method of delivery of antibiotic to the biliary system by
autological erythrocyte ghosts has been worked out experimentally and
applied clinically in the patients w3ith acute complicated cholecystitis and
high risk of urgent operation. We infused intravenously ghosts containing
single dose of antibiotic only two times a day. Clinical trial consisted of
two groups of patients. Group 67 patients who receivedd traditional
conservative therapy and aminoglicosides by intravenously or
intramuscularly route. Group 2 90 patients who received similar
antibiotics by above stated special technique. No significant differences
were noted among both groups as to sex, age and diagnosis. The results of
treatment are listed in table.
Patients No. (%) of No.(%) of Disappearence
septic com urgent of clinical,
plications operations laboratory
of disease symptoms of
disease
Group 30 (44.8) 20 (29.9) 9.0 + 0.4 days
Group 2 0 0 1.9 + 0.01 days
In patients of group 2, the amelioration immunological and clinical
states was more marked. They were underwent an elective operation after
detailed examination and preoperative management of multiple system
disorders. The special pharmacokinetic investigations have shown a high
concentration of antibiotic in the bile of patients (3 4.7 times) having
new method versus patients who received intravenously, intramuscularly
and even endolymphatic infusion of antibiotic. So, this new method is
effective, available for clinical practice. It is also economical and be used
in biliary surgery.
F056
EMBICA OFFICINALS:ANOVELPHARMACOLOGICAL
THERAPYFORACUTEPANCREATITIS
S.A. DAHANUKAR S.P. THORATAND R.D. BAPAT
Department of Pharmacology and Department of Gastroenterology Surgery, Seth G.S.
Medical College and K.E.M. Hospital, Parel, Bombay 400 012, India
Mortality due to acute pancreatitis, is very high when it is complicated
with secondary pulmonary damage. Management of pancreatitis is mainly
supportive, and no pharmacological agent has yet been found useful.
Based on its cytoprotective effect(i), Emblica officinalis (EO) was
selected to investigate its ability to reduce pancreatitis and associated lung
damage in dogs. This was compared with pentoxyfylline. 34 dogs of
either sex were divided into 5 groups (n--6-8 each): Gp I-control, Gp II-
acute pancreatitis, Gp III-sham operated, Gp IV-pretreatment for 15 days
withEO 28mg/kg/day orally and Gp V-pretreatment with pentoxyfylline
50 mg/kg i.v. bolus followed by 0.1 mg/kg/min for 1/2 hr. Acute
pancreatitis was induced by injection of a mixture of blood-bile-trypsin.
Serum amylase, ABG, peripheralWBC counts, neutrophil function tests,
and histopathology (HP) and electron microscopy (EM) of lungs and
pancreas were studied basally and 2 hrs after inducing pancreatitis. In Gp
II, pancreatitis was proven by a consistent rise in serum amylase (P<0.05)
as well as by HP & EM. HP of lungs showed alveolar septal disruption
and edema. EM showed the formation of large vacuoles with electron
dense vacuoles. PMN functions were found to be stimulated. In dogs
pretreated with EO, serum amylase did not rise significantly. Mild edema
without necrosis or haemorrhage was seen on HP on pancreas. EM
confirmed the normalcy of pancreas. Similarly lung damage was also
prevented. HoweverPMNS were still stimulated at 2 hrs suggesting that
PMNs may not play a role in lung damage. Pentoxyfylline suppressed the
PMNs as expected (P<0.05) but did not prevent lung damage, further
proving this point. This study documents for the first time the efficacy of
EO against pancreatitis and its pulmonary complication in dogs.
(1) Gogate VM, Ayurvedic Materia Medica, 1st Ed. Continental
Prakashan, 1982, 247-248.
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THEIMPACTOFANEW CLASSIFICATIONONTHE
TREATMENTOFPANCREATICPSEUDOCYSTS
A.D’GIDIO,M SCHEIN, C.G. BREMNER
Department of Surgery, University of Witwatersrand, Johannesburg, South Africa
Our working classification consists of three types of cysts based on the
two pathogenetic processes: autodigestion (Post-necrotic cysts) and ductal
obstruction (Retention cysts).
94 patients with pseudocysts, divided in three groups: post-necrotic
type I: in acute pancreatitis (50 patients). Post-necrotic type II: in chronic
pancreatitis (32 cases). Retention or type III: in chronic pancreatitis (12
patients). E.R.C.P. performed in all patients with chronic pancreatitis in 11
patients with acute pancreatitis.
Average follow-up: 10.2 months (range 1-82).
Type I: percutaneous drainage (PD) was successful and did not carry
complications nor did lead to cyst recurrence. Internal drainage PD should
be the treatment of choice.
Type II: PD was associated with prolonged drainage and risk of
complications, when cyst-duct communication was present. Internal
drainage was effective and carried low morbidity and mortality, therefore
it should be used when ductal communication is present.
Type III: PD not used. Internal drainage not adequate, leading to cyst
recurrence; the duct needs to be addressed by drainage or resection.
Reference:
A.D’Egidio, M. Schein Br J Surg 1991; 78:585-9
F058
THEPYLORICPRESERVING
PANCREATODUODENECTOMY INCHRONIC
PANCREATITIS
M. GAGNER D. McANNENY, R.L. ROSSI, J.W. BRAASCH
Dept. of Surgery, Lahey Clinic, Burlington, Massachusetts.
Standard pancreatoduodenectomy (PD) has been used in the
management of selected patients with chronic pancreatitis (CP). The
pyloric preserving modification has been introduced to maintain gastric
capacity and gastric emptying, decrease post-gastrectomy symptoms and
perhaps decrease malabsorption. Forty-five patients with the median age
of47 years, who underwent a pylorus preserving pancreatoduodenectomy
(PPPD) for CP since 1979 and have been followed for a median of 60
months (18 to 122) were reviewed. All had abdominal pain, 90% were
taking narcotics, a history of ethanol abuse was present in over half of the
cases, and 35% of patients had a mass in the head of the pancreas. There
was one operative death (2%) and ten major complications (22%). The
mean pre-operative pain score (0-5) of 4.5 improved to 1.3 (P<0.0001),
the mean pre-operative weight of 134 pounds improved to 137. The 40%
incidence of clinical pre-operative exocfine insufficiency was not changed
by PPPD. Ten patients (22%) had pre-operative endocrine insufficiency;
post-operatively, four patients (9%) had worsening of their endocrine
insufficiency. Early gastric complications (stasis) developed in 4% of
patients, while late gastric complications (gastric hemorrhages and/or
ulcerations) were present in 13% of patients. Ninety percent of the patients
felt their pain had improved with more than three-quarters of the patients
not taking narcotics or using a much lower dose than before operation.
PPPD in selected patients with CP improves the pain in the majority of
patients, can be safely performed, and is a good alternative to standard PD.
F059
EVIDENCEFORAUTOIMMUN1TY INCHRONIC
PANCREATITIS
RP JALLEH. JA GILBERTSON, CS FOSTER& RCN WILLIAMSON
Departments of Surgery and Histopathology, RPMS, Hammersmith Hospital, London,
United Kingdom.
The precise aetiopathogenesis of chronic pancreatitis is unclear. High
numbers of T-lymphocytes in livers and pancreatic specimens suggest
possible involvement of cell-mediated immune mechanisms. Aberrant
expression of major histocompatibility complexes (MHC) is a prerequisite
for organ-specific autoimmunity, and normal pancreatic epithelial cells do
not express such complexes. Expression ofMHC Class (2-
microglobulin) and Class II (HLA-DR) determinants were investigated in
93 patients (64 males, 29 females, mean age=41 years) operated on for
chronic pancreatitis. Aetiological agents were alcohol (63 patients),
recurrent acute pancreatitis (12), congenital lesions (2) and unknown (16).
Immunohistochemical staining of tissue sections involved standard
immunoperoxidase techniques using specific antisera. NoMHC
expression was seen in 10 histologically normal pancreases (controls). 2-
microglobulin expression in pancreatic epithelial cells was observed in 76
specimens (82%) while HLA-DR was present in 61(66%). Staining of
bothMHC determinants was confined to ductular and ductal epithelial
cells was observed in 76 specimens (82%) while HLA-DR was present in
61(66%). Staining ofbothMHC determinants was confined to ductular
and ductal epithelium with no staining of acinar cells: [2-microglobulin
(ductules 63%, ducts 51%;NS) and HLA-DR (ductules 59%, ducts
53%;NS). Positive staining was not related to aetiological agent or age.
This aberrantMHC expression, together with a T-cell infiltration, suggests
a cell-mediated component to chronic pancreatitis.
F060
PROGNOSTICVALUEOF CTSCAN INSEVEREACUTE
PANCREATITIS:APROSPECTIVE,MULTICENTRICST[Y.
N. ROTMAN D. PEZET, D. MATHIEU, D. CHERQUI, C. CHASTANG,
B. CHEVRET, P.L. FAGNIEZ
Hfpital Henri Mondor, Crfteil, et Hfpital Saint-Louis, Paris, France.
From October 1986 to January 1991,234 patients with severe acute
pancreatitis (SAP) have been entered in a prospective, multicentric study
to evaluate the prognostic value of early CT scan. The criterion for
inclusion was a first attack of pancreatitis requiring an admission in an
ICU. An initial CT scan was performed within 48 hours of admission in
228 patients. Each CT scan was performed throughout the entire abdomen
before and after intravenous injection of contrast medium. A form was
filled for each CT scan to collect the following data: size of the pancreas,
enhancement after contrast medium injection, visualization of the portal
and splenic veins on angioscans, number and location of peripancreatic
collections. Survival curves and curves of occurrence of a pancreatic
abscess were constructed by the method of Kaplan-Meier and compare
with the Log Rank test. The non visualization of the portal and splenic
veins on angioscans was related to increase mortality and abscess
formation (p<0.0001). Collections located in the lower parts of the fight
and left mesocolons, in the fight posterior pararenal space were predictive
of abscess formation and increased mortality rate (p<0.01). The non
visualization of a part of the pancreatic parenchyma on angioscans did not
influence the prognosis. Concerning the Ranson CT scan classification,
grade E was significantly related to increased mortality and abscess
formation when compared with the other grades (p<0.02).
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MANAGINGTHECOMMONDUCTSTONE INTHE
LAPAROSCOPIC CHOLECYSTECTOMYERA
D.R. FLETCHER R.M. JONES
University of Melbourne, Department of Surgery,
Austin Hospital, Melbourne, AUSTRALIA
At open cholecystectomy, operative cholangiography was performed to
confirm suspected or identify unsuspected C.B.D. stones allowing
concomitant treatment. Since laparoscopic cholecystectomy (L.C.),
instead of operative cholangiography, reliance has been placed on
E.R.C.P. to diagnose and treat by sphincterotomy (E.S) C.B.D. stones.
This has led to an increased incidence ofERCP and sphincterotomy with
possible complications. To determine if these stones could be managed
surgically in the laparoscopic era, L.C. with routine op. cholangiography
was attempted in 200 surgically unselected patients. In those with
suspected C.B.D. stones (L.F.T., U/S, pancreatitis, jaundice), in 75%, the
stones had passed by the time of surgery. In 7 of 10 patients with C.B.D.
stones, the duct was cleared with a combination of cholangioscopic or
image intensifier monitored trans cystic duct sphincter dilation and
flushing or basket extraction. There were no complications in this small
number. Three patients required post op. ERCP sphincterotomy (DRF).
We conclude laparoscopic exploration of C.B.D. at L.C. is possible
provided routine op. cholangiography is used. ERCP use will be reduced
if not used pre operatively to screen for and treat C.B.D. stones but
reserved for post op. retained stones the incidence of which may be
increased
F062
RECENTRF_ULTSOFELECTIVEOPEN
CHOLECYSTECTOMY INANORTHAMERICANANDA
EUROPEAN CENTER. COMPARISONOF COMPLICATIONS
ANDRISKFACTORS.
P-A. CLAVIEN, J.R. SANABRIA, G. MENTHA, F. BORST, L. BUHLER, B. ROCHE,
R. CYWES, R. TSIBISHIRANI, A. ROHNER, S.M. STRASBERG
Hepatobiliary-Pancreatic Section of the Division of General Surgery, Mount Sinai
Hospital, University of Toronto, Toronto, Canada.
Clinic of Digestive Surgery, Department of Surgery, University Hospital, Geneva,
Switzerland.
Results of elective open cholecystectomy (OC) in 1252 patients treated
in a North American and a European center just prior to introduction of
laparoscopic cholecystectomy were examined using a recent standardized
classification of complications. There were no deaths, but 12% and 14%
of the patients developed complications in each center, respectively.
About 6% of the patients developed grade (minor) complications. Grade
II complications (without residual disability) were noted in 6% and 8%,
and grade III (with residual disability) in 0% and 0.3%, respectively.
Using uni-and-multivariate analysis, individual risk factors for developing
the different categories of complications were different between both
centers, whereas two preoperative score systems, ASA and a simplified
APACHE II, were found to predictive for all types of complications in
both centers. Elective OC is a safe procedure and new therapeutic
alternatives should aim at similar results. Generalization of risk factors
identified in a particular center may be misleading since numerous local
conditions may significantly affect risk factors for surgery. The data also
demonstrate the advantages of a uniform way of reporting surgical
complications, which should allow the performance of valuable
comparisons.
F063
CHOLEDOCHODUODENALFISTULAASSOCIATEDWITH
CHOLELITHIASIS
P. DI GIORGIO, G. RIVELLINI, L. ESERCIZIO. B. DE LUCA
Endoscopy Unit, Vecchio Pellegrini Hospital-USL 44-Naples, Italy
Choledochoduodenal fistula (CF) situated on or around the longitudinal
fold is most probably caused by the spontaneous passage of gallstones. It
was very difficult to diagnose until the introduction of duodenal
fiberoscopy. At our Endoscopy Unit, of the 796 patients with
choledocholithiasis who were subjected to endoscopic cholangiography,
spontaneous CF was diagnosed in 58 (7.3%). The group consisted of 39
female and 19 male patients with an age range from 47 to 84 years. CF
was classified in two types: type was present on the longitudinal fold
(75%) type II was present at the duodenal mucosa adjacent the
longitudinal fold (25%). Common bile duct calculi were present in 49
patients (84%). The incidence ofjaundice at the time of endoscopic
examination in patients with fistula was 6.9% compared with 73.6% in
patients without fistula. The spontaneous disappearance ofjaundice in
choledocholithiasis is probably due to formation of CF. Sphincterotomy
was successful in all patients with fistula and common bile duct calculi
(84%).
F064
ROLEOFEXTRACORPOREALSHOCKWAVELITHOTRIPSY
INTHEMANAGEMENTOFCOMMONBILEDUCTSTONES
T.K. MALIK S. MADAN, S. RAWAT, R. MALIK.
Dept. of Surgery, M.A.M College, New Delhi.
We evaluated the role of extracorporeal shock wave lithotripsy (ESWL)
in the management ofcommon bile duct (CBD) stones. A total of40
patients were taken up for the study. All the patients had endoscopic
papillotomy done and biliary drainage was established in all by
nasobiliary catheter. Number of shocks given ranged from 700 to 11000.
No more than 4000 shocks were administered in each treatment session
with a minimum time interval of 48hrs. between consecutive sessions.
Most stones were crushed around 17.2 K.V. Stone fragmentation was
achieved in 80% of cases, and stone clearance was obtained in 70%.
Adjunctive non-surgical procedures were necessary for stone removal in
30% patients and 15% patients required surgery to clear the ducts. Mean
hospital stay was 8 days. There was no mortality and complication rate
was relatively low. Nine patients had skin bruising and ecchymosis, five
patients had exacerbation of cholangitis. Three patients had biliary pain. It
was therefore concluded that ESWL is a helpful and safe adjunct in
treating difficult-to-reach or difficult-to-remove bile duct stones in the
elderly or high risk patients.
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MANAGEMENTOF BILEDUCT STONES INTHEERAOF
LAPAROSCOPICCHOLECYSTECTOMY
A. ANTHONY, T. WILSON, L. KOW, P. JEANS, J. TOOULI
Gastrointestinal Surgical Unit, Flinders Medical Centre, Adelaide, South Australia,
Australia.
The development of laparoscopic cholecystectomy (LC) has led to new
dilemmas in the management ofcommon bile duct (CBD) stones. This
study examined the approach to CBD stones in 207 consecutive patients
submitted to LC.
CBD stones were suspected pre-operatively in 50 patients on criteria of
abnormal liver function tests, dilated CBD on ultrasound or a prior history
of biliary pancreatitis. 14/50 had pre-operative ERCP with CBD stones
found in 9 and extracted by endoscopic sphincterotomy (ES) in 8/9. In 4/9,
at subsequent LC and operative cholangiogram (OC), residual stones were
present. 2 required open operation and exploration of the EBD(ECBD),
had a follow-up ERCP and stone extraction and was followed clinically
as the stone was felt small enough to pass through the previous ES. 36/50
went to primary LC. In 35/36 OC was successful and in 24/35 the duct
was clear. In 10 of the remaining 11, duct clearance was attempted
laparoscopically by relaxing the sphincter pharmacologically and flushing
the CBD via the OC catheter. This approach was successful in 4/10. Of
the remaining 7, 3 went to open ECBD and 4 had follow-up ERCP within
42 days ofLC. In 2/4 the CBD stone had passed by the time ofERCP and
the remaining 2 required ES and stone extraction. CBD stones were
detected on OC in 6/159 patients without pre-operative suspicion ofCBD
stones. In 3/6 the stones were cleared primarily at LC. 2/6 required
subsequent ERCP. In of these the duct was clear and the other required
ES and stone extraction. patient has been left to clinical follow-up.
In conclusion, it is possible to deal with CBD stones by laparoscopic
techniques in over 1/3 of patients at the time of initial LC. In the
remainder, CBD stones can usually be cleared by subsequentERCP and
ES, but about 1/2 will actually have passed their CBD stone by the time of
follow-up ERCP. In this setting pre-operative ERCP should probably be
reserved for patients with clinical jaundice or cholangitis at presentation.
F066
EFFECTOFSURGICALMARGINONTHERECURRENCE
AFTERRESECTIONFORHEPATOCELLULARCARCINOMA
ASSOCIATEDWITH CIRRHOSIS
S.T. KIM, K.U. LEE, K.S. SUH, T.S. KIM
Department of Surgery, Seoul National University, College ofMedicine, Seoul, Korea
We studied to elucidate whether surgical margin is related to recurrence
after curative resection of hepatocellular carcinoma in patient with
cirrhosis.
Forty patients who underwent curative hepatic resection for
hepatocellular carcinoma with cirrhosis between Jan 1988 and Dec 1989
and met the following criteria (histologically proven cirrhosis, solitary
nodule less than 10 cm, resection less than formal segmentectomy, no
evidence of direct invasion or metastasis) were included in this study.
Resection margin was expressed asRMO andRM when resection
margin is less than cm and equal to or greater than cm, respectively.
There was no statistical difference in the recurrence free rate curve
between RMO(n=25) and RM1(n=15). In patients with tumor size equal
to or greater than 4 cm, there was no statistical difference in the recurrence
free rate curve between RMO(n=12) and RMI(n=5). But in patients with
tumor size less than 4cm, there was significant difference between
RMO(n=13) and RMI(n=10).
In conclusion, when tumor size is less than 4cm in diameter, recurrence
rate can be reduced with more than lcm of resection margin, but when
tumor size is 4cm or greater, the recurrence rate can not be reduced by
more than cm of resection margin. So when tumor size is 4 cm or
greater, another therapeutic modality may be necessary.
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1102HEPATIC RESECTIONSFORPRIMARYLIVERCANCER
wuMENG CHAO
Research Institute of Hepatobiliary Surgery, Shanghai Hospital, Shanghai 200433, China
From 1960 to 1989, 5160 patients with liver diseases were admitted in
our institute. Among them, 3760 cases were malignant tumors, most of
them were primary liver cancer (97%). Among 2210 (60.6%) exploratory
cases, 1102 were resectable with a 50% resection rate. There were 992
males and 110 females. Patients ages between 40-60 accounted for 90%.
95% were hepatocellular carcinoma, 85.6% associated with chronic
hepatitis or cirrhosis and 25.6% were with tumor smaller than 5cm in
diameter. The mortality rate (MR) within month after operation was
1.8%. The total 5-year survival rate (SR) was 28.4%, while in the group of
small tumor (<5cm), it was 75%. Before 1977, the 5-year survival rate
was 16% and since 1978, it has increased to 30.6%. The data of better
results during past decade were analysed and our experience were as
follows: (1) Early diagnosis and resection ofPLC became possible. The
resection rate was 90% in 313 small tumor cases and 5-year SR was
83.3% in patients with tumor smaller than 3cm. (2) Rehepatectomy for
early recurrent tumor. 78 cases undergoing 170 times of reoperation with
5-year SR of 36%. (3) Two-stage operation for unresectable large tumor.
The 5-year SR was 60% in 26 such cases. (4) Improvement of operative
technique made complication rate reduced from 20% to 5% andMR
lowered from 8.8% to 0.4%. (5) Postoperative comphensive treatment was
important for preventing tumor recurrence and increasing the
postoperative SR in our series.
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COMPLICATIONSOFHEPATO-PANCREATO-
DUODENECTOMY
JUNJI TANAKA SHIGEKI ARII, TADAO MANABE, MASAYUKI IMAMURA,
KEN-ICHI FUJITA
Carcinoma of biliary tract commonly invades into neighboring tissues
leading to frequent local recurrence after resection. This situation suggests
a requirement of extensive local resection for the prophylaxis. One is
considered to be hepato-pancreatoduodenectomy(HPD). The present
study is to clarify complications in HPD operation. Patients: 23 patients
(13 gall bladder carcinoma, 7 bile duct carcinoma and 3 others) underwent
HPD operation. Vascular reconstructions of 8 in artery and 4 in portal vein
were needed. Extent ofhepatectomy was as follows; 7 segmentectomy, 2
cases of 1.5 segmentectomy and 14 over 2 segmentectomy. En-block
resection of hepatoduodenal ligament (HLPD) with reconstruction of
portal vein and hepatic artery were performed in 5 cases. Among them, 4
operative deaths (3 HLPD) and hospital death cases were accounted.
The main causes of death were 2 leakage of pancreaticojejunostomy,
leakage of hepaticojejunostomy and liver abscess. Almost all were
associated with infection. In the late complications, fatty liver was seen in
8 of 18 cases, but without clinical significance. The longest survival is 67
months with performance status 0. The patients had a good quality of life
after discharge. The main cause of 12 late deaths was recurrence of
primary diseases. Conclusion: HPD operation itself except HLPD become
safe and the quality of life is relatively satisfactory. But, the indication
should be applied to the earlier stage for curative operation.
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THEEFFECTS OFMONOCYTEDERIVED CYTOKINESON
THEPROLIFERATIONOFHEPATOMA CELLS
WG JIANG andMCA PUNTIS
Department of Surgery, University ofWales College of Medicine, Cardiff,UK
Monocyte derived cytokines are important in immune regulation and
cell proliferation. We studied the proliferation of a hepatoma cell line,
PLC/PRF/5 under the effect of 7 monocyte cytokines: IL- 1,6,8, GM-GSF,
TNFa, TGF-I] 1, and hepatocyte growth factor (HGF). Cells were co-
cultured with recombinant cytokines for 72 hrs, and then quantified by a
[Dimethylthiazol-2-yl]-2, 5-diphenyltetrazolium bromide assay.
Result: mean_+SEM percentage proliferation compared with control
(medium only). *p<0.05 by StudentT test.
1:2 dilution 1:8 dilution 1:32 dilution
IL-1(100U/ml) +12.9_+3.8%* +8.8_+7.1% +4.3_+4.3%
IL-6(20ng/ml) +11.9_+6.5%* +2.5_+5.1% +2.5_+4.4%
IL-8(10ng/ml) -59.6_+7.8%* -7.9_+2.0% 1.7_+6.0%
HGF(40ng/ml) -39.9_+3.1%* -11.4+1.3%* -8.8_+1.9%*
TNFc(2.0ng/ml) -32.9+_21.9% -14.8+11.8% -0.9-+3.7%
TGFI(100RU/ml) -36.9-+2.4%* -22.4-+8.5%* -18.6-+6.9%
GM-CSF10(ng/ml) -32.7_+18.1% -8.7_+7.4% -4.6_+2.5%
These data show that among the monocyte derived cytokines, IL-1 and
IL-6 have stimulatory effects on hepatoma cell growth while others
especially IL-8, HGF, TNFa and TGF[ are inhibitory. Viability of cells
was tested by a trypan blue exclusion test and by morphological changes,
there was no difference between control and cytokine cultures, suggesting
that some cytokines are inhibitory to cell proliferation and are not
cytotoxic. We conclude therefore that monocytes and their derived
cytokines probably have a significant role in the host response to
hepatoma.
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THEUSEOFTECHNETIUM-99MLABELLED
MACROAGGREGATEDALBUMIN IN TIlEDETERMINATION
OFTUMOURVASCULARITYANDDEGREEOFLUNG
SHUNTING INHEPATOCELLULARCARCINOMA
*w.Y. LAU. #W.T. LEUNG, #S. HO, ^N. LEUNG, #W. SHIU, *A.K.C. LI
Departments of *Surgery, #Clinical Oncology and ^Medicine, Prince ofWales Hospital,
The Chinese University ofHong Kong, Shatin Hong Kong
In the selection of patients for selective internal radiation therapy with
yttrium-90 microspheres, it is important to know the vascularity of the
turnout and the degree of lung shunting prior to the treatment.
Forty patients with inoperable hepatocellular carcinoma had
Technetium-99m labelled macroaggregated albumin (MAA) injected
through an angiographic catheter into the hepatic artery. Angiotensin II, a
vasoactive agent, was given to enhance the tumour/normal liver tissue
ration(T/N ratio). Gamma scintigraphy of the liver and lungs were done.
The turnouts were localised by matching with computed tomography and
technetium-99m tincolloid scans of the liver.
The T/N ratio for 37 evaluable patients ranged from 0.9 to 15 with a
median of 3. In 3 patients, the T/N ratio could not be done because there
were too little normal liver tissue present for accurate assessment.
Lung shunting varied from 0.7% to 44.5%. 33 of40 patient had lung
shunting of <15%. In 3 patients the lung shunting was over 30%.
Five patients underwent selective internal radiation therapy afterMAA.
The actual doses were verifed with an intraoperation beta probe during
laparotomy and by liquid scintillation counting of biopsy samples taken
on representative sites. The correlations between the predicted and the
measured doses were good.
Our results showed thatMAA can be used to measure the T/N ratio and
to determine the lung shunting in patients with inoperable hepatocellular
carcinoma.
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COMPLICATIONSAFTERLAPAROSCOPICAND
CONVENTIONAL CHOLECYSTECTOMY:ACOMPARATIVE
STUDY
IRIS B. BRUNE K SCHONLEBEN
Chirurgische Klinik, Klinikum Ludwigshafen Ludwigshafen,Germany
Since growing popularity of laparoscopic cholecystectomy (LC) makes
a prospective, randomised, comparative study nearly impossible, we
compared retrospectively 500 LC with 748 conventional, elective
cholecystectomies (CC) for their intra- and postoperative complications.
Results:Lethality 0% for LC 0,4% (n=3) for CC. Intraoperative
complications requiting an extension of the operation: LC 0,8%
(n=4;lesion ofthe aorta ], the duodenum ], the common bile duct
[2]).CC ,5% (n=4;lesion of the duodenum [1], the common bile duct [2],
the liver [1]).Postoperative complications:LC 2,8%(n--14) of which 5
(1%) demanded a surgical reintervention. CC 3,7% (n=28) of which 5
(0,7) needed a surgical reintervention. The different complications and
their therapeutic consequences will be named. Overall complication rates:
CC 4,2% (n=32); LC 3,6% (n=l 8),this number decreasing rapidly with
growing experience (OP.Nr.I-30:13,3%31-70: 7,5%;71-500: 2,7%).
Conclusion: Lethality, postoperative and overall complication rates were
lower after LC.Particularly the non-specific complications and wound
problems were negligeable due to early mobilisation and the small
incisions. Intraoperative complications and surgical reinterventions
occurred slightly more often, but their number dropped with growing
experience. The actual results will be presented.
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A STUDYOFPOSTOPERATIVEPULMONARYFUNCTION
AFTERLAPAROSCOPIC CHOLECISTECTOMY
J.A. MAZZEI, J.DIEZ, R, DELBENE, A. FERRERES
Neumonology Division, Department Surgery University Hospital, Otamendi Clinic,
Buenos Aires, Argentina
A prospective evaluation study on pulmonary complications in laparoscopic
cholecistectomy was performed, comparing the results obtained with those ofa similar study
previously performed in open cholecistectomy, following the same method.
Patients were evaluated on respiratory symptems, preoperatory ThoraxX rays, forced
spirometry, flow volume loop and measurements of arterial blood gases, repeating the same
tests 48 and 72 hours later.
The sample consisted of30 patients (80% ofwhich were women). Average age was 49.57
years+ 11.88 years. Average weight: 66.8 Kg+ 14.5 Kg. Average Height: 1.60 rots+ 0.09
rots.
Ten per cent ofthe patients had a history of asthmatic conditions. None ofthem suffered
from chronic obstructive pulmonary disease. 30% were smokers and 50% had a history of
obesity.
Functional preoperatory tests were normal in the 73% ofthe cases, 4 cases presented a
restrictive pattern and 4 an obstructive pattern.
The average preoperatory vital capacity was of94.13 + 18.23. Average preoperatory
FEVI: 90.43+19.27. AverageFEV1/FVC relation was of 80.60L-6.99. AverageFEF 25-75%
was of91.90 +32.86.
PAO2 was normal in 80% ofthe cases presenting the missing 20% slight hypoxemias.
Average peroperativePAO2 was of 83.02 + 10.17 mmHg.
In all cases preoperatory PCO2 was normal being the average 37.02_+6.02 mmHg. Thorax
X rays showed in 9 ofthe cases laminar atelectasis (30%) 21 ofthe cases (70%) presented
diaphragmatic bilateral elevation. 13 cases (43%) showed increase in the bronchial marks
(tram lines).
Average postoperatoryFVC was 72.47 _+ 20.07. Average FEVI: 70.40 _+ 20.37. FEV1-
FVC relation was of 82.40+ 7.27. The FEF 25-75% was of69.4+28.82.
Of all the patients evaluated 16 (that is 53%) showed a restrictive pattern.
The average postoperatory PAO2 was of79.72_+ 10.35 and averagePCO2 of37.06 _+ 4.16
mmHg.
Average length ofhospitalization was of 1.40 days + 0.71 days and only 3 patients
presented clinical complications (10%) such as acute bronchitis in all three cases.
TheFVC variation was of-21.67 _+ 20.84. FEV1 variation was -20.03 _+ 21.08 and that of
FEF 25-75% of22.50+ 33.64.
PO2 variation was -3.30 _+ 12.54 andPCO2 variation of-0.04 _+ 6.78 mmHg.
Conclusion: Comparing these findings with those observed in the study performed with
conventional cholecistectomy we observe that with laparoscopic cholecistectomy
deterioration ofpulmonary function,X rays alterations, length ofhospitalization period andF073
LAPAROSCOPIC CHOLECYSTECTOMY INTHEOBESEAND
MORBIDLYOBESE PATIENT.
GARZON GM FRIED, EJ HINCHEY, MJ MAMAZZA, JL MEAKINS,
HH SIGMAN, MH WEXLER
McGill University, Montreal, Quebec, Canada
The expanding indications for laparoscopic biliary tract surgery
prompted us to assess the appropriateness of employing this treatment
modality in obese (O) 20% over ideal weight and morbidly obese patients
(MO) (100 bs over ideal body weight). Our initial concern was that
obesity may constitute a contraindication to laparoscopic cholecystectomy
(LC). In our McGill series of 907 LC, we have encountered 220 0 and 26
MO patients. The median operative time for the 0 andMO was 75 & 102
rain compared with 88 rain for all patients. The successfully treated
patients in the 0 andMO groups were discharged within 24 hours and
returned to their usual activity in one week. Intraoperative complications
which required conversion to open cholecystectomy occurred in 9% for 0
and 7.7% forMO patients compared to 5% overall. Reasons for
conversion included bile leak (1), hypoxemia (1), CBD injury (2), arterial
injury due to trocar insertion (3). Related complications included 3 wound
infections, 3 significant hematomas, biloma, and bile leak. Technical
recommendations include (1) the 30 scope (2) open insertion of the
trocar, (3) initial port selection just above the umbilicus. Our experience
supports the fact that 0 andMO are not contraindications to LC.
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LAPAROSCOPIC CHOLECYSTECTOMYUNDEREPIDURAL
ANESTHESIA ANIDEAL COMBINATIONOFMINIMAL
INVASIVESURGERYANDMINIMAL INVASIVE
ANESTHESIA
LEXER G.W.M.D. , LEXET G.CH. M.D.2, REICHENAUER A. M.D. LEHOFER
F.M.D. 3, PIMPL W.M.D. 1, BOECKL O. M.D.I
Ist. Dept of Surgery, LKA Salzburg 1; Depts of Surgery and anesthesiology 3,
Friesach; AUSTRIA
Epidural anesthesia (EPA) has been reported to exert beneficial
effects in surgical procedures. In this retrospective study we evaluated
the outcome of EPA in pat. undergoing laparoscopic cholecystectomy
(lap. CHE). Unselected 61 patients (39 female, 22 male), mean age
46,9 years (20/86), mean weight 71,7 kg (46/125) with symptomatic
gallstone disease were admitted to our lap. CHE-program maintaining
analgesia with EPA. Preoperative patient selection and indication for
lap. CHE were unchanged.
Ventilatory measurements and arterial blood gas analyses were
performed preoperatively (1) in the horizontal supine position with
TS-T10-1evel of analgesia, (2) after intraabdominal insufflation of
CO2 for pneumoperitoneum and (3) at the end of the procedure.
During the procedure the patients were maintained with oxygen
insufflation of 3 l/rain through an anesthetic face mask
Interaoperative sedation was given if necessary.
No significant changes of minute ventilation or arterial blood gas
measurements were observed. Furthermore, no intra- or postoperative
either anesthetic or surgical complications occurred.
|n review, our experience shows that EPA in lap. CHE is
associated with almost no risk and is an acceptable anesthesiological
technique even for unselected patients.
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LAPAROSCOPIC CHOLECYSTECTOMY: THE BAaR-
EXPERIENCE I
SL JENSEN*, J.DIEZ**, A MON***, P.FUNCH-JENSEN*,
R. DELBENE**, R.S.ALMEYRA***, P.WARA*, A.FERRERES**, A.SPIRANZA***
Aarhus University Hospital*, Aarhus,Denmark, Hospital Clinicas**, University ofBuenos
Aires, Argentina, and Clinico Britanico***, University of Rosario, Argentina.
New year 1991 the Universities ofBuenos Aires (B) (Hospital clinicas),
Rosario (R) (Clinico Britanico, Argentina and Aarhus(Aa), (Aarhus
Kommunehospital), Denmark introduced; laparoscopic cholecystectomy as
standard treatment of cholecystolithiasis and a collaboration was established
in order to evaluate its mortality and morbidity. During the first 10 months
of 1991 18 surgeons (10 consultants [6.9%];and 8 chief residents [3.1%])
perbrmed 425 (B:n=134,Aa:n=141 and R: n=150) laparoscopic
choleycystectomies for symptomatic cholecystolithiasis (95 [22.3%] with
chronic cholecystitis and: 30 (7.1%) with moderate to severe acute
cholecystitis. CBD stones were found preoperatively in 23 (5.5%) of the
patients. They were removed endoscopically. Preoperative cholangigraphy
was performed routinely in Rosario and selectively in Buenos Aires (n=3)
Aarhus (n= 1). However, the number of patients with residual stones was the
same in Rosario (n=3) Buenos Aires (n=l)and Aarhus (n=2). The residual
stones were removed endoscopically (n--4), laparoscopically (n=1) or
surgically (n= 1). The mean duration of the laparoscopic operations was 72
minutes (range 30-360 rain). They were performed with one death (0.2%)
and a morbidity rate of7.6% (major (biliary leakage (n=4), stenosis of the
CBD (n=l)): 1.0%; minor (wound infections (n=l 1), abdominal wall
heamatoma (n=7), residual common duct stones (n=6), mild subcutanoues
emphysema (n=4); respiratory problems (n=2), cardiovascular problems
(n=2), intraabdominal abscess (n=1):6.6%. There was one injury to CBD
(0.23%) which required reconstructive biliary surgery. Seventeen patients
(4%) required conversion to open cholecystectomy because of technical
difficulties. Ninety-one percent of the patients was on a regular diet the
morning after surgery. The mean hospital stay was 1.6 days (range 0-14
days)and the mean time of return to full activity was 6.35 days (range 3-21
days). The study shows that laparoscopic cholecystectomy can be
performed safely by the average surgeon in university hospitals and it
indicates that routine cholangiography has no advantages or disadvantages
compared with selective cholangiography.
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OUT-PATIENTLAPAROSCOPIC CHOLECYSTECTOMY
R.F. PACE R. SMITH.
Department of Surgery, Queens University, Kingston General Hospital, Kingston, Ontario
Canada.
Laparoscopic cholecystectomy has rapidly become the treatment of
choice for patients with symptomatic gallstones. This has, in part, in part,
been due to the significant decrease in post-operative pain, hospital stay,
and a rapid return to normal activities. Of our first 200 patients scheduled
for laparoscopic cholecystectomy, there was a 6% rate of conversion to
’open’, with an average post-operative stay for all patients 1.8 days. If
only successful laparoscopic cholecystectomy patients are included, the
post-op stay is 1.5 days. During our last 100 cases we have been treating
selected patients as out-patients. To be considered for out-patient therapy
patients must be highly motivated, live in or near the city and have a
significant other at home to care for them. Eighteen of 21 patients selected
for out-patient therapy were successfully discharged from hospital within
6 hours of surgery. None of these patients required re-admission to
hospital, nor did they have any complaints regarding their early discharge.
The 3 patients scheduled for out-patient laparoscopic cholecystectomy but
who required admission following surgery had nausea and vomiting
which precluded their early discharge. All 3 of these patients were
discharged the following day We conclude that out-patient laparoscopic
cholecystectomy is a viable alternative to admission in as many as 1/5th of
patients The option is safe and acceptable in the motivated patient.
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ESWLANDLAPAROSCOPICCHOLECYSTECTOMY-
ANAPPROPORIATEPROCEDURE INLARGEBARREL
SHAPEDGALLBLADDERSTONES
MEISER G. M.D, LEXER G. M.D. WACLAWICZEK H. M.D, BOECKL O. M.D.
Ist. Dept of Surgery, LKA Salzburg, Austria
Laparoscopic extraction of large barrel shaped gallbladder stones
through a small paraumbilical incision can be difficult and sometimes
impossible. In our surgical dept we performed ESWL (LITHOSTAR
PLUS, Siemens Comp.) in 52 patients 37 female and 15 male prior to
laparoscopic cholecystectomy. The single stone diameter was between 3
cm and 4,5 cm. 41 patients suffered from pure cholesterol, the other 11
from calcified stones. On average 3200 + 1250 shock waves with an
energy level of750 bar were applied The ESWL treatment time ranged
from 15 to 45 minutes (21 + 16 min.)
In all cases stones could be disintegrated successfully to a final
fragment size of 1-12 mm. Laparoscopic cholecystectomy was carried out
day postESWL routinely without problems. The gallbladder could be
easily removed using a 1,5-2 cm small incision of the abdominal wall.
No complications were seen in the postoperative course and all patients
were discharched on the 4th postoperative day.
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HYALURONICACIDENHANCED3H-5-FLUOROURACIL
UPTAKE INTHEMALPERFUSEDRATLIVER
W.HE, E.S. KLEIN, S.S. ASCULAI, J.A. NELSON, R.E. FALK
Department ofSurgery, University ofToronto School ofMedicine, Toronto, Ontario, Canada
Biological and chemical properties of hyaluronic acid (HA) qualify this
macromolecule as a prospective carrier of drugs particularly for targeting
to different tissues. To assess this we studied the effect ofHA on tritiated
5-Fluorouracil (3H-5-Fu) uptake by acute and chronic malperfused rat
liver tissue using two models:
1. Ischemia/reperfusion: Four groups of rats (A, B, C, D) were
subjected to 30 minutes liver ischemia followed by a period of
reperfusion. Two sham (E,_F) groups served as controls. All groups
received intravenous (i.v.) 3H-5-Fu at the end of reperfusion period with
(A, C, E) or without (B, D, F) i.v. HA (15mg/kg). Groups C andD also
underwent a "once-through" liver perfusion before liver tissue harvesting
to eliminate blood factor.
Group(n=) A(9) B(9) C(6) D(6) E(8) F(9)
meanCPM 42487 45392* 37372 40790* 45591 46261
SEM _+569 _+839 _+468 _+665 _+1328 _+536
2. Liver-implanted tumor: Two roups of rats with liver-implanted rate
mammary carcinoma received i.v. H-5-Fu alone or combined with i.v.
HA. Liver (LVR) and tumor (TMR) tissues were processed for
radioactivity counting.
Tissue(n=) TMR(9) TMR(HA)9 LVR(9) LVR(HA)(9)
meanCPM 314 461" 1979 2237*
SEM _+25 _+61 _+133 _+122
In the results, *means P<0.05 by ANOVA-1, vs. untreated groups
Conclusions: The exogenous HA may preferentially target depleted
tissue and therefore enhance drug delivery to such tissue.
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THEEFFECTONLIVERMETASTASES OF CIRCADIAN
PATTERNINGOF CONTINUOUS HEPATICARTERY
INFUSION (CHAI)OFFUDR
M.F.KEMENY G. ALAVA, J. OLIVER, F.B.SMITH
St. Vincent’s Hospital and Medical Center, New York City, New York, USA.
Previous studies have shown that using a circadian patterned CHAI of
FUDR has lowered the toxicity of the infusion and allowed for higher
doses ofFUDR to be given. The question of whether this decrease in
toxicity is accompanied by an increase in antitumor efficacy has not been
demonstrated. A hepatic artery catheter was placed in 18 Fisher Rats l0
days after an adenocarcinoma had been implanted subcapsularly in the
liver. Nine animals received a constant CHAI ofFUDR at a dose of
10mg/kg/d for 14 days. Another 9 animals received a circadian timed
CHAI of 15mg/kg/d ofFUDR. In this pattern 67% of drug was delivered
between 3pro and 9pm each day. Four of the rats on the constant schedule
died of toxicity from the infusion. All of the animals with the constant
infusions had a decrease in the tumor volume from 87 to 100%. In the
animals given circadian cycled continuous FUDR non died of toxicity.
One had an increase in tumor size while the rest had a decrease in size
from 94 to 99%. There was no significant difference in the response rates
in the two groups. This study shows that with circadian timing more drug
can be delivered with lower toxicity and have an equal anti-tumor efficacy
to constant CHAI.
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REPEATED TRANSIENTDEARTERIALIZATIONOFALIVER
TUMOUR IN THE RAT
LIQING WANG, BO G. PERSSON. BENGT JEPPSSON AND STIGBENGMARK
Depat. of Surgery, Lund University, Lund, Sweden
This experiment was designed to elucidate the optimum period of
repeated dearterialization of liver tumours without giving rise to
collaterals. Repeated dearterializations were achieved with a minioccluder
implanted around the hepatic artery. Forty rats assigned to receive
intermittent dearterialization for 0 (sham operation), 30, 60, 120 and 180
minutes respectively (A-E n=8 in each) and compared to permanent
dearterialization (F n=8). The tumour size was measured before and after
5 days of daily dearterializations. Another 18 rats were allocated to
repeated transient dearterializations for 2 hours/day prolonged to 18 days
(G), control (H) and permanent dearterilization (I) (n=6 in each).
Results: The tumour growth was almost totally retarded in groups D, E
and F after 5 days of dearterialization and highly significantly less
compared to group A, B and C (p<0.01). The growth rate was modestly
retarded in group C compared to groups A and B (p<0.05). After 18 days
of dearterialization the tumours resumed to grow though the growth rate in
group G was still much less compared to groups H and J (p<0.05). No
collaterals could be demonstrated inD and minor collaterals in E in
contrast to fully developed collaterals in F and J.
Conclusion: The optimun period of arterial blockade retarding this liver
tumour without giving rise to collaterals is between 2 and 3 hours.
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WATER-JET-COOLEDND: YAGLASERCOAGULATIONOF
RATLIVERMETASTASES: SELECTIVEOR
DESTRUCTION
R. VAN HILLEGERSBERG W.J. KORT, F.J.W. TEN KATE, O.T. TERPSTRA
Depts of Experimental Surgery and Pathology, Erasmus University, Rotterdam,
The Netherlands.
We investigated the use of laser in treating hepatic metastases from
colon cancer. A syngeneic colon carcinoma CC531 was implanted in the
liver of 68 Wag/Rij rats; 20 days after inoculation, when the tumor
diameter was about 5 mm, laser therapy was performed with a water-jet-
cooled Nd: YAG laser at energies of either 600 J, 850 J, 1,200 J, 1,700 J
or 2,400 J and a power setting of either 10 or 20 W. Liver damage was
determined on the basis of histological sections taken on day after
treatment using a computer integrated image analyzer and serum
ASAT/ALAT levels measured on day and 2. To assess liver function an
antipyrine clearance test was performed on day 2 after treatment. Sections
of day 36 were used to evaluate tumor remission Light microscopy on
day showed coagulative necrosis up to 10mm in diameter. Multiple
regression analysis of the parameters used indicated a significant
relationship between laser energy and liver damamge (R2=0.05,
P=0.01).At 20W liver damage was 22% larger than at 10 W. Tumor
damage also increased with energy applied, resulting in complete tumor
destruction at 2400 J, whereas massive tumor outgrowth occured in
control animals. No deterioration in liver function was found as measured
by antipyrine clearance. The results of this study show the ability of the
water-jet-cooled Nd:YAG laser to produce selective tumor necrosis with
minimal liver damage. Treatment of several superficial tumors at different
liver lobes would be possible, thus reducing surgical trauma and
diminishing complications like bleeding and liver failure.
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COLORECTAL LIVERMETASTASIS (LM): EXTRAHEPATIC
DISEASE,FOURORMORE LM,ANDCLEARMARGIN
SMALLERTHAN 1CMARENOTAUTOMATIC
CONTRAINDICATIONSTO LIVERRESECTION (LR)
D.ELIAS, PH. LASSER, PH. ROUGIER, F. FARHAT.
Gustave-Roussy Institute Cancer Center, 94805 VILLEJUIF, FRANCE.
AIM: TO retrospectively study the prognostic value of the 3 criteria
commonly recommended as contraindication to LR during the last ten
years: extrahepatic disease, 4 or more LM, and clear margin smaller than
cm.
Patients (pts): 85 pts with 2 years minimal follow-up had LR for LM;
20 had intraabdominal or pulmonary extrahepatic disease (also resected),
16 had 4 or more independentLM 17 had clear margin equal zero, 24
between 0 and 5 mm and 15 between 5 and 10 mm. One post-operative
death occurred (1,2%).
Results: crude and disease free survivals were similar for these pts and
for the pts with classical good prognostic criteria. Actuarial 2, 3, 4, and 5
year crude survival was 77%, 63%, 45% and 28% respectively; disease
free survival was 76%, 51%, 31% and 17% respectively for each group of
pts.
Conclusion: these 3 classical contraindications to LR have no real
value. Prognostic determinants ofLR forLM from colorectal cancers
always appear very vague in the literature and should be studied in an
extensive multicentric prospective study without exclusion criteria.
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ISOLATEDLIVERPERFUSIONWITHMITOMYCIN-C IN
PATIENTSWITHHEPATIC METASTASES.
LM DEBRAUW A MARINELLI, HJ KEIJZER+,JH VANBOCKEL,
CJH VAN DE VELDE
Dept of Surgery and Oncology+, University Hospital Leiden, The Netherlands
Nine patients with irresectable colorectal hepatic metastases (percent
hepatic replacement 25-75%) were subjected to new method of Isolated
Liver Peffusion (ILP).
Procedure: Surgical isolation and subsequently perfusion of the liver
coupled to an extracorporeal circuit during h.20 rain. withMMC (dose
30 mg/m2).
Results: All patients survived the procedure. One patient died after 40
days following the operation due to Veno-occlusive Disease (VOD). Two
other patients developed this syndrome, and needed a peritoneal-venous
shunt. The liver function tests LDH, SGOT, SGPT and bilirubin increased
significantly after ILP but all returned to normal within one week.
Responses: One patient had an objective complete response on CT scan
(alive NED > 9mo), and seven of eight evaluable patients had an objective
partial reponse (4 alive > 10-16 mo.)
Conclusion: ILP was well tolerated by the patients. ILP withMMC
induced significant toxicity and resulted in objective tumor regression in 7
of 8 evaluable patients, including one complete response.
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CONTINUOUS SIMULTANEOUSINTRAARTERIAL (IA)AND
INTRAVENOUS (IV) THERAPYOFLIVERMETASTASESOF
COLORECTAL CARCINOMA. RESULTS OFAPROSPECTIVE
RANDOMIZED TRIAL.
F. SAFI, H. G. BEGER
Department of General Surgery, University of Ulna, Steinhovelstr. 9, D-7900 Ulna, FRG
From 1982 to 1990 276 patients (pts.) with hepatic metastases of
colorectal carcinoma were admitted in our clinic. 159 pts. did not get a
treatment. Further 91 pts. were treated regionally and the remaining 26 pts.
underwent a surgical resection of the metastases. Since pts. died under IA
chemotherapy of extrahepatic spread of the metastases, we started a
randomized controlled trial to compare the effficacy ofIA to continuous
simultaneous IA and IV chemotherapy of liver metastases. The first 20
pts. were treated only IA (pilot group PG). The other 71 pts. were
stratified by primary tumor stage and the percentage of liver involvement
and were then randomly assigned before surgery to receive either IA (IA
group n=34pts.) or IA and IV therapy (IA/IV group n=37 pts.).
Intervention: 14 days continuous infusion ofFUDR each month (m) (0.2
mg/kg/day in all IA treated pts. and 0.3 mg/kg/day in the IA and IV group;
infusaid pump mo. 400, dual).
Results: The complete and partial response rate was 59%, 57% and
50% in the IA, IA/IV and PG respectively. 79% of the IA group, 75% of
the PG and 51% of the IA/IV group developed extrahepatic disease in a
median follow-up time of 24m (p<0.01). Hepatic and systemic toxicity in
the IA and IA/IV group were acceptable. No significant difference in
survival was found between the IA and IA/IV groups (p=0.09). The
difference in extrahepataic disease free survival was between the two
randomized groups significant p<0.01.
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IDENTIFYINGPATIENTSWITHCHOLELITHIASIS
UNLIKELYTOBENEFITFROMSURGERY
R.W. DICKINSON L.H.OAKES, J.S. GANI
Department of Surgery, John Hunter Hospital, Newcastle, NSW, Australia.
There is a 34% incidence of post cholecystecomy pain. This study was
undertaken to identify those patients with cholelithiasis unlikely to benefit from
surgery. Patients with gallstones who were referred to a general surgical clinic
were studied. A single investigator using a detailed questionnaire and an
objective biliary symptom scoring system completed an objective and a
subjective assessment of these patients. All patients also underwent
choleycystokinin octapeptide cholescintigraphy (OP-CCK-Scan)2. Patients
were reviewed after six months (non-operative group) or six months post-
cholecystectomy.
Results: 34 cases were included in the study. Following objective and
subjective symptom assessment these patients were then categorised. The
association between subjective and objective scores was almost linear with a
Cramer coefficient of0.93.17 patients were classified as having definite biliary
pain. All of these underwent surgery and all were significantly improved at
mean follow-up of nine momnths. 70% of theis group had an abnormal OP-
CCK Scan. In those patients classified as having possible biliary pain 37% had
an abnormal OP-CCK Scan. Most of these patients were managed non-
operatively and 50% had improved at six month review, although none were
cured. Six patients were classified as having non-biliary pain, 30% of these had
abnormal OP-CCK-Scans. All but one of these patients was managed non-
operatively, though this group did not improve with time. Finally, in a group of
asymptomatic controls with gallstones all patients had normal OP-CCK Scans.
Conslusions: The use of a biliary symptom questionnaire whether objectively
or subjectively scored results in accurate categorisation of patients into a group
unlikely to have post cholecystectomy symptoms and two other groups in
which post cholecystectomy symptoms are more probable. In those patients
with definite biliary pain OP-CCK Scanning tends to support the clinical
categorisation of patients but appear to offer no additional benefit in terms of
outcome prediction. Those patients with possible biliary pain are more likely to
have a normal OP-CCK Scan. It is in this group of patients that cholecystokinin
octopeptide cholescintigraphy may help identify those patients more likely to
suffer from the post-cholecystectomy syndrome.
References
I. Bates, T et al. Influence of cholecystectomy symptoms. Br. J. Surg. 1991 78 964-967.
2. Yap, L et al. Acalculous Biliary Pain: Cholecystectomy Alleviates symptoms in Patients
With Abnormal Cholescintigraphy. Gastroenterology 1991; 101:786-793.
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COSTANALYSIS OFPROTOCOLSFORTHE
INVESTIGATIONANDTREATMENTOFCOMMONBILE
DUCT STONES
DM SCOTT-COOMBES, JN THOMPSON
Department of Surgery, Hammersmith Hospital, Du Cane Road, London, England
Laparoscopic cholecystectomy is now widely accepted as the operation
of choice for patients with symptomatic gallstones but controversy exists
over the management of patients with common bile duct stones. The
optimal way to diagnose ductal stones is cholangiography, but this exists
in several forms and may be performed before, during or after surgery.
For surgeons performing laparoscopic cholecystectomy the choice of
treatment for patients with common bile duct stones is either open
operation or laparoscopic cholecystectomy preceeded or followed by
endoscopic removal of the stones.
Given the many permutations regarding the investigation and treatment
of ductal stones we performed a cost analysis study of different
management protocols based on the varying workloads and the cost of the
individual procedures. By combining our results of this economical survey
with the clinical considerations we have attempted to identify the optimal
approach to this condition in different patient categories.
A policy of selective operative cholangiography with postoperative
intravenous cholangiography for the technical failures is recommedned.
Low-operative risk patients are probably best managed by conversion to
an open operation, while postoperative stone clearance should be reserved
for higher risk patients and those whose stones are identified after
cholecystectomy.
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INCIDENCEOFHEHOBACTERPY (HP) INPATIENTS
WITHSYMPTOMATIC CHOLECYSTOLITHIASIS
F.E. LDTKE H. NIEMEYER, H. OHLER, F.E. BAUER*, R. TEGELER**,
G. LEPSIEN
Dept. of General Surgery, Clinical Pharmacolgy* and Med. Untersuchungsamt**,
University of G6ttingen, Germany
The incidence ofHP colonisation in the antrum of the stomach in
patients with symptomatic cholecystolithiasis was determined (n=117, m:f
1:2.25, median age 53 years, range 21-86 years) in preparation for a
prospective study. The results were compared to a control group of
healthy patients with the exact same age and sex distribution.
Material and Methods: The HP status was determined using positive
microbiological proof and/or thel 3 C-urea-breath test. In addition, 51
surgical gallbladders were examined for the presence ofHP. In 51
patients, a follow-up clinical examination and laboratory status was
performed 7 months after the cholecystectomy and the post-operative
course analysed with respect to any complaints reported.
Results: 1.) HP was found in 54 (46.2%) of 117 patients with
cholecystolithiasis, whereas HP was only found in (27.4%) of the control
group (p<0.05). 2.) No evidence forHP could be found in preparations of
the gallbladders removed. 3.) 25.5% of the 51 cholecystectomy patients
examined post-operatively complained of mild yet disturbing symptoms
whereby no evidence of a biliary origin of these complaints could be
found. No association between HP status and the post-operative course
could be elicited in the small patient collective.
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SENSEORNONSENSEOFROUTI,EPREOPERATIVEUPPER
GASTROINTESTINALENDOSCOPY INPATIENTSWITH
SYMPTOMATIC GALLSTONE DISEASE.
P. SUNGLER M. HEINERMAN, O. BOECKL
st Surgical Dept. and Ludwig-Boltzmann-Institute for Experimental and
Gastroenterologic Surgery, Landeskrankenanstalten Salzburg, Austria
Routine preoperative upper gastrointestinal endoscopy (UGE) in
patients with documented and symptomatic gallstone disease is carried out
before cholecystectomy. Of 1100 patients, who had consecutive
cholecystectomies performed, 250 had gastroduodenal disease, discovered
at endoscopy. Only 5 of those had an associated gastroduodenal operation
at the time of cholecystectomy. Mainly, upper gastrointestinal disease was
treated conservatively. 50% of the cases had delayed cholecystectomy due
to the diagnosis of ulcers. Four unexpected cancers of the stomach (TIS
and T1) were found.
11 patients were ruled out ot have alternative treatment such as
extracorporeal shock-wave lithotripsy (ESWL).
Despite the current trend toward critical analysis of costs of medical
care, we believe in the clinical value of routine UGE before
cholecystectomy or ESWL, complemented by indicated endoscopic
retrograde cholangiopancreaticography.
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LONGTERM (10YEARS)FOLLOW-UPOF CONVENTIONAL
CHOLECYSTECTOMY
J. KONSTEN MD, DJ. GOUMA MD. MAASTRICHT
University Hospital, Maastricht, The Netherlands.
INTRODUCTION: Long term follow-up of different (new) treatment
modalities for gallstone disease (with or without removal of the
gallbladder) is limited. However stone recurrence, biliary and
postcholecystectomy symptoms should also be evaluated to select the
optimal procedure. Therefore, long term follow-up of conventional
cholecystectomy (the gold standard) was studied with emphasis for
postcholecystectomy symptoms. PATIENTS AND METHODS: 351
patients (263 female and 88 male) underwent a conventional
cholecystectomy more than 10 years ago. Follow-up was obtained, (using
questionnaires) in 93% and bloodsamples of symptomatic patients alive in
69%.
RESULTS: The operative mortality was 0.3%, the procedure related
morbidity 5% and follow-up was obtained in 325 patients ofwhom 82%
were symptom free. Overall, 60 patients (18%) had complaints after 10
years and stone recurrence had been found in 5 patients (1.5%). Ten other
patients (3%) had biliary tract related complaints although bloodsamples
revealed no abnormalities. Additionally, 45 patients were found to have
atypical symptoms at the time of follow-up.
CONCLUSION: Ten years after surgery, conventional
cholecystectomy showed to cure 82% of the patients. Five % had biliary
tract related symptoms, whereas 13% had atypical symptoms. New
techniques should be compared with the follow -up of cholecystectomy to
select the optimal procedure for the individual patient.
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PLASMA CHOLECYSTOKININAFTER
CHOLECYSTECTOMY
IS BAILEY. TN WALSH, ADK HILL, S JAZRAWI, TPJ HENNESSY, CD JOHNSON.
University Surgical Unit, Southampton General Hospital, Southampton & Surgical Unit,
Trinity College, Dublin.
Receptors for the peptide hormone cholecystokinin are found on many
abdominal organs. Exogenous CCK causes a variety of abdominal
symptoms and abnormal endogenous release ofCCK may be involved in
such symptoms. Cholecystectomy may alterCCK release by altering
postprandial bile flow. Abnormal circulating levels ofCCK may be
responsible for the high incidence of dyspeptic symptoms reported after
cholecystectomy.
Using a specific CCK radioimmunoassay integrated plasmaCCK was
measured for one hour after a meal of 60ml corn oil in instant mashed
potato. Integrated plasmaCCK (pmol/1/hr) was 119 (31-215) in normal
adult controls (n=13), 145 (22-517) in patients with symptomatic
uncomplicated gallstones (n=22), and 229.5 (63-522) in patients after
cholecystectomy. Integrated plasmaCCK was 115 (62-360) in post
cholecystectomy patients with unexplained dyspeptic symptoms (n=8)
and 290 (94-522) in patients without symptoms (n=12) (p=0.06 [Mann
Whitney]). Integrated plasmaCCK was significantly higher in the post-
cholecystectomy patients compared with the controls (p=0.02 [Mann
Whitney]).
Postprandial plasmaCCK concentrations are significantly increased
after cholecystectomy. Increased CCK is not related to post-
cholecystectomy dyspepsia. Dyspeptic patients after cholecystectomy
have lower postprandial concentrations ofCCK than asymptomatic
patients. This would be consistent with these patients having reduced
gastric emptying compared to the asymptomatic post-cholecystectomy
patients.
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EFFECTOF CARBOHYDRATE-RICHDIETANDPORTAL
BACTEREMIAONPIGMENTSTONEFORMATIONAND BILE
COMPOSITION INHAMSTER
K.S. SUH, S.W. KIM, Y.H. PARK
Department of Surgery, Seoul National University, College of Medicine, Seoul, Korea
We performed an experimental study to see whether a high-
carbohydrate (CHO) diet induces pigment stone formation in hamster. In
addition, we studied the effect of biliary tract infection induced by portal
bacteremia on this high-CHO diet induced stone formation. Ninety male
hamsters were divided into 3 groups (Group 1: control chowfed group,
Group 2: high-CHO fed group, Group 3: high-CHO fed plus portal
bacteremia group). The high-CHO diet was 65% CHO(43% in control
chow), mainly composed of rice, and portal bacteremia was induced by
injection of endogenous E. coli into the portal vein. The hamsters were
sacrificed after 12 weeks of feeding. The stones were analyzed by infrared
spectrophotometry and the hepatic bile was analyzed by using commercial
Kit. No stones were found in Group but black-colored stones were
found in 24 out of 30 animals in Group 2 (p<0.0001 vs Group 1). In
Group 3, 12 animals survived and all ofthem developed stones. There was
no significant difference between Group 2 and 3 in stone formation. The
stone composition was similar to that ofhuman calcium bilirubinate
stones. In hepatic bile analysis, the phospholipid and total bile acid level in
group 2 were higher than those of Group (p<0.05). In conclusion a high-
CHO diet is a possible important etiologic factor of gallstone formation,
especially calcium bilirubinate stones. In addition an increased level of
phospholipid and total bile acid in hepatic bile may contribute to high-
CHO diet induced gallstone formation.
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FREERADICALANDPIGMENTGALLSTONEFORMATION
C.LIN, T,SHEN, X.B. FU, X.S.ZHOU
Department of Surgery, Third Teaching Hospital, Beijing Medical University, Beijing
100083, China
Since free radical signal in pigment gallstones (PS) appears in vivo, the
role of superoxide free radical (SOFR) in the formation ofPS was
explored in this study. In S group, a stricture at the common bile duct
(CBD) of guinea pigs were created by ligation. In S+V group, 10mmg/kg
of Vit.E and C were injected daily since 3 days before CBD ligation. In C
group, only laparatomy was performed as control. One week after
operation, the incidence (INC) of PS, total bilirubin (TBr), indirect
reactive bilirubin (UCB), Ionized calcium (ICa) contents, and SOFR
scavenge rate (SR) of gallbladder bile were measured and listed below.
When the UCB and ICa contents increased and SR decreased, the INC
elevated (S vs C). Once the SR recovered, even theUCB and ICa
remained high, the INC was supressed (S+V vs S).
C group S group S+V group
n Mean _+ SD n Mean _+ SD n Mear+SD
INC 0/15
TBr (uM) 7
UCB (uM) 7
ICa (uM) 11
SR 9
14/16 @ 5/14
13.7+8.1 16 40.8_+30.3 @ 13 69.2_+40.3
5.2 + 3.4 16 12.6 + 8.9@ 13 16.9 _+ 11.5
281_+113 16 765_+441 @ 14 720+304
.944_+.048 14 .683 +.311 @ 14 .921 _+.082@
(@: S vs C, S+V vs S, Chi-square (INC) or t-test, p<0.05)
CONCLUSION: the presence of superoxide free radical was essential
in pigment gallstone formation. (*supported by National Natual Science
Foundation of China)
25F093
CALCIUMSALTS OFFATTYACIDS IN GALLSTONES.ARE
THEYMARKERSOF BILEINFECTIONBYE.COLI ?
FLOMBARDO V GARGANO, F CETTA
Institute of Surgical Pathology University of Siena Italy
A content of calcium salts of fatty acids, mainly consisting of calcium
palmitate (CP) greater than 10% of stone dry weight was found in 79 of
960 consecutive patients with gallstones, who underwent surgery. In these
patients stones were homogeneously brown pigment stones in 48 cases,
black and brown in 9 and cholesterol or mixed stones in 2 cases. In the
other 19 cases CP was found in the brown periphery of composite stones or
in same brown stones, associated with mixed or cholesterol stones in the
some site. Bile infection by E.coli was associated with both brown pigment
and calcium palmitate containing stones. In particular E.coli overgrowth
was found in 100% ofbrown pigment stones in the common duct, all with
considerable CP content and in 98% ofbrown gallbladder stones.
It is suggested that: 1) Stones with a CP content greater than 10-15% are
associated and usually determined by bile infection. These stones are
mainly brown pigment (97.4%, 75 of 77) and are mainly found in the
common duct postcholecystectomy. 2) Not the simple bacterial overgrowth
in the bile, but also the type of bacteria, in particular the presence of E.coli,
alone or in association with other bacteria, in addition to other factors as
age of patients and site of stones, are of importance for calcium palmitate
precipitation. 3) Palmitate and carbonate are anions mutually exclusive of
each other in gallstones. 4) The presence ofCP both in the stone centre and
periphery can be used as a marker to determine whether
postcholecystectomy stones are true recurrent or residual stones. In
particular, E.coli overgrowth was found in 100% of patients with common
duct brown pigment stones all containing CP, and in 98% of"pure
gallbladder brown stones. On the other hand, a bacterial count in the bile
greater than 105 CFU per ml was not found in 6-9% of patients with brown
stones (in particular in those with composite stones or with brown stones
only in the gallbladder). Calcium palmitate was found in 33.6% of all
stones associated with bile contamination and in 51.3% of stones
associated with bile infection by E.coli.
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GALLBLADDERMOTILITYDETERMINED BY INFUSION
CHOLESCINTIGRAPHY BEFORE ANDAFTERTOTAL
GASTRECTOMY
M. MILICEVIC M. PETROVIC, V. ARTIKO, V. OBRADOVIC, G. JANKOVIC I.K. KOSTIC
Institute for Digestive Diseases and Nuclear Medicine Service, University Clinical Center
Belgrade 11000, Yugoslavia, Koste Todorovica hr.6
The aim of this study was to determine gallbladder (GB) motility in
patients before and after total gastrectomy and to compare the motility
pattern to a stimulated and nonstimulated control group. Infusion
cholescyntigraphy was performed with the patient supine using aROTA
scintillation camera connected to a MicroDelta computer system. Data
acquisition was performed during a 3 hour period of4mCi99m-Tc-EHIDA
continuous infusion, preceded by a bolus injection with increased
concentration. Stimulation was done by drinking fresh egg yolk. There
were 12 pts. in the control (C) group without stimulation, 10 pts. on the
control group with stimulation (CS) and 5 pts. before total gastrectomy
(BTG) and the same 5 pts. after total gastrectomy (ATG).
Gallbladder filling (GBF) in group C lasted 75.5 +/- 20.5 min., and
gallbladder emptyinga (GBE) lasted 58.8 +/- 28.0 min. The
ascending/descendingTA curve ratio, determined as slope ratio was
X=1.26+/-0.9 (integral X=2.22+/-1.1. Mean ejection fraction (EF) was
42.1% +/- 7.2 (SE=2.1). In the CS group BF filling lasted 66.1 +/- 27.0 min
and GBE 35.1 +/- 12.1 min. The ascending/descending TA curve ratio was
0.81 +/- 0.6 (integral 3.1 +/- 1.6. The mean EF was 77.5 +/- 19.2%. In the
BTG group GBF lasted 62.5 +/-27.6 min, GBE 41.5+/- 29.0 Min. The
ascending/descending TA curve ratio was 0.99 +/- 0.6 (integral 3.93 +/-
2.8. The mean EF was 89.5 +/- 8.4%. In theATG group GBF lasted 77.2
+/- 15.1 min, GBE 16.7 +/-6.8 min, the ascending/descending TA curve
ratio was 1.72 +/- 1.1 (integral 1.9 +/-0.9. The mean EF was 9.0 +/- 0.4. All
stimulated patients had a shorterGBE time (p) in comparison to the
nonstimulated group. The short GBE time in the ATG group (p) can be
explained by an very low EF (p).
Our results demonstrate clearly that afterTG the GB has impaired
emptying which is not significantly influenced by oral stimulation which
might contribute to gallstone formation.
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131I-LIPIODOLTARGETEDINTRAHEPATIC IRRADIATION
OFPRIMARYLIVERTUMOURS
R NOVELL A HILSON, A GREEN, K E F HOBBS
Hepatobiliary and Transplantation Unit, The Royal Free Hospital School of Medicine.
London
The therapeutic potential of 13I-Lipiodol was investigated in 15
patients with hepatocellular carcinoma (HCC) and 8 patients with
cholangiocarcinoma (CCA). Patients received one or two doses of 131I-
Lipiodol via hepatic arterial injection. The mean total adminstered activity
was 953 (SD 477) MBq in HCC and 723 (SD 559) MBq in CCA. One
patient with CCA retained I-Lipiodol. The cumulative radiation dose
was 9.6 Gy to tumour, 6.4 Gy to liver and 1.5 Gy to lung. The patient
remains asymptomatic 30 months from the start of treatment, whereas the
remaining 7 patients have exhibited tumour progreesion. The mean
survival in CCA was 11.6 (SD 14.5) months. All 15 patients with HCC
retained 3I with tumour:liver ratios of up to 30:1. The mean cumulative
radiation dose was 34 (SD 32) Gy to tumour, 3.5 (SD 1.4) Gy to liver and
4.7 (SD 2.1) Gy to lung. The mean dose per adminstered activity was 3.8
(SD 4.3) cGy/MBq. Partial response (reduction in tumour size > 50%)
was observed in 6 patients (40%). The mean survival was 8.3 (SD 8.6)
months.
3I-Lipiodol can deliver highly selective internal irradiation to foci of
HCC with evidence of objective response and may be the treatment of
choice for patients with cirrhosis and a small tumour.
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REPEATED INTERMITTENT DEARTERIALIZATION IN
THETREATMENT OF LIVERTUMOURS
BOG PERSSON. BENGT JEPPSSON, K-GTRANBERG AND STIG BENGMARK.
Department of Surgery, Lund University, Sweden
Hepatic artery ligation or dearterialization may result in objective turnout
regression but fails to provide prolonged disease control partly due to the
promptness with which collaterals develop after permanent interruption,
whether it comes from embolization or surgery. By performing intermittent
blockade of the hepatic arterial circulation, formation of collaterals is reduced.
Repeated intermittent dearterialization of short duration has been
accomplished with the use of an implantable occluder accommodated around
the hepatic artery.
Different occlusion periods have been investigated for development of
collaterals and the effect on liver turnouts have also been evaluated.
Collaterals seem not to develop if occlusions are performed for less than 2
hours each day (primary and secondary cancers) or 16 hours every second
month (liver carcinoid). Occlusions have been continued for 1-17 months (1-2
hours daily) and for more than 5 years in patients with liver carcinoid (16
hours). Nineteen patients have been treated according to this protocol (2
hepatocellular (HCC), 11 colorectal, 6 liver carcinoid). Both patients with
HCC responded and have had a sustained complete remission for 4 years.
All patients with carcinoid metastases had symptomatic relief and responded
with either reduction of measurable disease (3) or with reduction of urinary 5-
HIAA (4) or both (3). In patients with liver metastases from colorectal cancer,
who also received cyclic intraperitoneal infusion of 5-Fu, the effect was more
variable with a crude response rate of28%. Median survival was 17 months
(range 2-23) for all patients, and seemed to be comparable to intrahepatic
infusion but with much less toxicity.
An implantable occluder greatly facilitated the performance of repeated and
transient occlusions and a complete arrest of the flow through the hepatic
artery was generally achieved. Patient acceptance has been excellent and
many ofthem have performed the occlusions by themselves. Continued
occlusions have been possible for an extended period oftime and
complicaitons and toxicity have been few. Liver carcinoid (prolonged relief of
symptoms and disease control) and HCC (especially with a concomitant
cirrhosis) seems to be well suited for this treatment. Some patients with liver
secondaries from colorectal cancer (vascular tumours) may have a beneficial
palliation in combination with intrahepatic chemotherapy.F097
SELECTIVEINTERNALRADIATIONTHERAPYFOR
TREATMENTOFINOPERABLEHEPATOCELLULAR
CARCINOMA (HCC)
*w.Y LAU #W.T. LEUNG, #S. HO. ^N. LEUNG,#W. SHIU, *A.K.C. LI,
^C.METREWELI.
#Clinical Oncology, ^Medicine, Radiology and Organ Imaging, Prince ofWales Hospital,
The Chinese University ofHong Kong, Shatin, Hong Kong
Eight patients with histologically proven, alpha-fetoprotein (AFP) >20rig/l,
inoperableHCC were treated with either intra-arterial Yttrium-90 microsphere
(Y-90) or Lipiodol-IodineTM (Lip-I131). Five had Y-90 and 3 had Lip-ITM
treatment. Y-90 resin based microspheres have radioactive y90 attached to the
matrix which measure 29 to 35 microns. Y-90 emits high energy electron (2.3
MeV) which has a half life of 64.2 hours. During laparotomy,
cholecystectomy and insertion of a Port-A-Catheter into the gastroduodenal
artery were done and Y-90 were injected into the common hepatic artery
through the catheter. We had given various doses ranging from 2 GBq to
3GBq depending on the relative uptake of the tumour and normal fiver which
were measured intra-operatively by a beta probe and counter. All five patients
had tumour regression and decrease ofAFP to less than 20% of pre-treatment
level. The average duration of hospitalization was 2 weeks. There was no side
effects with respect to the internal radiation. The median survival of the five
patients was 6 months from time of diagnosis. Three patients who had
inoperable HCC diagnosed intra-operatively was offered LipITM treatment.
Lip-ITM is made by converting the iodine moiety ofLipiodol to TM through
an atom-atom exchange method. Cholecystectomy and insertionof a Port-A-
Cahteter were done in the usual way and on post-op days 12, 16, 20, 3
fractionated dose of Lip-ITM were given by injection into the arterial port. The
total dose ranged from 50 to 100mCi of ll. Dosimetry was documented with
serial gamma scans. Tumour regression and decrease ofAFP level to less than
10% of pre-treatment level were again observed in 2 patients who had
completed the course of treatment. The first patient survived 13 months from
time of diagnosis and the other two are still surviving at 4 and 5 months
respectively. Again, the treatment was relatively free of side effects and the
duration of hospitalization was 3 weeks on average. In conclusion, selective
internal radiation therapy is a feasible and effective treatment for inoperable
hepatocellular carcinoma.
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HEPATIC CRYOSURGERY INTHETREATMENTOF
PRIMARYLIVERCANCER
X.D. ZHOU Y.Q. YU, z.Y. TANG, J.M. WENG,Z.C. MA, D.B. XU
Liver Cancer Institute, Shanghai Medical University, Shanghai, China
Cryosurgery with liquid nitrogen (-196C) was performed on 87
patients with pathologically proven primary liver cancer (PLC) from
November 1973 June 1991. Of them, subclinical stage amounted to
31.0% (27/87), moderate stage 59.8% (52/87), and late stage 9.2% (8/87).
There were 30 cases with small PLC (_<Scm). Liver cirrhosis was
observed in 83.9% (73/87). Cryosurgery for PLC was mainly indicated for
(1) patients associated with severe liver cirrhosis in whom hepatfc
resection would be contraindicated; (2) residual tumor at the cut surface or
in the rest of liver after the main tumor resection; and (3) unresectable
recurrent PLC after major hepatic resection. The liver was exposed by
laparotomy. Flat surface cryoprobes were used to treat surface lesions.
Single and multiple trocar cryoprobes were used for freezing tumors deep
within the hepatic parenchyma. Intraoperative ultrasound was used to
monitor hepatic cryolesions. The 1-year, 3-year, and 5-year survival rates
were 60.5%, 32.0%, and 20.2%, respectively, for the whole series. Among
the 30 patients with tumor nodules <5cm in diameter, the 1-year, 3-year,
and 5-year survival rates were 92.6%, 66.6%, and 50.8%, respectively.
There were no operative mortality and complications, such as rupture of
tumor, delayed bleeding, bile leakage or abdominal infection. There
results indicate that hepatic cryosurgery is a safe and effective treatment
for unresectable PLC>
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EXPERIENCEWITHLIVERRESECTIONFOLLOWING
HEPATICARTERIALCHEMO-EMBOLIZATIONFOR
HEPATOCELLULARCARCINOMA
YE-QIN YU, DONG-BO XU, XIN-DA ZHOU, JI-ZHEN LU, PETERMACK
Liver Cancer Institute, Shanghai Medical University, Shanghai 200032, China
Thirty patients with huge primary liver cancers underwent percutaneous
transcatheter hepatic arterial chemotherapy and embolization (THACE).
The tumors were significant regression after THACE, converted them into
resectable lesions, and successfully resected them afterwards. Patients
received 1-5 treatment ofTHACE before surgery. The tumor diameters
reduced by 31.6+15.2%(2.3+1.2cm). Tumor necrotic area ranged from
40-100%. Adhesions of the tumor to the surrounding tissues were the
main operative findings but they do not significantly complicate the
surgery. In 5 cases there was 100% tumor necrosis. In 7 patients, their
AFP levels decreased to normal afterTHACE but of these, 5 still harbored
cancer cells in the resected specimen. Hence, resection of the tumor is
needed. The 1-,2-, and 3-year survival rates were 88.89%, 77.03% and
77.3% respectively. This mode of treatment appears promising for patients
with advanced or initially considered as a huge unresectable liver cancer.
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PERCUTANEOUSCHOLECYSTOSTOMY INTHE
TREATMENTOFACUTE CHOLECYSTITIS INHIGH RISK
PATIENTS
M. MORENO; J.L. RAMOS; MA.A. DELGADO; R. FERNANDEZ; G. MENDOZA;
P. ARIZAGA.
Hospital Universitario de Getafe. Getafe. Madrid.
Cholecystectomy is the treatment for acute cholecystitis, but in patients
with sepsis and risk factors, such as age over 65 and other pathological
conditions, operative mortality can reach up to 20%.
PATIENTS AND METHODS. From June 1986 to December 1990, 32
percutaneous transhepatic cholecystostomy (6-8F) have been carried out
in these high risk elderly patients. Emergency drainage (within 24h.)
because of septic shock was performed in 20 (62.5%) and delayed in 12
(37.5%) due to failure of conservative treatment. Average age was 76.03
y. Risk factors other than age appeared in all but one patient (87 y.).
RESULTS. Average lengths of drainage were 16.85 d. Complications
related to the technique appeared in two cases (6.2%) of pericholecystic
hematoma; three tube dislodgement (9.3%) and one catheter obstruction.
Four tubes were relocated. Correlation between bile and blood cultures
was highly significant (95.6%), E. Coli being the organism most
frequently isolated (56.2%). Mortality was 6.2% (two cases) and non
related to the procedure. Nineteen patients (59.4%) underwent delayed
cholecystectomy. In these cases, morbidity was 5.2% and operative
mortality was null. The eleven remaining patients refused or were not
considered suitable for further surgery.
CONCLUSION. Percutaneous cholecystectomy can be an alternative
procedure in the management in high risk patients with acute cholecystitis
and sepsis because its morbidity and mortality can be favorable compared
to emergency operations in such circumstances.
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SINGLE-DOSE CEFUROXIMEVERSUSMULTIPLE-DOSE
CEFAZOLINFORPROPHYLAXIS INHIGHRISK
CHOLECYSTECTOMY
K.R. SIRINEK Y.E. YELLIN, B.A. LEVINE, T.V. BERNE, P.N.R. HESELTINE, M.B.
APPLEMAN, M. GILL, K. PAPPA,
University ofTaxas Health Science Center, San Antonio, Tx
The efficacy and safety of single-dose cefuroxime and multiple-dose
cefazolin for surgical prophylaxis were compared in 295 patients
undergoing biliary surgery in a prospective, double-blind, randomized,
parallel-group study. Patients had at least one of the following risk factors:
obesity, diabetes mellitus, acute cholecystitis, jaundice, hyperamylasemia;
or they were _> 60 years old; or imaging evidence suggested the need for
common duct exploration. Thirty to 60 minutes before the incision,
patients received either cefuroxime 1.5 gm and then placebo every 6 hours
for 3 doses (n=149) or cefazolin gm and then cefazolin gm every 6
hours for 3 doses (n=146). A bile culture was obtained. Patients were
assessed daily while hospitalized and again within 30 days of surgery. Of
the clinically-evaluable patients, no signs or symptoms of systemic or
wound site infections were noted in 107 of 116 (95%)cefuroxime-and
111 of 117 (95%) cefazolin-treated patients (P=0.416, Mantel-Haenszel
test). Of the bacteriologically-evaluable patients, 105 of 110 (95%)
cefuroxime- and 110 of 112 (98%) cefazolin-treated patients were
classified as bacteriological successes (P=0.248, Mantel-Haenszel test).
Both drugs were well tolerated. We conclude that single-dose cefuroxime
and multiple-dose cefazolin are equally effective for surgical prophylaxis
in patients with risk factors for infection undergoing elective
cholecystectomy.
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MRIDIAGNOSIS OF CHOLECYSTITIS
F.YAMAMOTO l, YONGLIN PU2, H. IGIMI
Yamamoto Hospital, Imari, Japan1. Beijing Medical University, China2. Shionogi Institute,
Osaka, Japan
The utility ofMRI in the diagnosis of cholecystitis was evaluated in 31
individuals (5 healthy, 13 with acute cholecystitis, and 13 with chronic
cholecystitis). In the healthy volunteers the MRI scans were performed
after an overnight fast for 12-14 hours, 2 hours after breakfast, 4 hours
after lunch and 3 hours after supper, in all the patients MRI scans were
performed randomly. Imaging was performed in all cases with the 0.5T
RESONA unit. Spin-echo sequences were used. On the Tl-weighted
image (TRfFE=500/20, 620/25), T2-weighted image (TR/TE=1800/80,
2000/100), and proton-weighted image (TR/TE+1800/30, 2000/30) the
liver/bile signal intensity contrast was significantly higher in acute
cholecystitis than it was in chronic cholecystitis or in normal volunteers.
There was no overlap in the 95% confidence intervals between acute
cholecystitis and chronic cholecystitis or normal gallbladder on T1- and
T2-weighted images. So in the clinical setting of acute cholecystitis the
levels of 2.1 or more of the liver/bile contrast on the Tl-weighted image
and 0.384 or more on T2-weighted image can be used as diagnostic
criterion for acute cholecystitis. The concentration of total protein, total
bilirubin, cholesterol and fatty acid in bile in acute cholecystitis was
significantly lower than that in chronic cholecystitis, which may be the
cause of the high liver/bile signal intensity contrast in acute cholecystitis
on all the MRI sequences. In acute cholecystitis there are some
morphologic features known to be specific for the diagnosis of acute
cholecystitis by CT and sonography that can also be detected by MRI:
dilatation of the gallbladder, thickening of the gallbladder wall, wall and
pericholecystic effusion and loss of wall sharpness. The MRI appearance
of hemorrhagic cholecystitis was specific. On Tl-weighted and proton
weighted images in the gallbladder there is an irregular hyperintense area,
and on the T2-weighted image the irregular area was hypointense in its
center and hperintense in its periphery relative to the bile.
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ROLE OF KUPFFER CELLS IN HOST DEFENSE TNF & IL-
6 PRODUCTION IN SEPSIS
XU YING XIN. MENG XIAN JUN, SONG XUEHUANG
Institute of Basic Medical Science, The Great Wall Hospital, Beijing China
Liver, down stream from the gastrointestinal tracts, makes it the first
line of defense. Hepatic Kupffer cells (KC) comprise 70% of the tissue-
fixed macrophages. In sepsis KC become activated and produce a myriad
of cytokines which can impact both locally on adjacent hepatocytes and
systematically on distant target tissues. This study is designed to
investigate production of tumor necrosis factor (TNF) and interleukin-
6(IL-6) in relevance to the role liver plays in sepsis. Sepsis were produced
by cecal perforation and perforation (CLP). At 5hr and 15hr after CLP,
KC< peritoneal macrophage (PM), and alveolar macrophage(AM) were
harvested and assayed for TNF, IL-6 activities and kinetics following
stimulation with LPS> Results showed that for the same number of
macrophages(2x106) KC produced the highest IL-6 activity(107.10-+6.44)
15 hr after CLP as compared to PM (74.96_+6.68) andAM (44.26_+5.44).
AM produced the highest TNF activity 15 hr after CLP (54.69-&8.16)
compared withPM (14.06_+2.51) and KC (17.32_+1.62). At 15 hr after
CLP,AM responded to stimulation with LPS by increased production of
TNF but not IL-6. It is thus postulated that IL-6 is mainly confined in the
modulation of hepatocyte function in acute phase response. When hepatic
KC fails to clear endotoxins in the circulation, it may spillover to the lungs
and induce pulmonary injury by TNF production.
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CHOLECYSTECTOMY CAUSESA RISE INMEMEBRANE
SATURATION
MW SCRIVEN. JCM STEWART*, DF HORROBIN*, MCA PUNTIS
Dept Surgery, University Wales College Medicine, University Wales Hospital, Cardiff, UK
and *Efamol Research Institute, Kentville, Nova Scotia, Canada
The effect of surgical trauma on the saturation ofmembrane fatty acids
(FA) was investigated.
Red cell phospholipid FA were measured perioperatively by gas
chromatography, in 16 cholecystectomy patients (3M: 13F, mean age 57).
Results (molar%, median(IQR)) show saturatedFA (SFA),
monounsaturated FA (MUFA), n-6 polyunsaturated FA (PUFA) & n-3
PUFA. Statistics by Wilcoxon test comparing with preoperative:
ns=p>O.05, *p<O.05, **p<O.O1.
PRE OP DAY DAY 2 DAY 4
SFA 41.4 48.7 ns 52.1" 48.8 ns
(34.6-49.1) (36.9-54.6) (39.3-56.4) (36.5-55.9)
MUFA 20.5 24.5* 27.1" 22.6 ns
(17.5-25.0) (19.6-27.2) (18.3-28.1) (17.5-28.6)
n-6 28.2 23.7 ns 16.2" 18.3 ns
(19.4-35.1) (17.1-32.1) (13.2-33.9) (13.0-33.2)
n-3 6.6 2.6 * 1.0"* 3.1"
(2.7-12.3) (1.5-9.5) (0.0-8.1 (0.9-10.9)
This study shows significant changes in the saturation ofmembrane FA
after surgical trauma. Such changes affect cellular function and if reflected
in other cells, may explain some of the changes in cellular function that
are known to occur after trauma. They may open up new modes of
perioperative therapy.
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SANDOSTATIN (SMS) INTHELONGTERMMANAGEMENT
OFPORTALHYPERTENSION APRELIMINARY
PROSPECTIVERANDOMISEDCONTROLLED CLINICAL
SA JENKINS S ELLENBOGEN, BAXTER & R SHIELDS
University Department of Surgery, Liverpool, UK
Since SMS results in a sustained decrease in portal pressure, we have
examined its efficacy as an adjuvant to injection sclerotherapy (IS) in the
long term management of portal hypertension. Three weeks after their first
variceal bleed, 32 cirrhotic patients underwent a thorough investigation of
the severity of their liver disease, including assessment of
reticuloendothelial system (RES) activity (single photon emission
computed tomography), hepatocyte function (aminopyrine breath test) and
wedged hepatic venous pressure (WHVP). Sixteen patients were
randomised to IS and SMS, and 16 to IS alone. The efficacy of the two
treatments were evaluated 6 months later. In patients receiving IS and
SMS compared to those receiving IS alone there were significant
reductions in mortality (0/16 vs 5/16; p 0.0434 Fishers Exact Test),
number of variceal rebleeds (16; p<0.001 U Test) and 0 vs number of IS
sessions required to obliterate the varices (40 vs 89; p<0.05). Combined IS
and SMS also resulted in a sustained decrease inWHVP (25.1+ 1.3 to
19.2 _+ 1.2 mm Hg p < 0.002) but significantly stimulated hepatic RES
activity (19.8 _+ 1.3 to 29.8 _+ 1.5; % injected dose 99Tc sulphur colloid)
and hepatocyte function (1.5 _+0.2 to 3.7_+0.6% cumulative excretion 14
CO2 breath test). No significant changes in WHVP, RES activity or
hepatocyte function were observed in the IS group. These results suggest
that SMS may be a valuable adjuvant to IS in the long term management
of portal hypertension.
F106
MESOCAVALSHUNTVERSUSENDOSCOPIC
SCLEROTHERAPYFORLONGTERMMANAGEMENTOF
VARICELBLEEDING
B ISAKSSON, B JEPPSSON, P HERLIN, S BENGMARK
Department of Surgery, Lund University, S-221 85 Lund Sweden
Sclerotherapy (ST) is usually different in controlling acutely bleeding
oesophageal varices. For prevention of rebleeding it may not be as
efficient as shuntsurgery and therefore we undertook a prospective study
comparing mesocaval shunt (MCS) and repeated ST. Forty-five patients
who had survived a haemorrhage from oesophageal varices were
randomized to repeated ST (21 patients) orMCS (24 patients).
MATERIALAND METHODS:after workup, randomization was
performed. ST was performed every fourth month with flexible endoscop.
MCS was performed with 12mm graft.
RESULTS: There was an equal distribution according to Child’ in the
different group. There was no difference in survival in patients with
Child’ A and Child’ B in the treatment groups. In patients with Child’
C there was a statistically significant prolongation of survival compared to
ST.
In the ST group 12 patients had recurrent haemorrhages causing 5
deaths compared with the shunt group in which 4 patients presented
postoperative bleeding without associated mortality. There was no
difference in the incidence of encephalopathy.
CONCLUSION: The rate of rebleeding is significantly higher in the ST
group compared with the shunted group. In patients with Child’ C
cirrhosis MCS may be an alternative to ST for the prevention of bleeding
for oesophageal varices in patients not suitable for transplantation.
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AMMONIA CONCENTRATION INPANCREATICAND
DUODENALVENOUSBLOODFOLLOWING STIMULATION:
CH. N. SBAROUNIS, I. FARDELAS, :D. KARVOUNARIS: N. MAVROUDIS
2nd Surg. Prop. Dept. Univ. of Thessaloniki, Greece
There are indications that ammonia is produced in the pancreas and
duodenum, hypothesis that has not been proved. The aim of this
experimental study was to investigate whether ammonia is also produced
in the pancreas and duodenum and the possible factors that could
influence this production.
Material and methods. Fifteen dogs, divided into 3 groups (A,B,C)
were used. In all dogs the cranial pancreatic and the duodenal veins were
catheterized selectively and the parameters measured were: ammonia,
glucose and insulin in fasting state (A), following iv. infusion of
hypertonic glucose (B) and iv. infusion of glucose with simultaneous
stimulation of the pancreas with secretin (C). The levels of ammonia were
compared to those of the systemic circulation and in pairs between the 3
groups.
Results. The concentrations of ammonia in pancreatic and duodenal
venous blood are almost equal and are three times that of systemic
circulation (p<0.001). The infusion of hypertonic glucose (group B)
results in reduction of ammonia by one third in the pancreatic vein and by
one fourth in the duodenal vein (p<0.01), with a slight reduction of
circulating ammonia. The infusion of glucose and secretin (group C) had
the same results with the infusion of glucose alone (p<0.01).
We conclude that ammonia is produced by the pancreas by a
mechanism still not known. The relation of ammonia production to the
bicarbonate excretion is not proved, since the stimulation of pancreas with
secretin has no influence on the ammonia concentrations in pancreatic
venous blood (p<0.1).
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ENDOSCOPIC SCLEROTHERAPYCOMPAREDWITH
OESOPHAGOGASTRICDEVASCULARIZATIONAND
TRANSECTION INTHELONG-TERMMANAGEMENTOF
BLEEDINGOESOPHAGEAL VARICES: APROSPECTIVE
RANDOMIZEDCONTROLLED TRIAL
JEJ KRIGE PA GOLDBERG, PC BORNMAN, TERBLANCHE.
Department of Surgery andMRC Liver Research Centre, University ofCape Town and
Groote Schuur Hospital, Observatory, Cape Town, South Africa
Fifty patients (34 male, mean age 46.1 years, range 18 65 years) with
variceal bleeding were randomised after emergency endoscopic
sclerotherapy to continued endoscopic sclerotherapy (ES) using 5%
ethanolamine until variceal obliteration followed by regular check
endoscopy or to oesophagogastric devascularization with transection
(OGDT). Childs C score > 11, those over 65 yrs and high risk operative
patients were excluded. Thrity-six pts had alcoholic cirrhosis; 7 were
childs A, 24 Childs B and 19 Childs C. Mean follow-up was 16 months
(range 3 46 months).
All data was analyzed on an intention to treat basis. Mortality during
the first month after randomization was higher in the surgical group (2/25
v 0/25) but late deaths in the OGDT pts were fewer than among the ES
group (4 vs 8). Varices were eradicated in 22 of 25 pts in the ES group
after a mean of 5 injections (range 2-10). Three pts in the ES group died
before eradication at a mean of96 days. One patient in each group
required dilatation for an oesophageal stricture. No pt died from
rebleeding.
During follow-up there were no significant differences between the ES
and OGDT groups with regard to number of pts rebleeding from varices
(5 vs 6), number of bleeding episodes (8 vs 6) number of units ofblood
transfused per pt (2.9 vs 3.1), total number of days hospitalised (1203 vs
1143), total number of hospital admissions (79 vs 70), mean number of
days in hospital per pt (52 vs 45) or mean days per admission (15 vs 16).
We conclude that there is no significant difference between ES and
OGDT and that ES is as effective as ODGT in eradicating varices and
preventing rebleeding.
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MANAGEMENT OF BUDD-CHIARISYNDROME
(EXPERIENCE OF 260 CASES)
ZHONGGAO WANG. MD, FICA; SHIHUAWANG, MD; SHONGZHONG MA,MD
Beijing Heart Lung Blood Vessel Medical Centre, Vascular Institue, Post and
Telecommunications Hospital, Beijing, China.
Budd-Chiari syndrome is a rare disorder with manifestation of portal
hypertension caused by occlusion of hepatic veins (HVs) or suprahepatic
inferior vena cava (IVC). However 260 such cases were diagnosed and
treated by us in recent 10 years. There were 172 males and 88 females with
a male to female ratio of 2:1. The age ranged from 2.5 to 65 years with an
average of 33 and symptoms were present from between 3 days to 26 years.
All cases were confirmed by ultrasonography, cavography or
hepatovenography. Most of patients (249 cases or 95.8%) had occlusive
lesions involved the suprahepatic IVC.
Various procedures were performed in 217 cases including mesoatrial
shunt (53), membranotomy (44), cavoatrial shunt (53), balloon catheter
dilatation (22), radical correction (20), mesocaval shunt (11), mesojugular
shunt (5), combined innominate-atrial shunt (2), splenoatrial shunt (1), etc.
The overall effective rate was 77.4% and operative mortality of 7.3%.
The 5-year patency rate of the mesoatrial shunt, membranotomy and
cavoatrial shunt were 71.4%, 66.7%, and 50.0% respectively.
According to our experience, the therapeutic approaches are basically
described as follows: 1. Balloon dilatation is the first option for those with
webs or localized occlusive lesions without distal fresh thrombi. 2.
Transcardiac membranotomy is also suitable to the above-mentioned
patients. 3. Cavoatfial shunt is used for those with diffuse occlusive leisions
in the IVC with involvement of the HVs. 5. Portocaval or mesocaval shunts
are employed for those with pure occlusion in the HVs. 6. Mesojugular
shunt is a good alternative for those with intractable ascites, pleural effusion,
and high operative risk. 7. Innominate-atrial shunt can be supplemented in
those accompanying with superior vena caval syndrome. 8. Radical
correction is best indicated for those whose lesions require extirpation. 9.
Liver transplantation reserves as the last option.
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ENDOSCOPIC PALLIATIVE STENTINGOFMALIGNANT
HILAR STRICTURES
PPLO COENE. K. HUIBREGTSE, HFW HOITSMA,MN vd HEYDE, GNJ TYTGAT.
Dept. of Gastroenterology and Surgery, Academic Medical Center, Amsterdam, The
Netherlands
Endoscopic stent insertion has been shown to be an effective palliative
therapy for establishing biliary drainage in malignant obstructive jaundice.
Metastasis, multifocal disease, or extensive invasion may prohibit curative
resection in most patients, and those who are unfit for sugery because of
advanced age, extensive metastasis, or other unrelated illnesses should be
considered for nonsurgical biliary drainage. Success of drainage
procedures are related to the level of biliary tract obstruction, hilar
malignancies being less successful overall, compared to distal strictures.
An in depth analysis was established to evaluate factors which influence
stent function and clinical results, in 257 consecutive stented patients
(male/female ratio 0.70; mean age 69 years, range 28-92 years), followed
up over a 10-year period (cumulative success rate 85%, mean 1.2 ERCP).
Hilar strictures comprised a heterogeous group of malignant tumors
(23% of all malignant biliary strictures) including sclerosing
cholangiocarcinomas originating at the confluence of the left and fight
hepatic ducts (n= 163, or 64%; Klatskin tumor), locally invasive
gallbladder cancer (n=34, or 13%) as well as metastasis to the porta
hepatis (n=60, or 23%). Sixty three patients had type I, 72 type II, 62 type
III, and 60 type IV proximal biliary strictures (Bismuth classification).
Mean bilirubin 213 u mol/1, mean alkaline phosphatase 566 units/1.
Classification of bifurcation tumors revealed a significant correlation
(p<0.01) between length and type (according to Bismuth) of lesion, and
respective bilirubin decline (overall 86%), bilirubin normalization (overall
66%), early cholangitis (type 17%, type II 17%, type II129%, and type
IV 40% overall 25%), procedure related mortality (overall 9.5%), 30-day
mortality (type 14%, type II 17%, type II132%, and type IV 34%;
overall 23%), patient survival (type lesions median 137 days, type II 120
days, type II177 days, and type IV 43 days; overall mean 192 days,
median 95 days), and terminal clinical features (fever 31%, jaundice
74%). There was no difference in survival between primary cancer
MANAGEMENT OFHIGH BILE STENOSIS AND
OCCLUSIONWITHTHE RODNEY-SMITHMETHOD.
REPORT ON 34 CASES.
ANDRIOPOULOS ATHANASE R. BOTTICHER, HACK OBERARZT
Surgical Department I, Klinikum Furth Jakob-Henle-Str. 1, Germany
Surgical treatment of extrahepatic stenosis located at liver hilus due to
biliary carcinoma or strictures following previous surgery or trauma
represent some special problems. Difficult preparation of extrahepatic bile
tree especially in case of reintervention, inflammatory tissues, liver
insufficiency with cholostasis, clotting disorders and a high rate of
anastomotic leakage or shrinkage are undesirable life threatening conditions.
In such cases a sutureless hepato-jejunostomy with transhepatic
intubation using the Rodney-Smith method is a very effective technique to
repair high bile occlusions.
In the last ten years we used this method in 34 cases. Carcinoma of the
head of pancreas, posttraumatic lesions of the hepatic duct, strictures after
duodeno- or cholodocho- jejunostomy, stenosis due to cicatrix after
stomach-resection with insufficient duodenal stump, primary carcinoma of
hepatic duct or stenosis after bilio-digestive anastomosis were indications
for using the Rodney-Smith technique.
The transhepatic tube is normally moved after X-ray control within 3 5
month. In case of severejaundice with all its sequelae a preoperative
percutaneous cholangiography is recommended with remaining catheter till
liver function tests turn to levels permitting surgery.
Aprotinin was always administered to minimize blood loss during the last
two years. Preoperative antibiotic prophylaxis with mezlocillin or therapy
according to antibiogram was routinely used to prevent bacterial
complications.
No postoperative deaths occurred, no complications required
reintervention. In five cases repeated replacement of the tube was necessary
to dilatate restenosis due to malignancy. This procedure was easily and
always successfully achieved by pushing the tube externally beyond the
stenosis unter X-ray control.
(median 94 days for cholangiocarcinoma, and 95 days for gallbladder
carcinoma) and metastatic cancer (median 98 days). Acute cholangitis was
the most important early complication, directly related to the number of
endoscopic procedures and caliber of endoprostheses, and occurred in
23% of patients having one stent (85%), compared to 39% of those with
drainage of both liver lobes by at least two stents (15%; p<0.01). Median
stent patency was 175 days, overall incidence of stent change 30%. The
total number of stents required was directly proportional to patient
survival time (mean number 1.5, range 1-14). Cholangiographic
appearance (type I-IV, p=0.14), number of simultaneous placed stent
or multiple, p=0.91), or extent of drainage (one or both obstructed lobes,
p=0.65) did not influence stent patency.
Bifurcation strictures of both primary and secondary malignant origin
can be successfully treated with single stent insertion with reasonably low
risk of cholangitis and low mortality, and with a minimum number and
duration of endocopic procedures. However, patients with multiple
intrahepatic strictures and with extension of tumor into the segmental
ducts, in the absence of unbearable symptoms, should not be selected for
stenting procedures, because the benefits of drainage do not balance the
risks of complications.
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LOCALEXTENTIONOFPANCREATICAND
PERIAMPULLARY JMORS IN 55 SPECIMENSAFTER
PYLORUSPRF_ERVINGPANCREATECTOMY
A.PIETRABISSA, U.BOGGI, P.C.GIULIANOTTI, G.SARTONI, T.BALESTRACCI,
A. COSTA, A.GUADAGNI, *G.FORNACIARI, *J.BRUNO, F.MOSCA
Instituto di Chirurgia Generale Sperimentale,
*Instituto di Anatomia Patologica Universita de Pisa, Italy
Between Jan. 1982 and Jun. 1991, 146 patients underwent a pancreatic
head resection at our Institution. Among the 116 who had a diagnosis of a
tumor of the pancreatic area, 108 received a pylorus preserving procedure.
We report pathologic features of the last 55 cases of adenocarcinoma
whose surgical specimens were carefully analyzed focusing on local
extention of the tumor and lymph node involvement. The study comprised
33 tumors of the head of the pancreas, 14 of the papilla, 4 of the CBD and 4
of the duodenum. Each gross specimen consisted of the head of the
pancreas and a variable lengh of duodenum, always transected 2 cm. away
from the pyloric ring. The tumor ranged in size from 2 to 7 cm. (average
4.1) and on microscopic examination the pancreatic margin, judged
negative on frozen section, resulted to be involved by small foci of tumor in
3 cases. The duodenum was infiltrated in the area directly adjacent to the
tumor in 42% of cases, while in no instance the proximal duodenal
resection margin was involved by tumor spread. An average of 9+/-8
regional lymph nodes for each patient were available for pathologic
examination (range 1-28) including peripyloric and celiac nodes. Evidence
of tumor was shown in 36% of cases with an average of 3+/-2 lymph nodes
involved in each case (range 1-8). The adequacy of the pylorus preserving
procedure as a cancer operation is stressed by the same survival figures
obtained with the Whipple and we showed evidence that a microscopic
extention to the duodenal surgical margin seems very unlikely to occur and
therefore should not be considered as a theoretical limitation of the
procedure. In addition preservation of the pylorus does not compromize the
possibility to perform an extended regional limphoadenectomy. Our
experience suggests that an intraoperative conversion to a standard
Whipple operation for a cancer procedure should be undertaken only facing
with obvious spread of the disease ot proximal duodenum or gastric wall.
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PYLORUSPRFERVINGPANCREATODUODENECTOMY Vs
WHIPPLEPROCEDUREFORPANCREATIC CANCER: A
STATISTICALANALYSIS OF SURVIVAL
P.C.GIULIANOTIT *G.ROSSI, U.BOGG1, T.BALESTRACCI, A.PIETRABISSA,
A.COSTA,
Istituto di Chirugia Generale Sperimentale, *Dipartimento di Epidemiologia Biostatistica
C.N.R. Universit?a di Pisa, Italy
Doubts have been raised as to the advisability to perform the pyloms
preserving pancreato duodenectomy (PPPD) for malignant disease of the
pancreas, since it could compromise the only chance of cure in these patients.
We therefore undertook the present retrospective analysis to compare the
outcome following the PPPD with that of the classical Whipple resection in
57 pts. with histologically proven adenocarcinoma of the head of the
pancreas.
PPPDn =41 (25m-16fmean age 64.5+/-10.1,TNM stage :I [n=21] II
In=5] III [n=15] Whipple n=16 (10m-6fmean age 62.7+/-7, TNM stage:
In=9] II In=0] III In=7]). The variables examined were age, sex, stage, T
andN status,TNM grading, death for recurrence and survival time. Maximal
follow-up was chosen of three years. All pts. underwent the same post-
operative treatment. No pt. was lost at follow-up: 2 pts. (PPPD) died of
cardiovascular disease, without neoplastic recurrence. Patients alive with a
follow-up less than three years were considered censored. The statistical
software used to handle censored survival data was life table and survival
functions (Breslow and Mantel-Cox Test), Cox Proportional Hazard
Regression Model (three different tests were utilized to assess the treatment
effects while adjusting for baseline pt. characteristics L ratio, Wald Test and
Score Function Test). T Test, Exact Fisher Test (2-tail) orX2 were used to
assess differences between the 2 groups for baseline characteristics. The two
groups were comparable with respect to all the variables examined. The
analysis showed a statistically significant relationship betweenTNM stage
(P<0.05)N status (P<0.05) and survival time. Survival time was not
statistically different between PPPD and Whipple: median survival time was
14+/-1.9 and 13+/-3 months respectively. No statistical difference appeared
even after correction forTNM stage andN status using the Cox model.
On the basis of these results PPPD may be propsed as a cancer procedure
even when dealing with pancreatic carcinoma, except for those cancers that
are in close proximity to the first portion of the duodenum.
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PANCREATIC AND PERIAMPULLARY CANCER IN THE
ELDERLY: SHOULD IT BE RESECTED?
P.C.GIULIANOTTI T.BALESTRACCI. U.BOGGI, A.COSTA, A.PIETRABISSA,
A.GUADAGNI, M.FERRARI, F.MOSCA
Istituto di Chirurgia Generale Sperimentale, Universit?a di Pisa, Italy
The progressive increase of pancreatic and periampullary cancer incidence in
the western population, with a peak in VI VII decades, together with the elderly
increase, arises new problems in the surgical approach to these patients.
We performed a retrospective review of the data records of 21 pts. over 75
years (mean age 79.5+/-3.4, lm-10f) who underwent pancreato-duodenectomy
(PD) for pancreatic or periampullary malignancy from Jan. 1982 to Jun. 1991
(group A) to evaluate both post operative morbidity and mortality rates and post
operative quality of life. We compared them either with 98 pts under 75 yrs.
(64m-34f, mean age 63.7+/-11.01) who underwentPD with the same diagnosis
(group B), and with 35 pts. over 75 yrs. who received only a surgical palliative
procedure (20m-15f, mean age 79.37+/-3.7)(group C).
In groupA we had 13 pancreatic carcinoma (PC), 5 ampullary carcinoma
(AC) and 3 common bile duct carcinoma (CBDC); pts. had obtmctive
jaundice (mean bilimbin 10.8+/-12.5 mg/dl). 5 pts. with a more severe jaundice
(mean bilimbin 19.12+/- 12.8 mg/dl) and signs of metabolic failure, underwent
preoperatively percutaneous transhepatic drainage. Additional risk factors were:
ischemic cardiopathy (3 pts), essential hypertension (2 pts), diabetes (3 pts). One
bleeding pancreatic cancer, infiltrating the duodenum, demanded emergency
operation. In group B we had 62 PC, 21 AC, 9 CBDC, 5 duodenal carcinoma
and retroperitoneal limphoma and in groupC 33 PC, AC and carcinoid.
We have never considered the age (over 75 yrs) as an exclusion criterion for
radical surgery. Operative morbidity was 47.60% (40.8% group B; 50% group
C) and operative mortality for elective surgery, excluding the patient operated
on emergency who died forMOF, 4% (1 stroke) (11.5% group B; 8.5% group
C). the survival time ranged from 4 to 74 months (median 11.1) in group A,
while the median was 15.75 and 5 months in group B and group C respectively.
Patients in groupA as like group B pts. had a better quality of life than group
C pts. (time free from disease, possibility to resume a normal physical activity,
and lower need of analgesia).
We conclude that age is not an absolute exclusion criterion from radical
surgery which remains the only chance of cure and offers the best way of
palliation in the pancreatic and periampullary cancer.
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PRE-OPERATIVEEVALUATIONOFLIVERLESIONS;
MAGNETICRFONANCEIMAGING (MRI)VERSUS CT-
ARTERIOPORTOGRAPHY (CTAP)
M.S. LEEUWEN, J.C.M.HAVERBUS, E.D.DILLON, H. OBERTOP
Departments of Diagnostic Radiology and Surgery, University Hospital Utrecht, The
Netherlands.
In order to determine the best imaging modality for preoperative
evaluation of liver lesions, the results ofMRI and CTAP studies were
compared to each other and to surgical and pathology findings. A total of
24 patients, referred for liver resection were evaluated; 18 with metastatic
colorectal cancer, 5 with primary livertumour, and with FNH. All 24
patients underwent MRI; 20 out of 24 underwent CTAP, the remaining 4
had conventional CT>All lesions were localized according to Couinaud’s
classification and characterized as solid, cyst, or hemangioma. The results
were compared to the "gold standard", defined as the combination of
imaging, surgery and pathology findings.
A total of 142 solid lesions were present, distributed over 95
liversegments. Furthermore, 9 hemangioma’s were present. MRI detected
136 of 142 solid lesions leading to a sensitivity of95%. MRI detected
solid lesions in 90 of 95 diseased segments, i.e. 94%. In the 20 patients
who had CTAP 84 solid lesions were present in 71 segments. CTAP could
only identify 57 of 84 lesions, i.e. 68%. Lesions were found in 66 of 71
diseased segments, but in only 50 of 71 the lesions could be called solid
with certainty, leading to a sensitivity of 70%.
Ni of 24 patients were inoperable due to extensive tumorspread. The
remaining 15 patients were operated on. Ten had a successfull resection
while 5 turned out to be irresectable; 3 due to extrahepatic disesase, due
to an unrecognized lesion in the left lobe and due to encroachment on
the hepatic vein confluens.
In conclusion; MRI is more useful than CTAP in detecting, localizing
and characterizing lesions prior to liver resection.Fl16
SIMULTANEOUS COMBINEDPANCREASANDKIDNEY
ALLOTRANSPLANTATION INTHEPIG
P.G.SFIKAKIS P.J.TZARDIS, R.W.G.GRUESSNER, D.E.R. SUTHERLAND
1. Dept. of Surgery, University of Minnesota, Minneapolis Minnesota 55455, U.S.A.
2. Dept. of Surgery, Red Cross Hospital, Athens, Greece
We established a model of en bloc simultaneous pancreas and kidney
tranplantation that decreases preservation time, operation time and clamp
time. Our method was developed on 32 Yorkshire pigs with the following
technique The donor aorta with celiac axis, superior mesenteric artery
and left renal artery is anastomosed en bloc to the recipient’s aorta in a
side-to-oblique fashion. The portal vein is anastomosed end-to-side to the
distal vena cava, and the left renal vein end-to-side to the left common
iliac vein. The donor duodenum is anastomosed to the bladder to allow
monitoring of the urinary amylase for rejection.
The proposed technique facilitates the vascular reconstruction saving
one arterial anastomosis and additionally saves about 50rain of operating
and clamp time. None of our recipients has died from a technical
complication.
In conclusion, we believe that this technique could be used in humans,
especially in adult uremic diabetic patients who receive a combined
pancreas/kidney allotransplant from a pediatric cadaver donor.
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TIlEPATTERNOFPLASMA CHOLESTEROLESTERFATTY
ACIDS ISABNORMAL INOBSTRUCTIVEJAUNDICE
MW SCRIVEN JCM STEWART*, DF HORROBIN*,MCA PUNTIS
Dept Surgery, University Wales College Medicine, University Wales Hospital, Cardiff, UK
and *Efamol Research Institute, Kentville, Nova Scotia, Canada
We have investigated the effect of obstructive jaundice (OJ) on plasma
cholesterol ester (PCE) fatty acids (FA).
PCE FA were measured in 42 patients with OJ (mean age 65, 19F:
23M, mean bilirubin 247tmol/1, 12 benign 30 malignant) and 42
matched controls, by gas chromatography. The results were compared by
Mann-Whitney U tests.
Many FA were abnormal in OJ. Overall the mean number of double
bonds perFA was lower in the OJ group (p<0.001). This was a reflection
of a fall in total polyunsaturated FA (PUFA) (p<0.001) and a rise in total
monounsaturated FA (p<0.001). Total saturated FA were not different
between the two groups. The change in PUFA occurred in both the major
series ofPUFA- n-6 PUFA (p<0.001) and n-3 PUFA (p<0.002).
This study has demonstrated marked changes in FA esterified to
cholesterol in plasma in OJ. Such changes, in particular the shift towards
more saturated FA, are known to impair cholesterol transport. The
biological significance of these changes is unclear but they provide further
evidence of the profound metabolic effects of obstructive jaundice.
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SURGICALTREATMENT INHYDATICLIVERDISEASE
BERCEDO J, LOINAZ, C.JIMENEZ C, G-URENA M, PALMA F, ALVARADO A,
LOPEZ A, MORENOE.
The experience of surgical treatment in hydatidosisin our service is
analysed, studying the changes in our technique and results.
Since 1974-1989 410 patients with 561 cyysts were operated. We
divided the period of time in two groups: GROUP A since 1974 to 1984
(322 patients), and; GROUP B: since 1985-1989 (88 patients). We
compared both groups and the total resections techniques vs partial ones.
Both groups were homogeneous in age and sex.
The incisions made were: fight subcostal laparotomy (A--30.7%
B=43.7%); thoracophrenolaparotomy (A=25.8% B=5.7% p<0.001);
bilateral subcostal (A=12.7%) B=32.2% p<0.001) supraumbilical median
laparotomy (A=I6.5% B=4.6% p<0.05) supra and infraumbilical
(A=3.1% B=9.2% p<0.05). The surgical procedure was hepatic resection
(HR) (A=6.5% B=15% p<0.05); total cystopericystectomy (TQPQ)
(A=64.9% B=57.5%) partial cystectomy (PQ) (A=26.3% B=27.5%);
cysto-jejunostomy (A=2.1% B--0%). The total mortality was A=2.4%
B=2.1% Mortality, morbility and reoperations are shown in the Table.
The low morbi-mortality of resections techniques vs PQ is shown, so
that we think total resections must be used in the hydatid liver disease (if it
is possible).
MORTAL FISTULA ABCESS REOP. NUMBER
TQPQ 1.15% 3.08% 6.15% 3.08% 63.4%(260)
PQ 4.28% 17.0% 12.1% 8.5% 26.5%(109)
HR 2.9% 8.8% 8.2%(34)
p<0.05 between TQPQ vs QP; and between TQPQ andHR vs PQ
V001
REOPERATIONFORRECURRENTHEPATICHILUM
NEOPLASM
G.M. GAZZANIGA G.BONDANZA, M.FILAURO, C.BAGAROLO, F.ERMILI
st Department of Surgery S.Martino Hospital, Genoa Italy
The video shows the case of a 52 years old man, operated for klatskin
tumor in an other hospital one year before. He complaints episodes of
severe cholangitis, jaundice, pruritus, weight loss; pro-operative back up
showed dilatation of intrahepatic biliary tree, due to obstruction of the
previously confectioner hepatico-jejunostomy at the hilum. During
reoperation, a tumor recurrence on the anastomosis was found, with a
infiltration of externale layer of portal bifurcation. Hepatectomy was not
advisable for the presence of multiple, small abscesses in the fight lobe,
and for small size of left lobe. Resection of intrahepatic fight and left
hepatic ducts, distal part of Roux-en Y-jejunal loop (with the anastomosis)
was performed, in order to arrive in a free-of tumor biliary tract-resection
and reconstruction of portal bifurcation was performed with an extended
regional lymphadenectomy too. Biliary flow restoration was obteined with
a multiple cholangiojejunostomy between second oder biliary ducts on the
fight and left lobe, and Roux-en Y-jejunal loop; fibercolangioscopy was
performed in the post operative period (to check patency of anastomosis)
using transhepatic tracks created by tranparenchimal biliary stents
positioned during operations.
32